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Abstract 
Coxiella burnetii, the aetiological agent of Q fever, causes acute, chronic or 
asymptomatic disease in humans. Routine clinical diagnosis of acute and chronic Q fever 
primarily relies on serodiagnosis. Isolation of the organism is rarely attempted, as C. 
burnetii is known to be amongst the most infectious of bacteria. 
This thesis aims to define and characterise a relevant experimental model of Q fever and 
establish whether C. burnetii-specific antigens appear in the urine of experimental 
animals. It is further intended to characterise any antigens excreted and assess urinary 
antigen detection as a method for the laboratory diagnosis of Q fever. 
Experimental C. burnetii infection was established in the guinea pig using Lane strain (a 
previously uncharacterised British isolate from heart tissue of a patient suffering from Q 
fever endocarditis). The aerosol route of delivery resulted in a more severe disease 
compared to delivery by the intraperitoneal route and C burnetii organisms were shown 
to persist in heart tissues for at least thirteen weeks following aerosol infection. 
A capture ELISA assay was developed with a detection limit of 80 ng antigen ml*' 
(equating to approximately 800 organisms ml"). C. burnetii-specific antigens appeared in 
the urine of animals, infected by aerosol with approximately 1000 organisms and I-10 
organisms, at 1 and 10 days post-infection, respectively. During subsequent 
characterisation of the urinary antigens in severely diseased guinea pigs, viable C. 
burnetii organisms were detected and a C. burnetii-specific immunoreactive protein with 
an approximate molecular weight of 62 kDa was demonstrated. Evidence also suggested 
that LPS was present in the urine. 
The appearance of antigen in the urine was used as a marker of infection to assess the 
efficacy of doxycycline and ciprofloxacin in the treatment of experimental Q fever.. 
Preliminary studies supported other data (febrile response, serology and PCR) which 
suggested that doxycycline was more effective than ciprofloxacin in the treatment of acute 
experimental Q fever. 
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CHAPTER 1 
General Introduction to Q Fever and Coxiella burnetii 
1.1 Historical Background 
In August 1935, Dr. E. H. Derrick, director of the Laboratory of Microbiology and 
Pathology at Queensland Health Department in Australia, was asked to investigate 
an outbreak of undiagnosed febrile illness amongst abattoir workers in Brisbane. 
He discovered that guinea pigs when inoculated with either blood or urine from 
these patients became febrile, but was unable to make a diagnosis and therefore 
called the illness "Q (for Query) fever" (Derrick, 1937). Sir MacFarlane Burnet, a 
virologist and director of the Walter and Eliza Hall Institute, was then approached 
by Derrick in an attempt to identify and isolate the cause (Burnet & Freeman, 
1937). From a sample of infected liver sent to him by Derrick, Burnet was able to 
infect guinea pigs and mice and identify a "typical rickettsiae" which was unlike 
typhus, scrub typhus or spotted fever rickettsiae. 
At about the same time, an organism believed to be a rickettsia, and capable of 
passing through a bacteriological filter, had been isolated from the tick 
Dermacentor andersoni near Nine Mile Creek in Montana by Dr. Herald Cox and 
Dr. Gordan Davis at the Rocky Mountain Laboratory in Montana (Davis & Cox, 
1938). Following a visit to this laboratory in 1938 to review their findings, a Dr. 
1 
Rolla Dyer ( identified later as patient X) became ill with retroorbital pains, fever, 
chills and sweats; symptoms similar to those described by Derrick at the Brisbane 
outbreak. An organism was isolated from his blood by inoculation and passage in 
guinea pigs. After staining infected spleens from these animals and performing 
cross-immunity tests between isolate (X) from Dyer and murine typhus, epidemic 
typhus and Rocky Mountain Spotted Fever (RMSF) to exclude them as possible 
causes, the same organism was identified as that isolated from the ticks by Cox and 
Davis. 
Burnet subsequently sent Dyer spleen tissue from mice that had been 
experimentally infected with the original Q fever organism from the Brisbane 
outbreak and Dyer demonstrated that this organism was identical to those isolated 
from the ticks and his blood, and hence linked the Nine-Mile agent to Australian Q 
fever (Dyer, 1938). Cox named this organism Rickettsia diaporica, (Cox, 1939) to 
describe the rickettsial features of the organism with the ability to pass through 
bacteriological filters and Derrick named the organism Rickettsia burneti (Derrick, 
1939). 
The highly infectious nature of Rickettsia burneti gradually became evident during 
the 1940's as several outbreaks were identified at laboratories, meat packing 
premises and amongst troops based in Greece, Italy and Corsica. During the same 
decade sheep, goats and cows were identified as a reservoir for the organism and 
2 
raw milk was demonstrated as a potential source of infection (Huebner et al., 
1948). 
By 1948, it had become apparent that R. burneti possessed properties which made 
it distinct from other rickettsioses and it was eventually placed into a separate 
genus, called Coxiella with the single species burneti (Philip, 1948) 
1.2 The Organism 
C. burnetii is a obligate intracellular pleomorphic cocco-bacillus with a Gram- 
negative cell wall. It measures approximately 0.3 by 1.0µm and has a complex 
developmental cycle involving vegetative growth by binary fission and the 
production of endogenous-like spores by unequal cell division. Two distinct cell 
types have been identified: a large-cell variant and a small-cell variant. These two 
cell types are characterised by their ability to metabolise exogenously supplied 
substrates, the peptidoglycan content of their cell walls, size, and sensitivity to 
osmotic shock (McCaul, 1991). The developmental cycle begins by attachment of 
the small-cell variant to the host cell surface, then ingestion into the hosts' 
phagosome where fusion of the primary lysosome and the subsequent acid 
environment activates vegetative growth. At this stage, C. burnetii cells become 
larger and more elongated (large-cell variant) and are more susceptable to osmotic 
lysis and are capable of metabolising exogenous substrates. As infection of the cell 
progresses, asymmetrical division or sporogenesis of the cells begins to occur, 
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possibly as a result of exhaustion of available nutrients. Once released from the 
mother cell, continued development results in the original, resistant and 
metabolically inactive small-cell variant. The host cell eventually lyses and these 
small-cell variants of C. burnetii are released into the extracellular environment 
(McCaul, 1991). This cycle was confirmed by studies in vitro in the yolk sac of 
chick embryonated eggs and in cell culture and in vivo in the heart valves of 
endocarditic patients (McCaul et al., 1994). 
The formation of endogenous spores enables C. burnetit to be resistant to a range 
of stresses including acid pH and lysosomal enzymes within the eukaryotic cell, 
and dessication, UV-light and temperature in the external environment (McCaul et 
al., 1981). 
C. burnetii exhibits phase variation which was initially identified by 
immunological methods. Two different phases of the organism have been 
identified: phase I and phase II. The naturally occurring virulent phase I organism 
when passaged several times in embryonated chicken eggs gradually convert to the 
avirulent phase II organism. This process is thought to be mutational in origin and 
results in the loss of enzymes required for the synthesis of lipopolysaccharide 
(LPS) (Williams, J. C. & Waag, 1991) and although no morphological changes 
occur, differences have been demonstrated in the sugar content (Marcie, 1995). 
This phase change has been compared to the smooth-to-rough phase variations 
seen in members of the family Enterobacteriaceae. Organisms such as Escherichia 
4 
coli and Salmonella typhimurium exhibit phase variation and conversion from the 
smooth (virulent) form to the rough (avirulent ) form affects the amount and 
distribution of proteins in the outer membrane. Thus, major envelope proteins 
which are localised in the outer membrane are reduced by the mutational 
conversion from smooth to rough LPS. A similar finding was demonstrated in C. 
burnetii where the 125 I-labelling of surface proteins in the outer membrane was 
decreased in phase II organisms as compared to phase I organisms (Williams, J. C. 
& Waag, 1991). 
Other differences between the two phases include the differential uptake by 
phagocytes. Phase II organisms are taken up more readily than phase I organisms, 
and contain about one-tenth of the extractable amount of LPS than that found in 
phase I organisms. It is this fact which may explain the reduced rate of uptake of 
phase I organisms by phagocytes (Baca & Paretsky, 1983). 
1.3 Taxonomy 
C. burnetii is the sole species of its genus, and although significant differences 
between the various isolates are known, these are not sufficiently great to sub- 
divide these strains into more than one species (Mallavia et al., 1991). 
On the basis of 16S rRNA sequence data, C. burnetii falls into the gamma 
subdivision of the Proteobacteria (formerly known as purple bacteria), which are 
5 
distantly related to Legionella. Other bacteria in this subdivision include 
Chromatium vinosum, Escherichia coli, Legionella pneumophila, and 
Pseudomonas aeruginosa. The only other rickettsia placed in the gamma 
subdivision is Wolbachia persica. Like C. burnetii, W. persica was first isolated in 
chicken embryos from a tick, Argaspersicus. Both C. burnetii and W. persica grow 
within the phagolysosome of an infected host cell and each has an ecological niche 
as an intracellular parasite. Unlike C. burnetii however, growth of W. persica has 
only been accomplished in yolk sacs of fertile hens eggs, cell culture and 
arthropods but not in vertebrates (Weiss et al, 1991). 
Other rickettsia such as Rickettsia prowazekil, Rickettsia typhi and Rickettsia 
rickettsii fall into the alpha subdivision of the proteobacteria and show very close 
sequence homology and evolutionary distance between each other (Weisburg et al., 
1989). 
Apart from sharing the same phylum in the classification system, there are other 
similarities which are shared by Legionella species and C. burnetii. Both organisms 
are intracellular parasites, Legionella being facultative and Coxiella being obligate. 
Both have adapted, however, to a site specific microenvironment within the 
interior of eukaryotic cells. Legionella, in order to survive intracellularly inhibit 
phagosome-tysosome fusion (Horwitz & Maxfield, 1984), whereas Coxiella has 
adapted to the acid and lysosomal enzymes within the phagolysosome to survive 
(Moulder, 1985). 
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C. burnetii exhibits phase variation (see section 2.2) where phase II organisms are 
laboratory-derived and avirulent. A similar loss of virulence can be detected in 
Legionella after continued passage on buffered charcoal yeast extract media, or 
single passage on Mueller-Hinton media (Jepras et al., 1985). 
Legionella infection can present in two forms: Pontiac fever, a self-limiting disease 
which is usually less severe, and acute disease which presents as a pneumonia, and 
which is more severe and can result in death. C. burnetii displays similar variation 
in pathogenesis with disease ranging from acute self-limiting infection to chronic 
disease resulting in endocarditis, hepatitis and often death (Marrie, 1990a). 
Structurally, Coxiella and Legionella both contain lipopolysaccharide (LPS), 
phospholipid and protein as major constituents in their cell walls, and each have 
very similar fatty acid profiles (Tzianabos, 1981). 
1.4 The Disease in Animals 
C. burnetii is a zoonotic infection and affects a wide variety of animals. This 
represents the transmission of the organism within the environment, from tick- 
borne transmission to wildlife such as rodents and birds, to the aerosol transmission 
more commonly associated with livestock such as sheep, cows and goats. The 
transmission of Q fever to humans is primarily from infected livestock. Evidence 
for this is provided by the high incidence of Q fever among abattoir workers, 
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farmers and veterinarians and the correlation between increasing dairy herd 
infection rates and human Q fever statistics in a number of countries (Marrie, 
1990b). In addition, sporadic outbreaks of Q fever have occured as a result of 
indirect exposure to contaminated straw, manure and dust from farm vehicles 
(Salmon et al., 1982) and a number of studies have implicted residency in a dairy 
area as a risk factor for Q fever (Huebner and Bell, 1951). 
Coxiella infection in animals rarely produces illness but results in various 
responses to the organism. In sheep, organisms concentrate in the placentas and 
can be responsible for abortions and consequent spread of C. burnetil by aerosol 
transmission from parturient material. Some evidence suggests that Coxiella 
infection in sheep is transient (Abinanti et al., 1953; Williams, J. C., 1991). 
Infected sheep, two months after lambing, placed with healthy animals for five 
months were found no longer infectious After the second lambing, no C. burnetii 
were isolated from their blood, placenta or body secretions (Lang, 1990). Other 
studies which have concentrated on the measurement of the humoral antibody 
response by complement fixation (CF) in sheep demonstrated a steady decline in 
titre over twenty weeks until all animals tested negative (Lang, 1990). 
In cows and goats, infection by C. burnetii has increased over recent years 
(Williams, J. C., 1991). Unlike the transient infection in sheep, evidence suggests 
that C burnetii infection in cows and goats is passed from generation to generation 
creating a reservoir for the organism. 
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In goats, Coxiella has been isolated from the mammary gland, spleen, kidney, 
uterus, liver, lung and heart and also from whey indicating that goats shed this 
organism. Observations from America indicated that naturally-infected and 
experimentally-infected cows were asymptomatic during C. burnetii infection. 
Evidence from France, Switzerland, and Germany demonstrated that cows infected 
with C. burnetii have higher rates of abortion, excretion of the organism in milk 
and weak off-spring (Lang, 1990). 
The disease has been documented in a large number of animal species including 
cats and dogs and wildlife as well as livestock. In all these animals, however, 
coxiellosis is usually asymptomatic (Williams, J. C., 1991). 
1.5 The Disease in humans and treatment 
The development of a specific immune response follows vaccine administration or 
infection by C. burnetil in both humans and guinea pigs (Williams et al., 1986a, 
Williams J. C. and Waag D. M., 1991). A specific humoral immune response can 
act in a number of ways to aid inactivation and clearance of an invading 
microorganism. Secretory IgA can interfere with the adherence of the 
microorganism to mucosal surfaces. This however, has not been investigated in Q 
fever infections. Serum IgG, IgM and IgA can act as neutralising antibodies, 
however this mechanism is ineffective in C. burnetii infections. Opsonisation, 
9 
where specific immunoglobulin G, M and complement bind to the surface of a 
microorganism, may enhance C. burnetil infection by facilitating uptake within 
phagocytes where replication within the phagolysosome and subsequent 
dissemination throughout the host can occur. The presence of immune antibody 
however, as well as facilitating uptake of C. burnetii by macrophages also 
accelerates the appearance of a cellular immune response. 
The stimulation of cell-mediated immunity in humans is known to be the primary 
method of resistance to infection by C. burnetii. C. burnetii-infected euthymic 
mice were able to clear organisms from peripheral blood and spleen, fourteen days 
post-infection. In contrast, C. burnetii could be detected in the spleen of athymic 
(nude) mice for sixty days post-infection, even though both types of animals 
produced similar levels of antibody (Hall et al., 1981). 
The primary characteristic of cell mediated immunity against C. burnetfi in both 
guinea pigs and humans is the stimulation of differentiation and proliferation of 
lymphocytes leading to the appearance of bactericidal macrophages. Such activated 
macrophages present a more inhospitable intracellular environment for C. burnetii 
growth and hence infection can be controlled (Kishimoto, R. A. and Burger, G. T., 
1977 and Williams J. C. and Waag D. M., 1991). 
In humans, Q fever can be separated into three broad categories: the 
asymptomatic, the acute and the chronic (Baca & Paretsky, 1983). Of those 
individuals exposed to C. burnetii during an outbreak and on whom serological 
tests were performed, approximately 50% did not develop any clinical symptoms. 
Those individuals that do show clinical symptoms usually have an incubation 
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period of two to six weeks following exposure. The typical symptoms include an 
acute onset of high fever, chills with rigours, severe headache, retroorbital pain 
and general malaise. Some patients also suffer from vomiting, chest pain, diarrhea 
and coughing. The most consistent symptoms are high fever, usually greater than 
38.5°C , hepatomegaly and splenomegaly 
(Meiklejohn et al., 1981).. Unlike other 
rickettsial diseases, no rash is usually observed in C. burnetii infections. 
Acute Q fever is usually described as an atypical pneumonia, although pneumonia 
is rarely seen in countries where Q fever is endemic. In other countries, however, 
pneumonia is the primary symptom. This discrepancy may be as a result of 
variation in host response, organism variation or differences in the route of 
exposure (Marcie, 1995). 
Hepatitis, another symptom of acute Q fever, demonstrates varying rates of 
prevalence throughout the world, from 10% to 65% of cases (Reimer, 1993). The 
majority of cases of acute Q fever however, are self -limiting with symptoms 
resolving in 1 to 2 weeks. Approximately 1% of those individuals that are infected 
may not clear the organism entirely and can ultimately go on to develop chronic Q 
fever. 
Chronic Q fever can present with a number of clinical manifestations but the most 
serious result of infection is endocarditis. It has been suggested that specific strains 
such as the Priscilla strain, originally isolated from a placenta of a goat, are 
responsible for chronic Q fever and other strains such as the Nine Mile strain 
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originally from ticks cause acute Q fever. Alternative theories propose that chronic 
Q fever results from an earlier asymptomatic infection or result from 
immunosuppression or pre-existing valvular damage (Williams, J. C., 1991). 
Cases of Q fever endocarditis are prevalent in countries where acute Q fever is well 
known. However, the proportion of patients who suffer from Q fever endocarditis, 
out of the total number of Q fever cases reported, shows substantial country-to- 
country variation and may be due to the variation in diagnostic services available. 
Of those patients diagnosed as suffering from Q fever endocarditis, the majority 
reported pre-existing valvular abnormalities (Raoult et al., 1990a). In the U. K., Q 
fever is estimated to be responsible for approximately 1-2% of all cases of 
endocarditis. 
Treatment of acute Q fever is usually successful and a number of antibiotics 
including lincomycin, erythromycin, chloramphenicol and several tetracyclines 
(Yeaman & Baca, 1990). Treatment of chronic Q fever however, is less successful 
with the most serious complication being endocarditis (Yeaman & Baca, 1990). 
Replacement of infected valves is often undertaken; however, replacement valves 
are often found to be re-colonised by C. burnetii at a later date. Re-infection is 
probably from organisms from an extracardiac site such as the liver or may be 
reactivation of organisms residing in the heart tissue itself. Antibiotic treatment of 
endocarditis with tetracyclines, the drug of choice, has been reported as being 
bacteriostatic rather than bacteriocidal and treatment must be prolonged. C. 
burneiii has been isolated from cardiac valves following prolonged treatment with 
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tetracycline and penicillin (Yeaman & Baca, 1990). The majority of patients 
suffering from Q fever endocarditis die from primary endocarditis, relapse or 
reinfection or heart failure resulting from persistent C. burnetii infection. 
Therefore, prognosis for a chronic Q fever patient is poor. 
The differential response to treatment of patients with acute or chronic Q fever 
strengthens the argument that different strains may be responsible for each. The 
early diagnosis of C. burnetii infection may therefore help the efficient 
management of the disease (Fournier et al., 1998). 
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1.6 Epidemiology of Q fever 
Between 100 and 200 cases of human Q fever are encountered annually in the UK 
(Aitken, I. D., 1987). The majority are sporadic but occasionally large outbreaks 
occur. Such outbreaks in the UK are shown in table 1.1. 
Table 1.1 Outbreaks of Q fever in the United Kingdom 
Solihull 1 147 1 Smith, G., 1989 
Oxfordshire 1 25 1 Winner, S. J. et al. 1987 
Gwent, South Wales 1 29 1 Salmon, M. M. et al., 1981 
Staffordshire I No information I Brown, G. L. et al., 1968 
C. burneiii persists and is transmitted within the environment by a number of 
routes. These are summarised in Fig 1.1. The primary reservoir for transmission to 
man is by aerosol from domestic animals such as sheep, goats and cows and 
especially from parturient products. The placenta of infected ewes can contain up 
to 1012 organisms per gram, with the blood, urine and amniotic fluid also heavily 
contaminated (Marrie, 1990b). Q fever can survive in aerosols for long periods of 
time and is very resistant to dessication and UV radiation (Williams, J. C., 1991). 
During air-sampling experiments, C. burnetii was detected long distances from 
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parturient ewes and has been shown to have a very low infective dose (one 
organism can initiate infection) (Tigertt et al., 1961). 
In scientific institutions where sheep have been used for research purposes, 
employees became infected from using a lift that transported infected sheep. In 
addition, a number of cases of Q fever were reported along the route taken to 
transport the sheep to the laboratory (Meiklejohn et at., 1981; Hall, C. J. et al., 
1982) and (Curet & Paust, 1972). 
The ingestion of raw milk or unpasteurised goats cheese has also been shown to 
result in seroconversion but not infection. This was demonstrated in a number of 
trials where human volunteers drank C. burnetii infected milk and a small 
percentage of them developed specific antibodies (Editorial, 1950). 
The other pathways of transmission of C. burnetfi are less important in the 
transmission to man; however, they play an important role in the perpetuation of 
C. burnetii in the environment. Infected ticks can spread the organism via 
percutaneous transmission to domestic animals and wildlife such as deer and 
rodents, while infected tick faeces may be aerosolised presenting an additional 
method of transmission (Marcie, 1990b). 
C. burnetii has been isolated or identified by seroconversion in man and livestock 
in most parts of the world. The rate of human cases of Q fever is not consistent in 
some parts of the world with the rate of infection in animals in these parts. A 
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possible explanation for this could be strain variation resulting in less infective 
variants, or the organisms are transmitted more easily from some animal vectors 
than others. 
Fig. 1.1 Epidemiology of Q fever 
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1.7 Clinical diagnosis of C. burnetil infection 
Diagnosis of C. burnetfi is based on serology by either immunofluorescence (IFA), 
ELISA or microagglutination techniques. Antibodies to phase II antigens are 
detected during the acute phase of infection, followed by a rise in antibody titre to 
phase I antigens. Immunoglobulin levels can persist for many years, whilst the 
presence of specific IgM may indicate a recent or an active infection. Elevated 
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levels of both IgG and serum IgA to phase I antigens are indicative of Q fever 
endocarditis and that high titres of IgG and IgA to phase I and II antigens are 
highly suggestive of a chronic infection (Peacock et al., 1983). The ratio of phase I 
to phase II IgG antibodies is therefore characteristic of the type of infection. Hence, 
a ratio of phase I: phase II IgG antibodies of <1 is indicative of acute infection, a 
ratio of phase I: phase II IgG antibodies of >1 suggests the infection is chronic. 
Occasionally guinea pig inoculation is used to confirm C. burnetii-induced 
endocarditis. Macerated heart valves are injected intraperitoneally into guinea pigs, 
and sera tested by ELISA for phase II specific antibodies three weeks later 
(Williams, J. C. et al., 1986a; Fournier et al., 1998). Embryonated eggs and tissue 
culture, using shell vials, with subsequent confirmation by IFA, have also been 
described for the isolation of C. burnetti from clinical samples. Such methods, 
however, may isolate the more virulent or aggressive strains and select against the 
less virulent strains (Waag et al., 1991). 
The direct detection of C. burnetii is hazardous, requiring specialised containment 
facilities and trained personel, consequently this is rarely attempted in the clinical 
diagnostic laboratory. More recently, polymerase chain reaction (PCR) techniques 
have been applied to the laboratory diagnosis of suspected C. burnetii cases (Stein 
& Raoult, 1992; Willems et al., 1993). This technique has proven to be more 
sensitive than standard culture techniques and can be performed on a wide range of 
clinical samples including blood, cardiac valve biopsy and liver biopsy. In 
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addition, milk, placental tissue and aborted specimens from animals have been 
tested and proven to be positive for the presence of C. burnedi DNA (Fournier et 
a!., 1998). 
1.8 Aim of this study 
This study aimed to define and characterise a relevant experimental model of Q 
fever and establish whether C. burnetii-specific antigens were present in the urine 
of experimental animals. It was further intended to characterise any urinary 
antigens excreted and determine whether the detection of C. burnetii-specific 
antigens in the urine, could provide an additional or alternative method of 
diagnosis and assessment of cases of Q fever. 
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CHAPTER 2 
Development of an Animal Model of C. burnetii Infection 
2.1 Introduction 
Animal models are usually divided into two groups: screening and discriminative 
(Wilson & Raynor, 1993). Screening models are usually used for testing 
antibiotics, where large numbers of animals are involved for statistical analysis and 
the similarity between the infection profile and clinical situation plays a secondary 
role. Discriminative models are more relevant to the human disease, where route of 
infection, symptoms, pathology and state of immunocompetence are similar. 
The present study required a discriminative model, where disease progression and 
pathology was similar to the disease in humans, to provide relevant urine samples 
to study the excretion of specific antigens in urine. 
Previous work, using urine from guinea pigs experimentally infected with 
Legionnaires' disease demonstrated the usefulness of an animal model that 
accurately modelled the human disease (Williams and Featherstone, 1988). Such a 
model enabled the strain and infective dose to be controlled and urine and tissue 
samples could be obtained at known times post-infection. The use of urine from 
clinical cases of Q fever provide no information on the initial infective dose 
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received or the infective strain. In addition, no longitudinal study involving tissues 
and serum for pathological and serological analysis could be achieved. 
The guinea pig is highly susceptible to infection with C. burnetii however to date, 
no animal model has been described that accurately reflects the chronic disease 
seen in humans. This highlights one of the limitations in the use of animal models 
for the study of C. burnetii infection. The guinea pig in particular has limited use 
for the study of detailed cellular immune responses as few reagents are available. It 
has been suggested that the the relative ratio of IgG subclasses may play an 
important role in the progression of an acute disease to the chronic form in hmans 
(Camacho, et al. 1995) however such distinctions are limited in guinea pigs. 
2.1.1 Experimental infection in the guinea pig. 
The first published account describing the identification of C. burnetii involved its 
isolation in guinea pigs infected with blood and urine obtained from clinical cases 
of Q fever (Derrick, 1937). Specific C. burnetil phase II antibodies appeared two to 
three weeks post infection confirming the diagnosis of Q fever. 
A number of experimental animals have been described which proved to be 
susceptible to C. burnetii. Each show a characteristic pathology, aetiology and 
virulence. 
C. burnetli infection of guinea pigs by the intraperitoneal route produces pyrexia 
of 400 C or greater from 5 to 12 days post infection (Lang, 1990). The incubation 
time has been shown to be dependant on the virulence of the organism, the dose 
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received and route administered. The average incubation time was eight days, for 
guinea pigs injected intraperitoneally with one organism, compared to eleven days 
for those animals administered one organism by the respiratory route. The dose-to- 
incubation relationship, based on febrile response, observed in guinea pigs is 
similar to that observed in humans when C. burnetii was given by the respiratory 
route (Williams, J. C. & Thompson, 1991). 
Various methods' have been adopted for the measurement of the humoral immune 
response to experimental infection of guinea pigs with phase I C. burnetfi by either 
the intraperitoneal or respiratory route of infection. Earlier methods included 
microagglutination (Johnson et al., 1976; Urvolgyi & Brezina, 1978; Williams, J. 
C. et al., 1986a) and complement fixation (Kazan et al., 1977; Urvolgyi & Brezina, 
1978; Williams, J. C. et al., 1986a). More recently, immunofluorescence and 
ELISA have been utilised for the determination of antibody response to infection 
in guinea pigs (Williams, J. C. et at., 1986a). Using the above procedures, a trend 
in the time of onset of the humoral immune response has been reported, but the 
appearance of antibodies has been variable and dependant on the sensitivity of the 
test used. 
Following intraperitoneal inoculation with C. burnetii phase I whole cells, 
antibodies directed against phase II antigens appear first, at approximately day 6 
post-infection, when tested by ELISA, and day 8 post-infection by other standard 
tests i. e. immunofluorescence (IFA), microaglutination assay (MAA) and 
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complement fixation (CF) (Williams, J. C. et al., 1986b). Antibodies to phase I 
antigens appear by day 8 post-infection by ELISA, following intraperitoneal 
injection of virulent Nine Mile organisms (Williams, J. C. et al., 1986b). However, 
when the less virulent M-44 strain of organism was injected, no antibodies were 
detected against phase I antigens until 14 weeks post-infection (Johnson et al., 
1977). 
Following infection with C. burnetii phase I, certain pathological changes take 
place in the guinea pig. (Kishimoto & Burger, 1977) reported interstitial 
pneumonia at 5 days post-infection after aerosol challenge with Henzerling strain, 
which became pronounced and was characterised by extensive exudation of fibrin, 
neutrophils, macrophages and lymphocytes by 9 -11 days post-infection. Liver and 
spleen granulomas were present by day 9 post-infection persisting in the spleen 
until day 20 post-infection and in the liver until day 29 post-infection. Limited 
lymphoreticular myocarditis and epicarditis were reported by day 9 post-infection. 
Following intraperitoneal challenge with the less virulent M-44 strain, pathology 
in the guinea pigs resembled that seen with Henzerling infection; however, the 
severity of the lesions were less and splenitis was less severe. Myocarditis was 
reported in approximately one third of the infected animals, which had resolved 
after day 15 post-infection (Johnson et al., 1977). 
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C. burnetil is not completely cleared in the guinea pig and disease can be 
reactivated by pregnancy, or reduction of immunity by chemicals such as 
cylcophosphamide or methyl prednisolone to cause further acute infection 
(Johnson et al., 1977). The guinea pig displays characteristics therefore, of an 
overt acute disease following either intraperitoneal or aerosol challenge with 
C. burnetii phase I. 
2.1.2 Other experimental infection models 
Infection of mice with C. burnetii phase I produces a specific inflammatory and 
humoral response but with varying morbidity and mortality. A study conducted by 
(Scott et al., 1987) showed that of 47 inbred strains of mice, 33 were resistant (no 
morbidity or mortality), 10 showed intermediate sensitivity and 4 were sensitive. It 
was found that 1000-fold fewer organisms were required to produce an LD50 in 
susceptible mice compared to resistant mouse strains. 
An asymptomatic infection model in mice has been described, where the infection 
process is characterised by long-lasting multiplication of C. burnetii at specific 
sites but without apparent systemic or metabolic changes taking place. Changes 
such as anorexia, pyrexia, hypoglycemia, lipidosis of hepatocytes and loss of 
glycogen are common to Coxiella infection in the guinea pig but do not occur in 
mice. The relatively slow multiplication rate of C. burnetii in mice may be due, 
in part, to cell-mediated immunity, and also to the relative tolerance of mice to the 
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toxic effects of C. burnetii LPS. The relative tolerance or resistance to C. burnetli 
infection in mice is genetically linked. Sensitive A/J mice died even though they 
were able to mount an humoral immune response to C. burnetii but only a limited 
cellular immune response. Resistant C57BL/6J or C3H/HeN mice, however, 
showed no overt signs of disease, but did show significant tissue lesions as well as 
humoral and cellular immune responses (Williams, J. C., 1991) and (Williams, J. 
C. & Cantrell, 1981). The inability of A/J mice to mount an effective cell-mediated 
immune response correlated with a decrease in the number of lesions, and 
consequently death. 
High numbers of live or dead C. burnetii organisms or their LPS are required to 
kill mice. Splenomegaly has been observed in mice either vaccinated or infected 
with C. burnetii. Splenomegaly is a dose-dependant response and the proliferation 
of B-cells is correlated directly to the proliferation of C. burnetii within the spleen 
cells. Splenamegaly has therefore been used, to evaluate the initial infective dose 
in some studies (Khavkin, 1990). 
Immunocompromised balb/cJ (H-2 d) mice infected intraperitoneally with Nine 
Mile C. burnetii phase I were shown, at ten days post infection, to have 
C. burnetii-induced valvular endocarditis as a result of disseminated C. burnetii 
infection. At 150 days post infection, all cardiac valves were shown by 
immunocytochemistry to be clear of antigen. This work suggested that using an 
acute disease-causing strain, valvular endocarditis could only be demonstrated 
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immediately after infection and only as part of a disseminated infection (Atzpodien 
et al., 1994). 
Euthymic (normal) mice demonstrated clearance and reduction in the number and 
size of lesions in the spleen, liver and lung two weeks after aerosol infection, 
compared to athymic (nude) animals. This suggested that clearance of organisms 
was dependant, at least in part, on thymus-derived lymphocytes (Hall, W. C. et 
al., 1981). 
Cynomolgus monkeys proved highly, susceptible when exposed to 105 mouse 
median infectious intraperitoneal doses (MIPID50) of C. burnetii phase I 
Henzerling strain given as a small particle aerosol (Gonder et al., 1979). Signs of 
illness and pathological changes, such as pneumonia and detectable antibodies to 
C. burnetii, were demonstrated at day 9 and 7, respectively. Organisms were 
demonstrated by IFA in lungs, liver, spleen, testes, kidney and heart by day 14 
post-infection. Animals exposed to a lower infectious dose of C burnetii (103 
MIPID50) showed no clinical evidence of infection and no organisms were isolated 
from peripheral blood; however specific antibodies were detected by IFA on day 
21 post-infection. 
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2.1.3 Aim of this chapter 
The object of this study was to establish a discriminative experimental infection of 
C. burnetfi in guinea pigs, using a previously uncharacterised British isolate 
(Lane) delivered via the aerosol route. The airborne route of infection will be 
compared to the intraperitoneal route of infection in terms of the clinical 
symptoms, serology and histology, and the resulting disease profile of this strain 
of C. burnetii will be characterised. 
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2.2 Materials and methods 
2.2.1 Isolation of C. burnetii 
C. burnetil Lane strain, originated from a patient suffering from endocarditis with 
high IgG and IgA anti-C. burnetii whole cell phase I antibody titres. Isolation of C. 
burnetii Lane strain was performed by Dr. David Rutter. Fragments of aortic valve 
(received at CAMR) were homogenised in 20 ml PBS and allowed to settle. The 
upper 10 ml of the suspension was collected and 2.5 ml injected intraperitoneally 
into each of four Dunkin Hartley guinea pigs. Seroconversion confirmed the 
presence of C. burnetii, three weeks post-inoculation. 
Twenty, 6-day old embryonated eggs were inoculated via the air sac, with the 
remaining heart valve suspension, which had been made up to 20 ml with PBS. 
Each yolk sac received 0.5 ml of suspension. All eggs were candled daily. After 14 
days, or when 50% of the previous days eggs were dead, yolk sacs were harvested 
(5 yolk sacs into 5ml saline) and homogenised in 70 ml PBS for 1 minute. Two 
further passages in embryonated hens eggs were performed. Each yolk sac was 
inoculated with 0.1 ml of the first egg passage, diluted 0.2 ml in 5m1 PBS. When 
50% of the previous days eggs had died, the remaining eggs were harvested (as 
above). 
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2.2.2 C. burnetii whole cell antigen preparation 
Approximately 70 ml of homogenate was produced, of which 20 ml was added to 
100 ml of 1% formal-saline. The suspension was stored for at least one week to 
inactivate the Coxiellae then centrifuged at 6,000g for one hour and resuspended in 
1% formal-saline and homogenised for 2 minutes. An equal volume of ether was 
added to the suspension, shaken and left to separate overnight at 40C. The aqueous 
layer was removed and re-extracted with ether until a clear interface between ether 
and aqueous layer was achieved. Residual ether was removed by evaporation and 
the suspension washed and resuspended in PBS with 0.08% sodium azide to 1/10 
of the original volume. The final suspension was examined for purity by 
transmission electron microscopy. A non formalised suspension of C. burnetii 
(Lane strain), phase I organisms was used for all animal experiments. 
2.2.3 Phase conversion 
Conversion from phase I organisms to phase II organisms involved treatment with 
potassium iodide based on the methods of (Fiset et al., 1969) and (Schramek et al., 
1972). Briefly, a purified inactivated suspension of phase I organisms at a final 
concentration of 1mg/ml was treated with 0.01M potassium iodide for 4 hours at 
45°C. The reaction was stopped by addition of a 1/10 volume of 10% glucose. 
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Antigen was washed twice by centrifugation at 11,000 rpm in PBS pH 7.2 and 
resuspended to the original volume in peptone water, prior to dilution to Img/ml. 
2.2.4 Enumeration of C. burnetii 
A total count was performed on purified antigen preparation by phase contrast 
microscopy. Organisms treated with formalin were diluted 1: 2 in water and placed 
onto a Helber counting chamber. Using a 40 x objective lens, the number of 
organisms per graticule square were counted and 20 squares in total were counted. 
Applying the formula: 
Number of organisms m1'' = 2n x107 x dilution 
where n= average number of organisms per square (20 squares counted) 
and dilution = the original dilution of antigen preparation prior to count. 
An approximate count of the number of organisms present in the original egg 
preparation was calculated, allowing for the dilution factors during preparation. 
2.2.5 Safety and containment 
The guidelines for working with hazard group 3 pathogens, recommended by the 
Health and Safety Executive, were adhered to throughout all procedures involving 
manipulation of live C. burnetü (Advisory Committee on Dangerous Pathogens, 
1995) . Namely, class III safety cabinets within a containment level III laboratory 
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facility, for all laboratory procedures. Animal studies in conjunction with C. 
burnetii were undertaken within a ACDP category III animal containment facility, 
which included a complete change of clothes into disposable garments, use of 
personal respiratory protection and showering out on exiting from the room. 
Additional safety precautions undertaken, whilst infectious aerosols of C. burnetii 
were generated and delivered to animals included the complete containment of the 
Henderson apparatus (see Section 2.2.6) and the use of a downdraught post- 
mortem table on which the animals were placed for infection. 
2.2.6 Aerosol generation and respiratory infection 
Home Office Ethics Committee approval for animal experimentation was obtained. 
Female Dunkin-Hartley guinea pigs (barrier reared) weighing 300-400g were 
exposed to bacterial aerosols containing particles S Sµm in diameter, generated 
using a three jet Collison spray at 65% relative humidity in a Henderson-type 
apparatus (Henderson, 1952; Druett, 1969). Calculated inhaled and retained doses 
were based on previous findings with a variety of bacterial species (Fitzgeorge et 
al., 1983; Lever et al., 1995; Williams, A. & Lever, 1995; Cooper et al., 1996; 
McBride et al., 1998) and (Bracegirdle et al., 1994). Initial spray suspensions 
contained approximately 109 organisms/ml (high dose) and 106 organisms/ml 
(low dose). Guinea pigs were allowed to breath the aerosol for 5 minutes. Twelve 
animals were administered high dose and twenty animals administered a low dose 
of C. burnetii by aerosol. Rectal temperatures and weights were recorded daily. 
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Serum samples were obtained by cardiac puncture whilst the animals were under 
C02, and urine obtained by manual expression of the bladder. Tissue samples for 
histology were taken on day nine, of animals administered a high dose of C. 
burnetii, by aerosol (group 1) i. e. when animals were moribund. Guinea pigs that 
received a low dose of C. burnetii by aerosol (group 3) were killed when moribund 
or at day 92 post-infection. 
2.2.7 Intraperitoneal infection 
Eighteen guinea pigs were inoculated intraperitoneally with 0.1ml suspension 
containing approximately 109 organisms/ml (high dose, group 2). Six guinea pigs 
were inoculated with O. lml of a suspension containing approximately 106 
organisms/ml (low dose, group 4). Animals administered a high dose of C. burnetii 
were killed at 28 days post-infection and those adminstered a low dose; 92 days 
post-infection. Tissue samples for histology were taken approximately every four- 
seven days, from animals administered a high dose of C. burnetli. Tissue samples 
from guinea pigs that received a low dose of C burnetii were taken at post mortem 
(day 92 post-infection). 
2.2.8 Urine samples 
Urine was obtained from infected guinea pigs by manual expression of the bladder. 
Samples were taken every other day until day nine and twenty eight post-infection 
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from guinea pigs administered high dose C. burnetii by aerosol (group 1) and 
intraperitoneally (group 2) respectively. Urine samples were removed from guinea 
pigs in the low dose groups (groups 3 and 4) approximately weekly up to 50 days 
post infection. Urine from four animals was removed each day and pooled. 
2.2.9 Polyclonal antisera preparation 
Antiserum to C. burnetif was obtained by immunising three New Zealand White 
rabbits with whole inactivated C. burnetil phase II Lane strain. After a preliminary 
blood sample had been taken, each rabbit was injected with 500 µI of antigen 
(approximately 1,0 x 108 organisms/ml) in incomplete Freund's adjuvant (Difco). 
Immunisation was distributed between two intramuscular (hind legs, 2x 200 µl) 
and two dorsal subcutaneous (2 x 50 µl) sites. A boost was given with the same 
dose after two weeks and blood was taken after a further two weeks and assayed by 
direct ELISA. A further boost was administered after 10 weeks. Two weeks 
following this, the rabbits were exsanguinated under pentobarbitone anaesthesia. 
Sera with the highest titre was chosen and the immunoglobulin G (IgG) fraction 
obtained by Protein G affinity chromatography (Pharmacia) following 
manufacturers instructions. Briefly, the column was ' equilibriated with 20 mM 
phosphate buffer (pH 7.0) and 200 µl samples of sera in the same buffer were 
injected onto the column. Separation took place at a flow rate of 1.0 ml min 1 and 
the eluting buffer was 0.1 M glycine pH 2.7. Samples were collected in 1 ml 
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fractions with 50µl addition of 1M tris buffer pH 9.0 to neutralise the low pH 
conditions created by the elution buffer. Eluted fractions were tested for anti-C. 
burnetii phase I, II and LPS I IgG antibodies by indirect ELISA (see Section 
2.2.10). 
2.2.10 Indirect ELISA 
The method of (Cowley et al., 1992) was used. Sterile 96-well microtiter plates 
(Pro-bind; Falcon ) were coated with 0.1 ml of antigen suspension (C. burnetii 
whole cell, phase I or phase II) at 1/800 and 1/2000 respectively in coating buffer 
(0.04M sodium carbonate, 0.06M sodium bicarbonate in sterile distilled water, pH 
9.6). Plates were then incubated shaking for 1 hour at 37°C, and washed three 
times (Wellwash 4; Denley ) with 0.3 ml volumes of PBS (pH 7.2) containing 
0.1% (vol/vol) Tween 20 (PBST ). Guinea pig test serum was added at 1/100 
diluted in PBST +10% horse serum (HS) and double diluted out. A guinea pig 
positive and negative control serum was included as well as a blank control 
(PBST). Plates were incubated, shaking, for 30 minutes at 370 C, then washed 
three times as before and 0.1 ml anti-guinea pig IgG-HRP (1/2000) (Nordic) 
added. 
The presence of specific IgM was assayed as described above, with the exception 
that each serum sample was pretreated with goat anti-guinea pig IgG (Sigma) at 
1/2000 dilution in (PBST) to remove any possible interference from rheumatoid 
33 
factor. Anti-guinea pig IgM-HRP (1/2000) (Nordic) was then added. Plates were 
incubated for 30 minutes at 370C shaking and washed three times in PBST before 
addition of 10011 of TMB substrate, consisting of one TMB tablet (Sigma) 
dissolved in 10ml of citrate buffer (Sigma), and left for 15 minutes to develop. The 
reaction was stopped by the addition of 25µ1 2M sulphuric acid and the OD read 
immediately at 450 nm. 
For the assay of specific IgA in infected guinea pig serum, the above method was 
employed except guinea pig test sera was initially diluted 1/20 in PBST+ 10% HS 
and then double diluted out. A sheep anti-guinea pig IgA antibody (Nordic) was 
then used at 1/2000, incubated for 30 minutes shaking and rabbit anti-sheep IgG (H 
and L) peroxidase conjugate (Nordic) at 1/2000 added and incubated as detailed 
above. The substrate step was as above. 
2.2.11 DNA extraction from C. burnetii-infected guinea pig tissue 
DNA was purified from tissues using the QlAamp tissue kit (Qiagen Ltd, Crawley) 
following manufacterers instructions. Approximately, 25 mg of tissue was cut into 
small pieces and added to a microfuge tubes (1.5m1) containing 180 µl of tissue 
lysis buffer (guanidium thiocyanate based). Proteinase K was added (20 µl) and the 
suspension vortexed and incubated at 55 °C until completely lysed. Lysis buffer 
was then added (200 µl) and sample was vortexed and incubated at 70 °C for 10 
minutes. Ethanol (210 µl) was added and the sample mixed by vortexing. The 
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mixture was then applied to a QIAamp spin column and centrifuged at 6000 xg for 
1 minute and filtrate was discarded. The spin column was then washed twice with 
wash buffer (500 µl) by centrifugation as above and filtrate again discarded. DNA 
was then eluted from the spin column by addition of 200 µl of distilled water 
heated to 70 °C followed by centrifugation as above. 
2.2.12 PCR analysis of C. burnetii-infected samples 
Primers were designed to target a 495 bp DNA sequence within the superoxide 
dismutase gene sequence published by (Heinzen et al., 1990). The primers were, 
Cox 3 [5'-GAATTACCGGATT'TGCCC-3'] 
Cox 4 [5'-CGGGTATCGATGTAATAG-3']. 
Each PCR reaction was set up in sterile pyrogen free tubes. PCR was performed in 
a total volume of 50 µl containing 2 µl of template (extracted sample), 5 pmoles of 
each primer, 200 µM of each dNTP (NBL) and 5µ1 of x 10 buffer. Tubes were 
placed on ice for 5 minutes before 2.6 units of a Taq and Pwo polymerase mix 
(Boehringer Mannheim Expand High Fidelity PCR System) was added. Tubes 
were briefly flicked and spun to mix and returned to ice. Each reaction was 
overlaid with two drops of mineral oil. The PCR reaction took place in a Biometra 
Thermocycler. Reaction tubes were incubated at 94°C for 2 minutes followed by 
40 cycles of 94 °C denaturation for 1 minute, 50°C annealing for 2 minutes and 
72°C extension for 30 seconds followed by a final extension of 72 °C for 7 
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minutes. PCR products were resolved on 2% agarose gels stained with ethidium 
bromide and viewed under U. V. light. 
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2.3 Results 
2.3.1 Mortality and Clinical Symptoms 
Guinea pigs infected by high dose C. burnetii by aerosol (group 1) became febrile 
(> 40.0 °C) beginning at day 2 post-infection. Pyrexia continued, in those animals 
that survived, until day 9 post-infection, when all remaining animals were killed. 
Fifty percent of animals had died by 9 days post-infection and the remainder were 
moribund and therefore sacrificed. Guinea pigs infected by high dose, C. burnetii 
intraperitoneally (i. p. ) (group 2), became febrile from day 4 post-infection and 
pyrexia lasted until day 8 post-infection, when temperatures returned to those seen 
in non-infected animals (Fig 2.1). No mortality was observed in animals infected 
i. p. (Table2.1) . Whilst febrile, guinea pigs were inactive and food and water intake 
was reduced, affecting their weight and general condition. Weights in aerosol- 
infected animals in particular decreased rapidly from day 2 post-infection and 
continued to decrease in survivors, until termination of the experiment at day 9 
post-infection. Weights of animals infected i. p. increased gradually, at an 
equivalent rate to non-infected animals until day 4 post-infection. Weights then 
decreased for four days, coinciding with the febrile response, after which weights 
gradually increased in-line with non-infected animals. 
Animals infected with low dose by aerosol (group 3) and low dose i. p. (group 4) 
had a milder form of the disease with fewer fatalities, less pronounced weight loss 
and pyrexia, although still higher than non-infected controls. In -both cases, 
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infection by the aerosol route induced a greater level of disease. Weights of guinea 
pigs decreased significantly from day 1 to 3 post-infection but increased gradually 
thereafter. However, weights in the aerosol group remained lower than non- 
infected control animals throughout the course of the experiment. Pyrexia of >40 
0C was evident in animals administered low dose C. burnetii by the aerosol route 
from day 14 post-infection which continued to day 28 post-infection when 
measurements were stopped. Pyrexia was also evident, beginning at day 1 post- 
infection, in i. p. -infected animals where temperatures remained above those 
detected in non-infected control animals. Peak temperatures in these animals, 
however, remained lower than aerosol-infected animals throughout the 28 days 
measurements (Fig 2.2). 
Table 2.1 Mortality in guinea pigs infected by the aerosol and 
intraperitoneal routes. 
Groin) 
1 
Estimated 
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(lose 
(ergs/nil) 
10- 
Route 
Aerosol 
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infection 
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4 10' 1. P. 92 0/14 0 
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Figure 2.1 Mean temperature elevation in °C (a) and weight in grams (b) of 
non-infected control, high dose aerosol (group 1) and intraperitoneally- 
infected (group 2) guinea pigs. Values shown represent the mean of four 
animals. 
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Figure 2.2 Mean temperature elevation in °C (a) and weight in grams (b) of 
non-infected control, low dose aerosol (group 3) and intraperitoneally-infected 
(group 4) guinea pigs. Values shown represent the mean of four animals. 
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2.3.2 Humoral Immune Responses - high dose (groups 1 and 2) 
animals. 
Immunoglobulin M anti-C, burnetii titres in guinea pigs challenged i. p. and by 
aerosol began to rise by day 6 post-infection and IgG titres by day 8 post- 
infection. Intraperitoneally-infected animals however, produced approximately 
100 times greater anti-C. burnetii IgM and IgG titres than aerosol-infected animals 
by day 9 post-infection. At the time of sacrifice, all immunoglobulin levels were 
rising (Fig 2.3 a and b). Anti-C. burnetii phase I IgG and IgM antibodies in animals 
challenged by both aerosol and intraperitoneal routes of infection showed no 
response above background. 
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Figure 2.3 Guinea pig serum immunoglobulin M and G anti-C. burnetil 
phase II whole cell antibodies. Data is the mean of two animals. 
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2.3.3 Humoral Immune Response - low dose (groups 3 and 4). 
Infection by i. p. inoculation with 103 fewer organisms, produced significantly 
reduced levels of anti-C. burnetii phase II IgM and IgG antibody responses 
compared to levels detected in animals that received a higher challenge dose. A 
dose response was therefore evident. 
Anti-C. burnetii phase II IgM in low dose i. p. -challenged guinea pigs appeared at 
day 5-6 and peaked at day 19 post-infection. By day 25 post-infection, no IgM was 
detectable. In contrast, anti-C. burnetii phase II IgM levels appeared later, at day 
10 post-infection, and peaked at day 28 post-infection, in animals challenged with 
low dose C. burnetii by aerosol (group 3). By day 42 post-infection, IgM was no 
longer detectable. Anti-C. burnetti phase II IgG antibody levels in aerosol and i. p. 
challenged animals reached similar levels up to day 50 post-infection. By day 92 
post-infection, levels continued to rise in i. p. -infected animals but had begun to 
decrease in aerosol infected animals (fig 2.4a and b). 
Levels of anti-C. burnetii serum IgA antibodies to phase II cells were greater in 
aerosol-infected animals. Levels appeared by day 25 post-infection, reaching a 
maximum by day 40 post-infection and decreasing to low levels by day 92 post- 
infection. In contrast, levels of anti-C. burnetii serum IgA antibodies in i. p. - 
infected animals (group 4) remained at low levels until day 50 post-infection, and 
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then gradually increased until the end of the experiment at day 92 post-infection 
(fig 2.4c). 
Anti-C. burnetfi IgG and serum IgA antibody response to phase I antigens in i. p. 
and aerosol-infected groups were similar. IgG levels peaked at day 50 post- 
infection and serum IgA levels were continued to rise up to 92 days post-infection 
(Fig 2.5a and b). 
Figure 2.4 Mean titres against C. burnetii phase II whole cells, determined 
by ELISA, from guinea pigs infected by low dose aerosol (group 3) and 
intraperitoneal infection (group 4). Each point represents the mean value of 
four animals 
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Figure 2.5 Mean titres (IgG and IgA) against C. burnetii phase I whole cells, 
determined by ELISA, from guinea pigs infected by low dose aerosol (group 3) 
and intraperitoneal infection (group 4). Each point represents the mean of 
four animals. 
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2.3.4 Histopathology and immunocytochemistry 
2.3.4.1 Group 1- aerosol challenge (high dose) 
Lungs from guinea pigs infected with C. burnetii revealed an extensive exudative 
pneumonia causing widespread consolidation, characterised by focal congestion, 
haemorrhage and observable emphysema (Fig. 2.6). In addition, diffuse exudation 
of macrophages and neutrophils were observed in the alveoli and respiratory 
bronchioles. Around many of the arteries, perivascular oedema and cuffs of 
lymphocytes were detected (Fig. 2.7). Specific staining confirmed the presence of 
C. burnetii antigen associated with the cellular infiltrate (Fig. 2.8). 
In the liver, vacuolation of the periportal hepatocytes was thought to be due to the 
presence of intracellular lipid. Foci of hepatocyte necrosis with macrophage 
infiltration was common to all animals studied (Fig. 2.9). Small brown 
intracytoplasmic bodies were seen in degenerate hepatocytes in three foci, these 
being interpreted as evidence of C. burnetii invasion. Immunocytochemical 
analysis of liver sections identified areas of specific staining within hepatocytes 
(Fig. 2.10). 
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Fig. 2.6 Haemotoxylin and eosin (H+E) stained section of guinea ping lung 9 
days after infection with a high dose, by aerosol, of C. burnetii (group 1). 
Magnification x 480. 
Fig. 2.7 Haemotoxylin and eosin (H+E) stained section of guinea pig lung 9 
days after infection with a high dose, by aerosol, of C. burnetii (group 1). 
Magnification x 480. 
Fig. 2.8 Immunocytochemical analysis of guinea pig lung, 9 days after 
infection with a high dose by aerosol, of C. burnetii (group 1). Sections were 
immunostained with anti-C. burnetii whole cell phase II IgG antibody. C. burnetii 
antigen is stained brown (indicated by arrow), and the tissue counterstained with 
haematoxylin. Magnification x 480. 
Fig. 2.9 Haemotoxylin and eosin (H+E) stained section of guinea pig liver 9 
days after infection with a high dose, by aerosol, of C. burnetü (group 1). L, indicates 
the presence of intracellular lipid and N, indicates an area of hepatocyte necrosis. 
Magnification x 480. 
Fig. 2.10 Immunocytochemical analysis of guinea pig liver, 9 days after 
infection with a high dose, by aerosol, of C. burnetii (group 1). C. burnetii antigen is 
indicated by the arrow. Magnification x 480. 
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Thrombi were evident in the heart adherent to both atrio-ventricular and aortic 
valves in six (50%) guniea pigs. Focal myocardial necrosis was also observed in 
the heart tissue of one animal (Fig. 2.11). 
Immunocytochemical investigation of tissue at 9 days post-infection, confirmed 
the presence of C. burnetii. Specific staining was observed within myocardial cells 
(Fig. 2.12). In addition, examination of areas of specific staining by scanning 
electron microscopy identified individual bacteria (Fig. 2.13a, b, c and d). 
Spleens were often enlarged, particularly in the red pulp, as a result of macrophage 
infiltration. Giant cells with multiple or giant nuclei were also common features in 
the red pulp (Fig. 2.14). 
No histopathological abnormalities were detected in the kidneys of any animal. 
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Fig. 2.11 Haemotoxylin and eosin (H+E) stained section of guinea pig heart 9 
days after infection with a high dose, by aerosol, of C. burnetii (group 1). Arrows, 
indicate foci of necrosis within the myocardium. Magnification x 50. 
Fig. 2.12 Immunocytochemical analysis of guinea pig heart, 9 days after 
infection with a high dose, by aerosol, of C. burnetii (group 1). Magnification (large 
picture) x480, and (inset) x 550. 
Fig. 2.13 a and b Scanning electron micrographs of C. burnetii cells within de- 
waxed sections of guinea pig heart 9 days after infection with a high dose of C. 
burnetii by aerosol (group 1). 
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Fig. 2.13 c and d Scanning electron micrographs of C. burnetii cells within de- 
waxed sections of guinea pig heart 9 days after infection with a high dose of C. 
burnetii by aerosol (group 1). 
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Fig. 2.14 Haemotoxylin and eosin (H+E) stained section of guinea pig spleen 9 
days after infection with a high dose, by aerosol, of C. burnetii (group 1). The arrow 
indicates a giant cell within the red pulp. Magnification x 480. 
2.3.4.2 Group 2- intraperitoneal challenge (high dose) 
Lungs of eleven guinea pigs (78%) challenged by the intraperitoneal route showed 
focal acute pneumonia and pneumonitis. Focal thickening of alveolar walls by 
macrophage-like cells was also noted, although this was seen in non-infected 
controls and therefore could not be ascribed to infection by C. burnetii (Fig. 2.15). 
The hearts of seven animals (50%) that had been infected, presented with focal 
chronic endocarditis and/or myocarditis which was characterised by lesions 
composed of small foci of lymphocytes in endocardial or myocardial connective 
tissue (Fig. 2.16). No histopathological abnormalities were observed in any spleens, 
and regenerated tubules were observed in the cortex of kidneys of all animals. This 
was regarded as mild focal damage 
In the liver, focal necrosis, focal granulomas and perilabular macrophages were 
common observations in all animals. Focal granulomas in the liver were composed 
of small numbers of macrophages and lymphocytes, while the presence of 
macrophage-like cells in portal areas was also common (Fig. 2.17a and b). 
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Fig 2.15 (H+E) stained section of guinea pig lung 15 days after a high dose 
intraperitoneal injection of C. burneiii (group 2). Magnification x 480. 
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Fig. 2.16 (H+E) stained section of guinea pig heart 15 days after a high dose 
intraperitoneal injection of C. burnetii (group 2). The left atrioventricular valve is 
shown, infiltrated by lymphocytes and macrophages with sloughing of the 
endocardium. Magnification x 120. 
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Fig. 2.17 a (H+E) stained section of guinea pig liver 9 days after a high dose 
intraperitoneal injection of C. burnetii (group 2). The portal area is infiltrated by 
lymphocytes. Magnification x 480. 
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Fig. 2.17 b (H+E) stained section of guinea pig liver 15 days after a high dose 
intraperitoneal injection of C. burnetii (group 2). A focus of necrotic hepatocytes, 
lymphocytes macrophages and fibroblasts. Magnification x 500. 
2.3.4.3 Group 3- aerosol challenge (low dose) 
Post mortem tissue taken from twelve guinea pigs 92 days post-infection, showed 
less severe lung and liver pathology but more extensive heart and kidney 
involvement. In particular, heart sections revealed thrombosis and endocarditis, 
indicating active disease, in at least four animals with additional observations of 
vacuolation and fibrosis present in one animal. The left atrio-ventricular valve 
showed evidence of thrombosis and endocarditis consistent with active disease 
(Fig 2.18). In addition, sub-acute and chronic areas of inflammation were observed 
at the base of the aorta and the chronic inflammation affected the left atrial wall. 
Areas of vacuolation and fibrosis in the myocardium were features consistent with 
healed lesions. Immunohistochemical analysis demonstrated the presence of C. 
burnetii antigen, by specific staining, within myocardial cells in one animal (Fig. 
2.19). Scanning electron microscopy confirmed that individual bacteria were 
present in areas of specific staining (Fig. 2.20a and b). 
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Fig. 2.18 (H+E) stained section of guinea pig heart, 92 days after infection with 
a low dose, by aerosol, of C. burnetii (group 3). Arrow indicates thrombosis present 
in the left atrioventricular. Magnification x480. 
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Fig. 2.19 Immunocytochemical analysis of guinea pig heart, 92 days after 
infection with a low dose, by aerosol, of C. burnetii (group 3). C. burnedi antigen is 
stained brown (indicated by arrows). Magnification x480. 
Fig. 2.20 a and b Scanning electron micrographs of de-waxed sections of guinea 
pig heart 92 days after a low dose aerosol infection of C. burnetii (group 3). 
a) 
b) 
Foci of interstitial fibrosis and nephritis with tubule regeneration in the cortex 
which was indicative of chronic infection was evident in the kidneys of four 
animals studied (Fig. 2.21). 
Liver pathology was confined primarily to small foci of lymphocytes and areas of 
necrotic hepatocytes encircled by collagen, in three animals, indicating healed foci 
of earlier damage (Fig. 2.22). 
No abnormalities were detected in lung or spleen tissue from guinea pigs examined 
92 days post-infection (Fig. 2.23). However, imunohistochemical staining of lung 
sections revealed that four infected animals examined, showed specific evidence 
of C. burnetii involvement (Fig. 2.24). 
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Fig. 2.21 (H+E) stained section of guinea pig kidney 92 days after infection with 
a low dose, by aerosol, of C. burnetii (group 3). The heavily stained area (N) 
indicates chronic interstital nephritis in the cortex. Magnification x 350. 
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Fig. 2.22 (H+E) stained section of guinea pig kidney 92 days after infection with 
a low dose, by aerosol, of C. burnetii (group 3). Arrow indicates a small group of 
lymphocytes. Magnification x 500. 
Fig. 2.23 (H+E) stained section of guinea pig lung 92 days after infection 
with a low dose, by aerosol, of C. burnetii (group 3). No abnormalities were detected. 
Magnification x 500. 
Fig. 2.24 
after infection with a low dose, by aerosol, of C. burnetii (group 3). C. burnetii 
antigen is stained brown and the tissue counterstained with haemotoxylin. 
Magnification x 480. 
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Immunocytochemical analysis of guinea pig lung, 92 days 
2.3.5 Histopathology and immunocytochemistry summary 
Tissues examined from animals that received high dose aerosolised C. burnetfi 
showed no abnormalities in the trachea or kidneys. Lesions were seen in the heart 
and spleen and severe pathology was seen in the lungs and liver. 
Immunocytochemical staining showed that the heart and lung were the primary 
targets of aerosolised infection. The liver and spleen were also involved during the 
acute phase of infection. 
Tissues from animals infected intraperitoneally with high doses of C. burnetii 
(group 2) and examined at 28 days post-infection demonstrated mainly liver 
pathology. No evidence of C. burnetii antigen could be detected, in any organ, in 
this group of animals as tested by immunocytochemistry. 
Evidence of heart and lung involvement remained during the convalescent phase in 
animals that received low doses of aerosolised C. burnetii (group 3). Less severe 
lung and liver pathology but more extensive heart and kidney involvement was 
observed in tissues examined ninety two days post aerosol challenge with low dose 
C. burnetii. 
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2.3.6 Polymerase Chain Reaction (PCR) 
C. burnetii-specific DNA was detected in all tissues obtained from animals 
challenged with high levels of C. burnetii by either the aerosol or i. p. routes (group 
1 and 2), nine days post-infection. Alternatively, only heart and lung proved 
positive for C. burnetii DNA at ninety-two days post-infection in guinea pigs 
receiving low levels of C. burnetli by both the aerosol and i. p. routes of infection 
(groups 3 and 4) (Table 2.2). 
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Table 2.2 Detection of C. burnetii DNA in guinea pig tissues following 
aerosol and intraperitoneal infection. Tissues from two animals were tested. 
Key: += present -= absent 
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2.4 Discussion 
The object of this part of the study was to establish a discriminative animal model 
of C. burnetii infection which accurately reflected the disease in humans. 
C. burnetii infection of experimental animals can be categorised as inapparent or 
apparent infections. The guinea pig is an example of an experimental laboratory 
animal which is highly susceptible to C. burnetii, where morbidity and mortality 
are characteristics of the disease. Alternatively, C. burnetii infection in the mouse 
is a model of inapparent infection, (unless infected with large numbers of 
C. burnetii), and the infectious process is characterised by long-lasting 
multiplication of the pathogen in infectious foci, without apparent systemic and 
metabolic changes (Khavkin, 1990). The guinea pig was selected in this study for a 
number of reasons. Firstly, clinical symptoms, mortality and serology could be 
used as parameters of infection. Secondly, much previous work had been 
conducted on the guinea pig by other groups, providing comparative data. Thirdly, 
the guinea pig had been used routinely in this laboratory for the confirmation by 
serology, of the presence of C. burnetii in clinical material (heart valves). 
The aerosol route of infection is the most common and relevant mode of 
transmission of C. burnetii to humans (Baca & Paretsky, 1983) and was used in 
this study to deliver a mono-dispersed infectious aerosol of C. burnetil to guinea 
pigs. 
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A number of parameters were monitored during infection including mortality, 
pyrexia, anorexia, histopathology, immunocytochemistry, serology and direct 
antigen detection. 
2.4.1 Mortality and clinical signs. 
Previous workers have shown that mortality was directly related to the virulence of 
the strain of C. burnetii and the initial infective dose received (Ormsbee et al., 
1978; Kazar et al., 1993b). In this study all animals that received high dose 
C. burnetii (group 1) were observed to be in distress with pyrexia and dehydration, 
and therefore killed at day nine post-infection. Mortality for this group was 
therefore classed as 100%. Animals administered low dose C. burnetii by aerosol 
(group 3), suffered 40% mortality. Therefore, a dose response was observed. 
Mortality figures in low dose animals (group 3) however, are higher than other 
workers have reported with comparable febrile reaction data (Kishimoto & Burger, 
1977; Kazar et al., 1993b). (Kazar et al., 1993b), reported that mortality and a 
strong febrile reaction in guinea pigs was characteristic of infection, when an 
inhaled retained dose of approximately 106 egg infectious dose 50 (EIDso) 
organisms of acute causing strains (Lugs and Nine Mile) and chronic causing strain 
(S) of phase I C. burnetil were administered. However, no mortality and a reduced 
febrile reaction was observed, with similar doses to that used in the present study, 
when C. burnetii strain Priscilla (a chronic disease causing strain) was given by 
aerosol. A similar pattern of virulence emerged when Priscilla, Nine Mile and S 
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strains of C. burnetii were given by the intraperitoneal route to guinea pigs and 
Balb/c mice. 
Other workers have reported a febrile response in guinea pigs following inhalation 
of C. burnetii Henzerling strain (a strain associated with acute disease) (Kishimoto 
& Burger, 1977), and Qi Yi (a strain associated with chronic disease) (Fan et al., 
1982). However, no mortality following infection was reported by these groups. 
The characteristic febrile response observed in guinea pigs infected by the aerosol 
route during this study, was similar to those reported by (Kaiar et al., 1993b) 
using Nine Mile strain and (Kishimoto & Burger, 1977) using Henzerling strain. 
In all studies, by day seven post-infection there is an elevation of temperature, 
although initial infective doses are quoted as 6.6 x106 EID50 by (Kazan et al., 
1993b) and 104 mouse median infective doses by (Kishimoto & Burger, 1977). 
(Kazan et al., 1993b) found very little variation in the febrile response of guinea 
pigs given C. burnetil Luga and Nine Mile strains (both associated with acute 
disease) and C. burnetii strain S (associated with chronic disease), but found that 
the C. burnetii Priscilla strain produced no significant febrile reaction. (Kazar et 
al., 1993b) concluded that their results supported and extended previous work by 
(Moos & Hackstadt, 1987) which suggested that the Priscilla strain associated with 
chronic disease was less virulent in guinea pigs than the Nine Mile strain 
associated with acute disease. However, further strains of C. burnetii phase I 
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organisms would need to be tested to determine if strains associated with human 
endocarditis (chronic disease-associated strains), proved less pathogenic than 
strains associated with acute disease. 
The present study suggests that, based on febrile reaction, the Lane strain 
(isolated from a heart valve from a patient suffering from endocarditis) is at least as 
virulent for guinea pigs as Nine-Mile strain or Henzerling strain when given by 
aerosol. This study also questions the statement by (Waag et al., 1991) that strains 
isolated from humans suffering from endocarditis are highly infective but poorly 
pathogenic for guinea pigs. This study has shown that when given as a small 
particle aerosol (< 5 µm) the Lane strain is highly virulent for guinea pigs even at 
low doses. 
2.4.2 Route of infection 
The aim of this section of the work was to establish an experimental C. burnetii 
infection in the guinea pig. Much research has been conducted on guinea pigs and 
mice infected by C. burnetii via the intraperitoneal (I. P. ) route including (Tigertt et 
al., 1961; Paretsky et al., 1964; Heggers et al., 1975; Johnson et al., 1976,1977; 
Gonder et al., 1979; Scott et al., 1987; Williams, J. C. et al., 1990), and the first 
isolation experiments of C. burnetii (Derrick, 1937) therefore the I. P. route of 
infection was included in this study for direct comparative purposes with previous 
work. In addition, the Lane strain used in this study was an uncharacterised strain 
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of C. burnetii. Previous workers, when evaluating the comparative virulence of 
different strains of C. burnetii delivered organisms by both the aerosol and I. P. 
routes of infection (Kazar et al., 1993b). Both routes of infection were therefore 
chosen in this study to obtain the maximum amount of information on the virulence 
of the Lane strain. 
The route of infection has been shown to be important to the pathogenesis of 
C. burnetii within the host (Manie et al., 1996) and (La Scola et al., 1997). 
(Williams, J. C. et al., 1990) demonstrated that spleen weights, and the number of 
infectious C. burnetii organisms within spleens, were significantly greater in mice 
infected by the intraperitoneal route than those infected by the aerosol route. 
Intraperitoneally-infected guinea pigs showed reduced mortality and length of 
febrile reaction compared to animals infected with a comparable dose via the 
aerosol route (Kazan et al., 1993b). In addition, (Marrie et al., 1996) demonstrated 
that I. P. -challenged mice developed hepatosplenomegaly and interstitial 
pneumonia, whereas mice challenged via the intranasal (I. N. ) route developed 
only pneumonia. 
In the present study, no mortality was observed in guinea pigs given high or low 
dose C. burnetii by the I. P. route, and the febrile reaction observed in both dose 
groups was less severe and, in the case of the low dose animals, less prolonged. 
Guinea pigs given C. burnetii I. P. in the present study would have received 
significantly higher numbers of organisms than those challenged by aerosol. Based 
on previous studies with guinea pigs using Legionella pneumophila, Bacillus 
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anthracis, Listeria monocytogenes and Mycobacterium tuberculosis, the inhaled, 
retained dose is routinely between four and six log colony forming units (CFU) less 
than the total number of viable organisms originally in the nebuliser (personal 
observation). This would be equivalent to an inhaled retained dose of 
approximately 10 3'5 organisms/ml and 100-2 organisms/ml for groups 1 and 3 
respectively. Therefore, the number of organisms received by guinea pigs in the 
I. P. groups would be significantly higher than the number of organisms retained by 
guinea pigs in the aerosol groups. 
The dose levels chosen in this study do not provide an ideal range of dose 
responses. An high and low dose of C. burnetil administered by the aerosol route 
produced 100% and 40% mortality respectively. The inclusion of a range of 
challenge doses, centrered around the low dose challenge, would have provided a 
more precise set of detailed data, as a greater number of animals would have 
survived for comparison. In addition a more realistic human infective dose (1-10 
organisms), could have been achieved. Febrile response data from guinea pigs 
challenged with a high and a low dose of C. burnetii by the I. P. route indicated that 
a dose level intermediate between the high and low would have produced a more 
informative dose response. 
As the number of animals available for studying are limited and animal 
containment level 3 working conditions are restrictive, future studies should 
concentrate on a greater range of dose levels but administered by one route only. 
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2.4.3 Serological response 
The ELISA is the serological method of choice due to greater sensitivity and 
reproducibility (Peter et al., 1987) and specific IgM, IgG and IgA can be 
distinguished more easily than using IFA and agglutination techniques. The 
detection of anti-C. burnetii antibodies provides the best indication of exposure to, 
and infection by C. burnetii and is true for both experimental animals and humans. 
The serological response, measured by ELISA, against whole cell phase I and II 
antigens in our study demonstrated how route of infection and dosage can produce 
different responses. 
The serology results in the present study followed a similar trend to those reported 
elsewhere (Ormsbee et al., 1968; Kazar et al., 1977; Williams, J. C. et al., 1986a) 
for experimental infection in the guinea pig. Procedures such as 
immunofluorescence (IFA), complement fixation (CF) and microagglutination 
assay (MAA), which are less sensitive than ELISA, were employed in previous 
studies, and hence detection of immunoglobulin occured slightly later than in the 
present study. 
Guinea pigs given high dose C. burnetii by I. P. injection produced an 
approximately ten-fold stronger'serological reaction than those animals given high 
dose C. burnetii by aerosol. As mentioned earlier, animals challenged by aerosol 
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would be expected to receive less organisms (4-6 loglo organisms ml''), than 
animals challenged by the I. P. route. The serological response to whole cell phase 
II antigens (QII) demonstrated that over the same period both IgG and IgM levels 
were significantly reduced in the high dose aerosol-infected animals. Both routes, 
however, showed levels of IgM against QII to be higher throughout the duration of 
the experiment than levels of IgG. By day nine post-infection, the titre of IgG 
directed against QII began to rise. No humoral response directed against whole cell 
phase I (QI) antigen was detected in those animals given high dose C. burnetii by 
either route. 
Titres (IgM and IgG) reached higher levels sooner, in animals given high dose 
C. burnetii by I. P compared with animals given low dose I. P. A similar dose 
response was observed for IgM titres of aerosol-infected animals. However, IgG 
titres in aerosol-infected animals over the early days post-infection showed no 
such dose response. (Kazar et al., 1977) reported a similar finding in that 
immunoglobulin levels were higher in those guinea pigs given a low (103 EID50 ) 
intraperitoneal injection of phase I Nine Mile strain than those given a high (108 
EID50) injection by the same route. 
The I. P. route of infection in animals given a low dose of C. burnetti produced an 
IgM peak titre which appeared earlier, and was greater than that produced by the 
aerosol route. This could represent a dose response. In contrast, virtually identical 
peak IgG titres, at similar days post-infection were detected for both routes in low 
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dose animals and, therefore, no dose response or route-dependant variation was 
observed in IgG titres. 
No IgM was detected against QI antigen in our study which is consistent with work 
reported by (Kazar et al., 1977) following I. P. infection of guinea pigs. 
Immunoglobulin G and A titres to QI antigen in guinea pigs given low dose 
(groups 3 and 4) were detected in our study at approximately twenty five and forty 
days respectively, post-infection. Appearance of these immunoglobulins appeared 
to be independant of route and therefore dose. 
Many workers have reported on the value of humoral immune response to 
C. burnetti infection in humans and its applications for serodiagnosis including 
(Peter et al., 1987,1988; Cowley et al., 1992; Dupont et al., 1994; Uhaa et al., 
1994; Waag et al., 1995) and (Dupuis et al., 1985). 
In acute infection, specific IgM immunoglobulins against QII antigens are detected 
within seven days following exposure (Dupuis et at,, 1985). Immunoglobulin G 
levels to QII antigens rise after seven days, reaching a peak three to four weeks 
post infection. Approximately three weeks following onset of illness, a maximum 
serological titre is reached which may continue for eleven to seventeen weeks. 
Specific antibodies to QII and QI antigens may develop as the acute illness 
progresses to chronic disease which may occur from three to twenty years later 
(Peacock et al., 1983). 
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Chronic Q fever in humans is characterised serologically by persistently elevated 
IgG and IgA titres to QII and QI. When the titres of immunoglobulins to QI and 
QII antigens are measured, a ratio of anti-QII to anti-QI of >1 represents acute Q 
fever, a ratio of z1 represents granulomatous hepatitis and a ratio of S1 is 
indicative of Q fever endocarditis (Peacock et al., 1983). 
In the present guinea pig study, only IgA levels to QI antigen were higher at the 
end of the experiment than IgA levels to QII antigen. No high IgG titre to QI was 
detected. These titres levelled out by day ninety two post-infection. In guinea pigs, 
based on the above ratios, the serodiagnosis would be suggestive of granulomatous 
hepatitis. This assumes, however, that the humoral immune response in guinea pigs 
is comparable to that seen in humans. 
(Camacho et al., 1995) reported that elevated levels of subclasses IgG 1 and IgG3 
were present in chronic human cases of Q fever and that a combination of 
decreasing IgG2 and increasing IgG3 levels may be predictive of disease 
progression from acute to chronic. Further studies of immunological subclasses in 
our guinea pig model may prove useful to determine the disease state at various 
times post infection. 
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2.4.4 Host response to infection 
Although useful as a means of serodiagnosis, the humoral immune response plays a 
minor role in the defence against infection by C. burnetii. The primary defence 
against infection is cell mediated immunity (CMI) (Hinrichs & Jerrells, 1976; 
Kishimoto & Walker, 1976; Kishimoto et al., 1977). It is possible that the reduced 
IgM and IgG response in animals given C. burnetii by the aerosol route was a 
consequence of the lower retained dose as discussed earlier. However, mortality in 
the aerosol group would suggest that dose alone was not the only important factor. 
Following phagocytosis, C. burnetii resides within the acidic vesicles of the 
phagocytes. C. burnetii antigens are presented by MHC class II molecules on the 
cell surface where CD4 T cells activate both B cells for a humoral immune 
response and T cells for a cell-mediated immune response. (Williams, J. C. et al., 
1982; Harding et al., 1988) and (Mims, C. A. et al., 1995). Those animals that 
received high dose C. burnetii by the I. P. route mounted a strong IgM and IgG 
response, and animals in the low dose by IT also mounted a strong IgM response. 
The production of IgG and IgM by the host controls infection by a process of 
opsonisation. IgM and IgG promote the phagocytosis of C. burnetii by binding 
specifically to antigens via the Fab variable region of the antibody molecule which 
in turn facilitates binding to Fc and complement receptors present on polymorphs 
and macrophages, and increases the development of a CMI. The relative lack of an 
effective antibody response may explain why mortality was higher in animals 
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infected by the aerosol route compared to those infected by the intraperitoneal 
route. 
C. burnetii delivered via the aerosol route was shown to be more infective than by 
intraperitoneal inoculation. A possible hypothesis for this observation could be that 
alveolar macrophages may be more numerous or efficient at phagocytosing 
organisms presented to them than peritoneal macrophages. Once organisms are 
intracellular they are inaccessible to immunoglobulins, and extracellular 
organisms are cleared from the infection site by a transient influx of 
polymorphonuclear leukocytes (PMNs). Intracellular C. burnetii are stimulated to 
multiply by the acidic conditions (Williams, J. C., 1991), and destroyed host cells 
release microorganisms and their components, which prime the humoral and CMI 
response as described. Lymphocytes and polymorphonucleocytes (PMN) are 
usually observed in the vicinity of destroyed host cells. C. burnetii circulates either 
freely in the plasma, on the surface of blood cells or within macrophages released 
from infectious foci. Secondary infectious foci then result in other organs around 
the body. This was demonstrated by intratesticular challenge of guinea pigs with C. 
burnetii and the subsequent demonstration of infectious foci in the lungs, liver, 
spleen and kidneys (Khavkin, 1990). It was also demonstrated that from infectious 
foci, C. burnetii could be released into the outer environment such as the urine and 
bile from infected glomeruli and kidney stroma and hepatocytes. 
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The present study suggests that systemic spread of C. burnetii occurred throughout 
organs of the body in a set pattern of infection which was dose-dependent, and 
route dependent. In the high dose animals administered C. burnetii by aerosol, the 
most severe pathology was observed in the lungs, followed by the spleen, liver, and 
heart. The kidneys showed no abnormalities. In animals receiving low C. burnetii 
by aerosol, the heart, liver and kidneys showed lesions and abnormalities but no 
pathology was seen in the lungs or spleen. Molecular (PCR) and 
immunohistochemical studies confirmed that clearance of organisms occured more 
rapidly in animals administered C. burnetit by intraperitoneal injection. No antigen 
could be detected in tissue sections by immunohistochemical methods or by PCR 
after day 12 post infection in high dose I. P. animals. In contrast PCR analysis 
revealed the presence of organisms in the lungs and immunohistochemistry and 
scanning electron microscopy showed organisms to be present in heart tissue at 92 
days post-infection in aerosol-infected animals. These observations suggest a 
resolving systemic infection with prolonged clearance in animals that received low 
dose C burnetii by aerosol. 
In the earliest attempts to identify the agent responsible for the fever observed in 
humans, experimental mice and rats were found to develop splenamegaly and 
hepatomegaly, following I. P. inoculation of infectious material (Burnet & 
Freeman, 1937). In the present study, only guinea pigs that received a high dose of 
C. burnetii showed splenamegaly and hepatomegaly. Those animals given low 
dose of C. burnetii and examined ninety two days later, showed no splenamegaly 
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and virtually no hepatic involvement. This pattern of pathology was reported by 
(Heggers et al., 1975) and (Paretsky et al., 1964) in guinea pigs following I. P. 
injection of 106 median embryo lethal doses of Nine Mile phase I cells and 105.6 
. egg LD50 Nine Mile phase I cells, respectively. Similar self-limiting lesions in the 
spleen and liver of guinea pigs were reported by (Johnson et al., 1977) following 
I. P. inoculation of a low virulence strain (M-44) C burnetii. In their experiment, 
lesions in spleen and liver were minimal and confined to the early phase of 
infection. The reduction in severity and pathological observations were attributed 
to the less virulent strain (M- 44) used. 
In experimental mice, splenamegaly has been shown to be proportional to 
infective dose (Hackstadt & Williams, 1981; Scott et al., 1987) and occurs in both 
sensitive (A/J) strains of mice and resistant (C57BL/6J) strains. Aerosol infection 
of athymic nude mice with C. burnetii resulted in a progressive infection and 
splenamegaly, and also occured in euthymic mice similarly infected. Euthymic 
mice however, were able to clear the infection (Hall, W. C. et al., 1981). 
In the present study, it was impossible to determine if animals in the low dose 
group developed splenamegaly or hepatomegaly as no sequential samples were 
taken from this group. Based on similar work performed elsewhere, the low dose 
animals may have developed splenomegaly and hepatomegaly. The remaining 
small foci of lymphocytes, necrotic hepatocytes and neutrophils observed in three 
out of the twelve animals could represent residual infection prior to complete 
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clearance. The spleens in low dose guinea pigs showed no lesions or abnormalities 
suggesting clearance may have occurred earlier during the infection. 
Present studies suggested that the kidneys appeared to be the last organ, of those 
examined, to become infected. Animals given high dose C. burnetii were killed 
before the kidneys became involved. The kidneys of guinea pigs given low dose 
C. burnetii by aerosol remained with foci of infection after ninety two days post- 
infection; however, immunocytochemical staining and PCR proved negative for 
specific antigen. 
The pathology found in the heart of animals given, high dose C. burnetii was 
consistent with (Heggers et al., 1975; Powanda et al., 1978) and (Johnson et al., 
1977) where epicarditis and myocarditis were observed. Low dose C. burnetii 
animals demonstrated pathology of the heart tissues, probably as a result of the 
widespread disseminated infection mentioned earlier. However, no other studies in 
guinea pigs have reported pathology in the heart, or identified antigen by 
immunocytochemical staining so long after infection. 
2.4.5 Persistence of C. burnetii within the host 
Although the guinea pig is highly susceptible to infection by C. burnetii, the 
infectious foci are cleared of microorganisms faster and more effectively in the 
guinea pig than in mice (Khavkin, 1990). In both mice and guinea pigs, however, 
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clearance is incomplete and acute infection can be reactivated in the 
immunocompromised host or during pregnancy (Atzpodien et al., 1994); (Kazar 
and Kovacova, 1983); (Tokarevich, 1979). 
In human cases of C. burnetii infection, the organism is able to remain dormant 
and unaffected by the immune system for long periods of time. It has been 
suggested that the spore-like formation of C. burnetii enables the microorganism to 
survive in a dormant state. The developmental cycle of C. burnetii consists of both 
vegetative growth and spore formation and the appearance of different antigens in 
the cell walls provides a mechanism of evasion from the immune response 
(McCaul, 1991). Aerosol delivery of organisms may inadvertantly select for small 
cell variants which are phagocytosed and express fewer antigens on the surface of 
the phagocyte and consequently avoid detection by antibodies. This may be a 
possible reason why aerosol-infected animals showed a reduced serological 
response. The small cell variant, which is more stable in the environment, would be 
the most likely cell to be transmitted to humans and animals aerogenically in the 
natural environment, and may explain why the route of infection determines the 
eventual disease outcome (McCaul, 1991). 
The specific cell type within which the microorganisms reside may also be 
responsible for the survival of cells (Khavkin, 1990). Cells able to retain 
C. burnetii organisms within them would be long-lived non-phagocytic cells rather 
than short-lived mononuclear phagocytes. Such cells may be stromal cells, 
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belonging to the lymphoid tissues called limbocytes. These cells are non- 
phagocytic, non-haematopoietic and relatively long-lived. Ultra-structural studies 
on stromal cells within the spleen and lymph nodes containing C. burnetii bear 
similarities to limbocytes. Other microorganisms such as Mycobacterium leprae 
and Toxoplasma gondli are found in non-phagocytic cells such as muscle, neural 
and Schwann cells when acute infection converts to chronic and latency (Khavkin, 
1990). 
It is possible that lesions seen in heart tissues of guinea pigs given low dose 
C. burnetii are due to organisms that have avoided clearance by the CMI responses, 
or alternatively these organisms are the remnants of a disseminated infection. 
Immunocompromised mice were shown to have endocarditis of the atrioventricular 
and semilumar valves ten days post IT injection of Nine Mile phase I organisms. 
At one hundred and fifty days post-infection, however, cardiac valves were clear 
of antigen and lesions (Atzpodien et al., 1994). Guinea pigs are able to clear 
infection more rapidly than mice; therefore it would be expected that heart tissues 
in the. guinea pig would be free of C. burnetii before one hundred and fifty days. 
Immunocytochemistry and PCR studies in the guinea pig model correlated well 
with the histological findings. Antigen was detected in the lungs, heart, liver and 
spleen of animals tested from the high dose group. Only PCR was able to detect 
antigen in the kidneys from these animals, This may have been due to greater 
sensitivity of the PCR compared to immunological techniques. 
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The histology of the liver and spleen would have predicted a greater quantity of 
antigen present than was detected. However, the observed CMI response could 
have been directed against organisms which had subsequently been cleared or 
insufficient quantities of antigen may have been present to be detected 
immunocytochemically. Alternatively, the progression of disease may have been 
less advanced in those animals tested for antigen compared to those processed for 
histology. 
Electron microscopical analysis demonstrated that antigen detected by 
immunohistochemical techniques in heart sections from 9 days post infection, in 
the high dose group, and 92 post-infection. in the low dose group, were whole 
organisms. Such antigen detection, particularly in the heart and lungs has not been 
reported elsewhere in experimental infections as most studies in the guinea pig 
have been confined to the acute response. 
Immunohistological demonstration of C. burn eilt from human heart valves has 
been reported (Brouqui et al., 1994). These authors concluded that the absence of 
granulomas in a number of their patients, but the presence of C. burnetii, suggested 
persistence by the organisms due to an aberrant host immune response. It was 
proposed that during acute infection, C. burnetii-infected monocytes circulated 
within the host and attached to previously damaged heart valves where persistence 
eventually led to chronic infection. 
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In the present guinea pig infection studies, organisms were shown to persist in the 
heart and lung for long periods of time after histological evidence suggested 
clearance had occurred. This supports previous findings that infection can be 
reactivated by pregnancy and irradiation in experimental animals and may explain 
why reactivation can occur in humans (Yeaman & Baca, 1990). 
(Kazar & Kovacova, 1983) also reported that, during acute infection in mice and 
guinea pigs, large numbers of C. burnetii were present in spleen and livers. 
Persistence of organisms was noted in kidneys and reproductive tracts for longer 
intervals after the acute phase of infection. Immunocytochemically, this was not 
found to be the case in our study; however, lesions were observed histologically 
in the kidneys of some animals in the low dose group long after spleen pathology 
indicated no abnormalities. 
In conclusion, this study has presented evidence that route of infection greatly 
affects the virulence of C. burnetii. A previously uncharacterised strain of 
C. burnetfi (Lane), a British isolate of low passage history, isolated from a human 
suffering from endocarditis, was shown to be highly virulent when given to guinea 
pigs by the aerosol route. This is contradictory to the suggested theory that human 
endocarditic causing strains are less pathogenic for guinea pigs. 
The serological response elicited in guinea pigs was characteristic of an acute 
phase reaction and supports previously published data for acute C. burnetii 
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infection in both guinea pigs and humans. No data has been published previously 
on the IgA response in C. burnetii infected guinea pigs and hence the serology data 
presented here extends this information. 
This study has also corroborated previously published results indicating persistence 
of C. burnetii within organs after clinical signs suggested clearance. Persistence of 
organisms in heart tissue, thirteen weeks after low dose aerosol infection in the 
guinea pig, has not been reported elsewhere. 
The guinea pig study represents a well characterised model system of acute human 
Q fever. This model can therefore be used to study the pathogenesis of respiratory 
Q fever and to provide samples for diagnostic research. In the following chapter, an 
assay for the detection of Q fever infections by detection of specific antigens in 
urine was developed. Urine, obtained from animals infected with C. burnetii by 
aerosol, provided samples with which to validate the assay in place of urine from 
human Q fever cases. 
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CHAPTER 3 
Development of an Assay for the Detection of Antigen in 
Urine from C. burnetii-Infected Guinea Pigs. 
3.1 Introduction 
3.1.1 Diagnosis of C. burnetii infection 
The primary objectives for laboratory diagnosis of infectious diseases, including Q 
fever, are early, accurate and rapid identification of the causative organism, 
enabling suitable patient management. As outlined in the general introduction 
(Section 1.7) current procedures for the clinical diagnosis of disease rely on direct 
isolation of the microorganism or, serodiagnosis. Direct isolation of organisms 
however, including C. burnetii, are not always achievable or reliable from body 
fluids such as sputum, blood and urine during various stages of the disease, as 
bacteraemia may be transient. In addition, organisms may be bound by serum 
antibodies, sequestrated into the reticuloendothelial system, metabolised, or at low 
levels within the individual (Baca & Paretsky, 1983; Reimer, 1993). 
3.1.2 The detection of specific antigens in urine for the clinical 
diagnosis of disease 
The object of an immunoassay which detects C. burnetii-specific antigens in urine 
is to identify infected patients from non-infected for the clinical diagnosis of C. 
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burnetii. The assay should provide a positive or negative result based on an 
established cut-off value. The clinical sensitivity measures how well the assay 
detects those patients with infection and is the proportion of true positives that are 
correctly identified. 
The clinical specificity measures how well the assay correctly identifies those 
patients who do not have the infection and is defined as the proportion of true 
negatives that are correctly identified. Sensitivity and specificity, however do not 
provide information on the probablity of the assay giving the correct diagnosis in a 
given population. Such information is provided by the positive predictive and 
negative value of the assay. The positive predictive value is therefore the 
proportion of patients with a positve result that actually have the disease and the 
negative predictive value is the proportion of patients with a negative result who do 
not have the disease. 
The bulk of research into antigen detection in body fluids has concentrated on site 
specific fluids such as cerebrospinal fluid in cases of bacterial meningitis, and 
sputum in pneumonia cases. As early as 1917, however, specific capsular 
polysaccharide was detected in the urine of rabbits with pneumococcal bacteremia 
(Dochez & Avery, 1917), and a large number of infectious diseases have been 
diagnosed by the detection of specific antigen in urine (Table 3.1). 
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Table 3.1 Infections diagnosed by urinary antigen detection. 
Infection Reference 
Chlamydia trachomatis (Chernsky et al., 1989) 
Legionella pneumophila (Williams, A. & Featherstone, 1988). 
(Lebrun et al., 1983) 
Aspergillus spp. (Rogers et al., 1990) 
Brucella abortus (Limet et al., 1988) 
Borrelia burgdorferi (Magnarelli et al., 1994) 
Trypanosoma cruzi (Corral el al., 1989) 
Streptococcus pneumoniae (Farrington & Rubenstein, 1991) 
Salmonella typhi (Chaicumpa et al., 1992) 
Mycobacterium leprae (Sharma et al., 1992) 
Mycobacterium avium (Sippola et al., 1993) 
The above studies proved the potential of urinary antigen detection as a method of 
rapid and early diagnosis of infectious disease. 
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Such conclusions have been particularly validated in the case of Legionnaires' 
disease. Experimental infection of guinea pigs with L. pneumophila has shown 
that specific breakdown products of this organism are shed into the urine 2 days 
post-infection coinciding with the onset of disease symptoms (Williams, A. & 
Featherstone, 1988), and before any detectable antibody response (approximately 
7-10 days post-infection). In addition, it has been demonstrated that the antigen 
appearing in the urine of a guinea pig model of Legionnaires' disease is 
lip opolysaccharide (LPS), and is identical to the antigen in urine of human cases 
of Legionnaires' Disease (Williams, A. & Lever, 1995). 
Detection of specific antigens in urine has the potential, therefore, to provide a 
specific, rapid, sensitive and early diagnostic test with a non-invasive sample 
collection procedure enabling drug therapy to be targeted to specific pathogens 
earlier, thereby improving the efficiency of the treatment. It also offers several 
advantages over either direct isolation of organisms or detection of specific 
antibodies. It is a non-invasive procedure to collect samples and is adaptable to 
automated routine testing in laboratories where specialised equipment is not 
always available for the isolation of infectious agents. It is also a rapid method of 
detection, where tests can be performed in a matter of hours using well established 
reagents and methodologies. Furthermore, it has the potential to be adapted to the 
'dipstick' format for use outside the laboratory, for example, in general 
practitioners surgeries or the Third World. The procedure also yields large volumes 
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of fluid which is easily concentrated 20-50 fold enabling low levels of antigen to 
be concentrated (Coonrod, 1983). 
It has been documented previously (Derrick, 1937; Marcie, 1990b), and (Baca & 
Paretsky, 1983) that infected animals and humans shed C. burnetii in urine, 
therefore the detection of organisms or C. burnetii-specific antigens would provide 
direct evidence of infection. The development of an experimental animal model for 
acute C. burnetii infection, described in the previous chapter, provided 
appropriate urine samples with which to study the appearance of C. burnetii- 
specific antigens in infected guinea pig urines over time. 
3.1.3 Aim of this chapter 
The aim of this element of the work was to determine if C. burnetil-specific 
components are excreted in the urine of experimentally-infected guinea pigs. It is 
intended to develop an ELISA to detect this urinary antigen and determine the 
appearance of the antigen in the urine post-infection, and relate this to the infective 
dose. It will then be determined whether urinary antigen detection is a potential 
method of'diagnosis for Q fever. The experimental strategy is outlined below in 
Fig. 3.1. 
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Fig. 3.1 Outline of strategy for development of assay 
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3.2 Materials and methods 
3.2.1 Preparation and concentration determination of C. burnetii 
phase I lipopolysaccharide (LPS) 
The method of (Hitchcock & Brown, 1983) was followed. A wet preparation 
(approximately 0.5g) of C. burnetii phase I organisms were resuspended in 10m1 
of 0.0625M Tris buffer containing 2% SDS and heated at 100°C for 10 minutes. 
Sample was cooled to 55°C and proteinase K added at 0.15mg/ml and incubated at 
55°C for 3 hours, then at 20°C for 18 hours. Sodium dodecyl sulphate (SDS) was 
added at 0.02g/ml and heated to 100°C for 10 minutes. Sample was centrifuged at 
12,000g for 30 minutes at 20°C and the LPS precipitated by addition of three 
volumes of isopropanol at 4°C for 30 minutes. The sample was then centrifuged 
again at 12,000g for 30 minutes at 4°C and the pellet resuspended inlO ml of 
distilled water. The precipitation and centrifugation step was repeated twice, then 
the LPS suspension was digested with RNase A and DNase I (Boehringer 
Manheim) both at 0.01mg/ml and 37°C for 30 minutes. Proteinase K at 0.01mg/ml 
was then added and incubated at 55°C for 3 hours, then at 20°C for 18 hours. 
Following another LPS precipitation stage with three volumes of isopropanol at 4° 
C for 30 minutes, the sample was centrifuged at 12,000g for 30 minutes and the 
resultant pellet resuspended in 1 ml distilled water and lyophilised or left in 
solution. The concentration of LPS present in solution was determined by an assay 
based on 3-deoxy-D-manno-2-octulosonate (KDO) to give an approximate value as 
to the concentration of LPS present in the sample. 
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3.2.2 KDO assay 
This method was based on that of (Weissbach & Hurwitz, 1959). Briefly 0.025M 
periodic acid was dissolved in 0.0625M concentrated sulphuric acid and 0.4 ml of 
this solution was added to a set of tubes prepared using standard KDO (Sigma) in 
the range of 1-15ug/ 0.2 ml and the test sample. These were left to oxidise at room 
temperature for 20 minutes then 0.6 ml of 2% sodium arsenite in 0.5M HCI was 
added and mixed rapidly. Following this 2.5m1 of 0.3% thiobarbituric acid in 
0.01M HCl was added and heated for 20 minutes at 100°C until the tubes 
developed a pink colouration which was read at 548 nm whilst still warm. 
3.2.3 Direct ELISA 
3.2.3.1 Titration of antisera 
Materials, buffers and incubation times were as detailed in section 2.2.10. 
Coating antigens were: C. burnetii phase I stock antigen diluted 1/200, phase II 
stock antigen diluted 1/2000 and LPS I diluted to a concentration of 0.65µg ml*'. 
The optimum working dilution of C. burnetii phase I (QI) and phase 11 (QII) was 
determined using reference serum obtained from a patient suffering from C. 
burnetii-confirmed endocarditis as primary antibody. Each antigen was diluted 
appropriately to give an absorbance reading of 1.0, when read at 450nm, after 
reaction with the reference serum. 
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Serial dilutions of rabbit anti-C. burnetii phase II polyelonal antibody and a 
monoclonal antibody 7H12G (prepared by Dr. P. Doyle, Queens University, 
Belfast, against inactivated C. burnetli whole cell phase II) were added to 
determine optimal titres. An experiment to determine the sensitivity of the 
polyclonal antibody was performed where the coating antigen (LPS I) was serially 
diluted and antibody added at 3 dilutions of 1/1000,1/2000 and 1/4000. Antibodies 
were detected with anti-mouse HRP (Sigma) whole molecule (1/2000) or anti- 
rabbit HRP (Sigma) whole molecule (1/2000). Detection was with TMB substrate 
as detailed in Section 2.2.10. 
3.2.3.2 Detection of antigen in spiked urines 
LPS I was serially diluted in non-infected guinea pig urine or PBS. The dilutions 
were coated on an ELISA plate and tested in the direct ELISA with rabbit 
polyclonal antibody at 1/1000 dilution. The urine and PBS with no LPS added 
were used as controls. 
3.2.4 Capture ELISA 
3.2.4.1 Purification of IgG from rabbit polyclonal serum 
A Protein G, sepharose column in conjunction with an FPLC system (Pharmacia) 
was used to purify the IgG fraction from the rabbit anti-C. burnetii serum. Serum 
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was loaded on the column in Iml aliquots, a pH gradient of 7.0 to 2.7 was applied, 
and I ml fractions were collected. The fractions were tested in a direct ELISA 
against C. burnetii phase II whole cell antigen coated on the plates at 1/2000 
dilution. Fractions were diluted 1/1000. Fractions which reacted with the phase II 
antigen were re-tested in the ELISA but serially diluted to determine optimum 
titres of IgG. 
3.2.4.2 Optimisation of capture ELISA 
The purified IgG was used to coat ELISA plates and experiments to determine 
optimum conditions for binding were performed. Incubation times of 2 or 4 hours 
at 37°C or overnight at 4°C were compared. Varying dilutions of IgG and the 
detector monoclonal antibody-HRP conjugate were tested. A series of controls 
were also run in the ELISA to determine non-specific and cross-reactions in each 
layer of the assay. These were: 
+ve control - QII antigen diluted 1/2000 in PBS 
-ve control - PBS in place of QII antigen 
-ve control - PBS in place of monoclonal detector antibody 
-ve control - Non-infected guinea pig urine in place of the antigen and PBS in 
place of the monoclonal detector antibody 
-ve control - PBS only 
+ve control - QII antigen diluted 1/2000 in non-infected guinea pig urine. 
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3.2.4.3 Detection of C. burnetii-specific antigen in infected guinea pig 
urine 
Urines obtained from guinea pigs infected with C. burnetii by the aerosol and 
intraperitoneal routes (see section 2.1) were tested in the capture ELISA. The 
positive control was C. burnetii QII antigen diluted 1/2000. Non-infected guinea 
pig urine was used as a negative (background). The cut-off level was defined as 
twice the SD above background levels (Wood and Wreghitt, 1990). 
3.2.4.4 Biotin-extravidin capture assay 
The capture ELISA was modified to increase sensitivity by replacing the 
monoclonal HRP conjugate with biotin-conjugated, anti-mouse antibody in 
conjunction with extravidin peroxidase. A series of controls were run as for the 
peroxidase assay to determine non-specific reactions. These were: 
-ve control - No coating antibody, QII as antigen 
-ve control - No coating antibody, -ve urine as antigen 
-ve control -- No coating antibody, PBS as antigen 
-ve control - PBS as antigen 
-ve control - inappropriate IgG as coating antibody, PBS as antigen 
+ve control - QII as antigen 
-ve control - negative urine as antigen. 
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The detection limit of the assay was determined by testing serial dilutions of a 
stock suspension of QII whole organisms diluted in non-infected guinea pig urine. 
The stock suspension contained approximately 1x 109 organisms ml'', and 1µI (i. e. 
1x 106 organisms) of this was added to the first well in the dilution series. 
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3.3 Results 
3.3.1 Characterisation of reagents 
Antigens used throughout the course of this study were C. burnetii phase I and II 
whole cells (both formalin inactivated) and lipopolysaccharide prepared from C. 
burned! phase I whole cell (LPS I). The working dilution for QI and QII control 
antigens was 1/200 and 1/2000, respectively. The concentration of KDO present in 
the LPS I preparation was used to determine the concentration of LPS. Typically, 
KDO constitutes 5% of LPS molecules and could provide, therefore, a measure of 
the concentration of LPS present. KDO standards were prepared and the LPS I 
preparation was tested. The concentration of KDO in the test was approximately 
12.60 µg/0.2 ml, or 63.0 µg/ml (Table 3.2). 
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Table 3.2 Determination of KDO in LPS I preparation 
Test Concentration K[)U 
(ng/ 0.2 ml) 
Absorhan 
Standard 1 1.25 0.073 
Standard 2 2.50 0.160 
Standard 3 5.00 0.351 
Standard 4 10.00 0.604 
Standard 5 15.00 1.143 
Test (1/20 dilution) 12.60 0.630 
Two antibodies were produced for use in the development of an ELISA, a rabbit 
polyclonal and a mouse monoclonal antibody (ascites fluid, 71-112G) both raised 
against C. burnetii inactivated phase II antigen. The reactivity of each antibody 
was evaluated by direct ELISA (Table 3.3). The anti-C. burnetii polyclonal rabbit 
sera reacted against inactivated C. burnetii phase I whole cell antigen (QI), 
inactivated whole cell phase II antigen (QII) and lipopolysaccharide prepared from 
QI (LPS 1). The monoclonal antibody reacted against QII only (Table 3.3). 
Table 3.3 Reactivity of polyclonal and monoclonal antibodies in direct 
ELISA with various antigens 
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The rabbit anti-C. burnetil phase II polyclonal sera reacted in direct ELISA to a 
dilution of 1/4000 against LPS I preparation. The optimum antibody dilution was 
1/1000 against a KDO (LPS) concentration of 1.25µg/m1(Fig 3.2). 
Fig 3.2 Sensitivity of polyclonal rabbit sera, in direct ELISA, at various 
dilutions against different coating concentrations of KDO 
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The optimum working dilution for the monoclonal antibody ranged from 1/200- 
1/6400 (fig 3.3). 
Fig 3.3 Reactivity of monoclonal antibody (ascitic fluid) for C. burnetli 
whole organisms phase I, II and LPS I in direct ELISA. Background was 
defined as background mean plus two standard deviations (2 SD). Points 
represent the mean of two readings. 
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3.3.2 Development and optimisation of assay 
3.3.2.1 Direct ELISA on Urine 
A direct ELISA, using non-infected guinea pig urine spiked with various 
concentrations of LPS I, was performed before testing urine from C. burnetii 
infected guinea pigs. At 1/1000 dilution, the polyclonal rabbit serum reacted with 
coated LPS at concentrations from 1.25 µg/ml to 0.01 µg/ml with peak reaction 
ocurring at 0.75 µg/m1. In contrast, serum did not detect LPS diluted in non- 
infected guinea pig urine at any of the concentrations tested (Fig 3.4). To 
overcome the reaction inhibition, a capture ELISA format was attempted using 
rabbit polyclonal antibody as a capture antibody and monoclonal antibody 
(7HG12) as detector antibody. 
Fig 3.4 Detection of LPS I-spiked urine samples by direct ELISA with 
rabbit anti-C. burnetii whole serum 
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3.3.2.2 Capture ELISA on urine 
3.3.2.2.1 Optimisation of the capture assay 
Purified IgG was prepared from the rabbit anti"C. burnetii polyclonal serum 
characterised above. The first stage in the development of the capture ELISA was 
to determine the adsorption of the coated, purified IgG to the microtitre plate. The 
effect of temperature and coating time was studied on adsorption of the IgG over a 
range of coating dilutions. Incubation at 37°C for four hours, and overnight 
incubation at 4°C, produced high absorbance readings, and hence efficient binding 
of the IgG to the microtitre plate, over all dilutions of coated IgG tested. Lower 
absorbance values, and therefore less binding of IgG to the plate, was achieved 
with a two hour incubation at 37°C (Fig 3.5). Four hour incubations at 37°C were 
used, therefore, for all future experiments. 
Fig 3.5 Variation of coating avidity of rabbit IgG on ELISA plate with 
incubation time. 
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3.3.2.2.2 Optimum IgG coating and monoclonal detector antibody dilution 
determination 
A chequerboard assay was performed, to determine the optimum coating dilution 
of IgG and monoclonal detector antibody, for the next stage in the development of 
the capture ELISA. IgG was coated at a range of dilutions on a microtitre plate and 
inactivated C. burnetii whole cell phase II (QII) antigen, diluted 1/2000 in non- 
infected guinea pig urine, was added. Monoclonal detector antibody at various 
dilutions was added. The optimum working dilution for both coating IgG and 
monoclonal detector antibody was 1/200 (Fig 3.6). In addition, this experiment 
confirmed that the coated IgG and the monoclonal detector antibody were capable 
of capturing and detecting QII antigens diluted in non-infected guinea pig urine. 
Hence the reaction inhibition observed in the direct ELISA (Section 3.3.2.1. ) had 
been overcome. 
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Fig. 3.6 Optimum dilution determination of coating IgG and detector 
monoclonal antibody, using QII diluted in non-infected guinea pig urine as 
antigen. 
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Controls (in triplicate) were performed, using the capture ELISA, to determine 
background values and eliminate non-specific reactivity (Fig 3.7). 
Controls 1 and 6, where QII was diluted in PBS and non-infected guinea pig urine, 
respectively, served as positive controls. Both produced absorbance values of 
between 0.3 and 0.4 absorbance units. Various negative controls were tested (2,3, 
4 and 5). PBS replaced the QII antigen (experiment 2), PBS replaced the 
monoclonal detector antibody (experiment 3) and only PBS was coated on the plate 
in control S. Control experiment 4 contained coating IgG with non-infected guinea 
pig urine added. Absorbance values for all the negative controls remained below 
0.1 absorbance units indicating that levels of non-specific reactivity were low. 
107 
Fig 3.7 Control experiments to determine background and levels of non- 
specific reactivity of the capture ELISA. 
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Experimental controls 
Control 1= Capture ELISA with QII diluted 1/2000 in PBS. 
Control 2= Capture ELISA with PBS as antigen. 
Control 3= Capture ELISA with PBS added instead of monoclonal detector 
antibody. 
Control 4= Capture ELISA with non-infected guinea pig urine and no monoclonal 
detector antibody. 
Control 5= PBS negative control. 
Control 6= Capture ELISA with QII diluted 1/2000 in non-infected guinea pig 
urine. 
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3.3.2.3 Evaluation of infected guinea pig urines in the capture assay. 
Urine from four guinea pigs infected with C burnetii, either by the aerosol route 
(group 1 and 3), or by the intraperitoneal route (group 4), were pooled and tested 
in the capture ELISA for C. burnetii specific reactivity. 
Reactivity was detected (above background levels of pooled non-infected guinea 
pig urine), from 3 days post-infection in animals challenged with high dose (1000 
organisms ml'1) C. burnetii by aerosol (group 1). Levels of C. burnetii-specific 
urinary antigen peaked at 6 days post-infection, but remained at detectable levels in 
the urine until the animals were killed at 9 days post-infection (Fig 3.8). 
Animals challenged with a low dose of C. burnetii (1-10 organisms ml''), by the 
aerosol route (group 3) and low dose (105 organisms ml") by the intraperitoneal 
route (group 4), proved positive for C. burnetit-specific urinary antigen (above 
background levels) between 3 to 50 days post-infection. Considerable fluctuation 
in levels of urinary antigen between sample days was observed; however, levels 
were generally greater up to 24 days post-infection, and gradually reduced by 50 
days post-infection (Fig 3.9). Levels of urinary antigen, throughout the course of 
the experiment, were lower in urine from guinea pigs infected intraperitoneally, 
compared to those animals infected by aerosol, except at 23 days post-infection. 
Comparable levels of urinary antigen was detected in urine of guinea pigs infected 
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by the aerosol route with either high or low dose of C. burnetil. Consequently, no 
dose response was observed. 
Fig 3.8 Capture ELISA using urine from guinea pigs, infected by 
aerosol, with high challenge dose (group 1). Points indicate the mean of three 
samples. The standard deviation from the mean is indicated by error bars. 
and background was defined as the mean of non-infected urine plus two 
standard deviations (2 SD). 
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Fig 3.9 Capture ELISA using urine from guinea pigs, infected by aerosol 
and intrapritoneal routes, with low challenge dose (groups 3 and 4). Points 
indicate the mean of three samples. The standard deviation from the mean is 
indicated by error bars and background was defined as the mean of non- 
infected urine plus two standard deviations (2 SD). 
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3.3.2.4 Detection of C. burnelil-specific antigen in the urine of infected 
guinea pigs using the biotin-extravidin assay. 
Levels of reactivity achieved with the capture ELISA described in Section 3.3.2.3 
were low (although above background controls). To amplify the reaction, biotin- 
conjugated anti-mouse antibody was used in conjunction with extravidin- 
peroxidase, as a further modification to the capture ELISA. Extravidin has four 
binding sites for biotin; therefore, it is possible to increase the number of enzyme 
molecules bound per antigen. 
Control experiments were carried out to determine background levels of 
absorbance (Fig 3.10). Non-infected guinea pig urine gave the highest non-specific 
absorbance (control 7, Fig 3.10). Absorbance values were less than 0.2 for all other 
controls with very little variation between replicates. Negative control 
backgrounds were higher than in the original capture ELISA; however, reactivity 
of the QII positive control was significantly higher using the biotin-extravidin 
assay (1.0 absorbance units compared to 0.3 in the original capture assay). 
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Fig 3.10 Control experiments to determine background and non-specific 
reactivity of the biotin-extravidin capture assay 
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Experimental controls 
Control 1= No IgG coating antibody, QII and all other reagents added. 
Control 2= No IgG coating antibody, non-infected urine and all other reagents 
added. 
Control 3= No IgG coating antibody, PBS and all other reagents added. 
Control 4= Capture ELISA with PBS as antigen. 
Control 5= Non-specific IgG as coating antibody and PBS as antigen, all other 
reagents added. 
Control 6= Capture ELISA with QII whole cells as antigen. 
Control 7= Capture ELISA with non-infected urine added. 
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The detection limit of the biotin-extravidin capture ELISA was determined (Fig 
3.11). Stock suspensions of whole phase II organisms (original concentration of 
lmg/ml which was equivalent to approximately 1x109 organisms m1) were 
initially diluted 1/100 so that each microtitre well contained approximately 1x107 
organisms ml" or 1x106 organisms/well. The detection limit cut-off for the capture 
ELISA was at dilution of 1/12800 of the stock suspension which was equivalent to 
approximately 800 organisms ml" or 80 organisms/well (8ng of antigen/well). 
Fig 3.11 Detection limit for C. burnetil phase II whole organisms in the 
biotin-Extravidin capture ELISA. Each point represents the mean of two 
readings and background is defined as the mean of uninfected guinea pig 
urine plus 2 SD. 
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Urine obtained from C. burnetil infected guinea pigs (groups land 3) were tested in 
the biotin-extravidin assay. Evidence of C. burnetii-specific urinary antigen at 1 
day post-infection was detected and continued to the end of the experiment at 8 
days post-infection in urine from animals infected with high dose by aerosol (group 
1). Levels of urinary antigen were low, compared to the QII positve control, with 
the peak amount of antigen appearing at 6 days post-infection (0.4 absorbance 
units). The addition of biotin-extravidin to the assay amplified the reactivity and 
in addition, the standard deviation from the mean was less than the variation 
detected by the original capture ELISA (Fig 3.8 compared to Fig 3.12). 
Specific urinary antigen was evident at 10-15 days post-infection, and continued to 
be detected until 43 days post-infection, in those animals given low dose by 
aerosol (group 3). By 50 days post-infection, reactivity dropped below background 
levels. A peak in antigen excretion (0.5 absorbance units) was detected at 34 days 
post-infection, and a greater deviation from the mean was detected throughout the 
experiment compared to urines obtained from group 1 animals (Fig 3.9 compared 
to Fig 3.13). Less fluctuation in levels of antigen detected between sample times 
was evident, however, compared to values obtained by the original capture assay, 
for the same experiment. The absorbance values, and hence the amount of antigen 
detected were low, however, compared to the QII positive control. 
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Fig 3.12 Capture ELISA using urine from guinea pigs, infected by 
aerosol, with high challenge dose (group 1). Points indicate the mean of six 
replicates. The standard deviation from the mean is indicated by error bars 
and background is defined as the mean of non-infected guinea pig urine plus 2 
SD. 
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Fig 3.13 Capture ELISA using urine from guinea pigs, infected by 
aerosol, with low challenge dose (group 3). Points indicate the mean of four 
replicates. The standard deviation from the mean is indicated by error bars 
and background is defined as the mean of non-infected guinea pig urine plus 
2 SD. 
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3.4 Discussion 
3.4.1 Assay Development. 
Characterisation of the polyclonal rabbit antiserum confirmed that although 
animals were immunised with inactivated phase II antigens, immunoglobulins 
reactive against lipopolysaccharides and whole phase I organisms were also 
produced. In contrast, the monoclonal antibody proved to be specific for phase II 
antigens only. Consequently, the polyclonal antibody was used initially in the 
direct ELISA, to ensure that all potential antigens in the urine could be detected. 
The simplest and most rapid format for ELISA is the direct ELISA. Sample is 
adsorbed directly onto the microtitre plate and specific detector antibody, either 
directly conjugated with an enzyme or using a conjugated anti-species antibody, is 
added afterwards. The direct ELISA was used as the standard diagnostic assay for 
the detection of specific human anti-C. burnetii immunoglobulins at CAMR and 
was found to be as sensitive and specific as IFA or dot-immunbiotting (Cowley et 
al., 1992). The direct ELISA was initially chosen therefore, as it was sensitive and 
compatable with existing equipment and procedures. Direct ELISA, however, can 
be less sensitive and specific than other formats, but this is dependant upon the 
sample being tested, and the antibody used (Kemeny, 1991). 
In this study, reaction inhibition in direct ELISA occured when non-infected 
guinea pig urine was introduced into the system. This suggested that urine was 
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either inhibiting the binding of antigen to the microtitre plate, or inhibiting 
antibody-antigen binding. The reaction between the rabbit polyclonal antibody and 
the anti-rabbit conjugated antibody may also have been inhibited. Reaction 
inhibition in ELISA, by urine, has been described previously. (Yamanaka et al., 
1992) reported an unknown substance in urine that interacted with the Fc portion 
of the immunoglobulin molecule, and (McKeating et al., 1986) showed that ß2- 
microglobulin bound to viral envelope protein, masking the antigenic determinants. 
It is possible, therefore, that similar components were responsible for the lack of 
reaction in spiked urine samples in this study. 
A capture ELISA or double antibody sandwich format was attempted to overcome 
the reaction inhibition. In this format, IgG was passively adsorbed onto plastic 
microtitre wells by hydrophobic adsorption. Coating the solid phase (microtitre 
well) with IgG from whole rabbit antiserum has been shown to reduce non-specific 
absorbance (Williams, A. & Featherstone, 1988; Wood & Wreghitt, 1990). 
The optimum concentraton of the reactants in an ELISA is related to the assay 
incubation time and temperature. Optimum incubaton time for the coating IgG 
antibody was determined before the optimum working dilution, as the amount of 
antigen that can be bound to antibody is proportional to the concentration of free 
antibody. The sensitivity of the ELISA would be reduced, therefore, if the capture 
antibody concentration was limited (Yolken, 1982). Optimum dilutions of both 
capture IgG and detector monoclonal antibody were determined using a chequer- 
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board assay. Absorbance values, using a standard dilution of QII whole cell antigen 
as a positive control however, were comparatively low. This could be because 
monoclonal antibodies are directed at specific epitopes on a large molecule 
whereas polyclonal antibodies react at various sites on one molecule. Also 
monoclonal antibodies directed against high-molecular-weight protein antigens can 
have low affinity constants (Yolken, 1982), (Frankel & Gerhard, 1979). The result, 
however, is that monoclonal antibodies can be less sensitive than polyclonal 
antibodies. This may explain the low sensitivity of the monoclonal antibody and, 
therefore, the capture ELISA used in this study. Although the sensitivity of the 
original ELISA for QII was low, absorbance values for negative controls were 
significantly lower. Non-specific reactions between reagents, and between 
reagents and non-infected guinea pig urine were also low proving that the capture 
format had overcome the original reaction inhibition. 
The detection limit calculated for the biotin-strepavidin assay based on dilution of 
QII whole cells was 80 ng antigen ml*' or 800 organisms ml''. This is less 
sensitive than that reported for a number of other capture ELISA-based assays, but 
higher than some alternative techniques such as agglutination and dot-ELISA for 
urinary antigen detection in human and experimental animals. Table 3,3 provides 
some comparative examples reported elsewhere. 
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Table 3.3 Detection limits of various urinary antigen assays 
Organism - ----------- Antigen -------- Detection limit 
^ 
- ------- Assay Reference 
S. t; phi Vi antigen 1ng/ml FLISA (Barrett et al., 
1982) 
L. pneumophila lipopolysacchar 10 ng/ml FLISA (Willimns, A. 
ide & Featherstone, 
1988) 
B. abortus lipopolysacchar 0.1 ng/ml FLISA (Limet et al., 
ide 1988) 
C. hurneiii whole cells 10 cells/ml dot-blot ("hylewska- 
Wierzbanowska 
K. Kruszewska, 
1993) 
N. meningilidis polysaccharide > 100 pg/nil agglutination (Suwanagool 
et al., 1986) 
It inf uenzae polysaccharide 6 ng/ml agglutination (Kaldor et al., 
1979) 
3.4.2 Assay Findings 
Excretion of C. burnetii has been shown to occur, via urine, fl Ilowing secondary 
infection by C. burnetii in the glomeruli and kidney stroma of guinea pigs 
(Khavkin, 1990). In this study, C. burnetii DNA was detected at 9 days post 
infection, in the kidneys of animals given high dose C. burnetii, and histological 
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evidence of infection was detected, 92 days post-infection, in low dose animals 
(Chapter 2). Such evidence, therefore, suggested whole organisms may have been 
excreted into the urine during infection, and that the capture assay described may 
have detected these organisms. Bacteriemia, characterised by a febrile response, 
occurred much sooner in animals administered high dose C. burnetii compared to 
animals given low challenge dose (Chapter 2), consequently, secondary infection 
sites in the kidney would be expected to occur much sooner in animals challenged 
with a high dose of C. burnetii. The detection of urinary antigen by day 1 post- 
infection in high dose animals compared to day 10-15 post-infection in low dose 
animals provided further evidence that the assay detected whole 
organisms, excreted into the urine, due to kidney damage. 
The monoclonal detector antibody, in the capture ELISA, was specific for a C. 
burnetii phase II epitope only, however C. burnetri phase I cells or antigens would 
be expected to be excreted into the urine of infected guinea pigs. It was established 
that the monoclonal antibody was unreactive against C. burnetii whole phase I 
cells, but was able to detect a C. burnetii-specific antigen in guinea pig urine. This 
suggested that the urinary antigen was not whole phase I cells, but partially 
degraded cells where the phase II epitope was exposed. (Williams, J. C. & 
Stewart, 1984) and (Williams, J. C. & Waag, 1991) showed that immune sera from 
mice immunised with phase 11 cells detected an 86 kDa protein antigen, present in 
soluble detergent extracts of both phase I and II cells grown in vitro. This antigen 
was not detected, however, by sera from mice infected or immunised with phase I 
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cells. Therefore although the antigen was synthesised by both phase I and II cells, 
it was inaccessible to the murine immune system, when challenged with viable or 
killed phase I cells. Likewise, the monoclonal antibody in this study may be 
directed against a phase II antigen, which was present on both phase I and II cells, 
but only exposed on phase I cells after processing through an animal. Other 
antigens may be excreted during infection, such as LPS or QI specific antigens, 
but these would not be detected by the assay as the monoclonal detector antibody 
was only capable of detecting QII antigens. 
The antigen detected in this assay, therefore, may be a degradation product 
resulting from the intracellular digestion of the organism in the phagolysosome and 
subsequently released during host cell lysis. In the present study there was an 
increase in the level of antigen detected, beginning at thirty days post infection, 
which coincided with the end of the febrile response in those animals given low 
dose C. burnetif by aerosol (chapter 2). In addition, specific immunoglobulin levels 
rose in animals administered a low dose of C. burnetil, beginning at ten days post 
infection, to a peak at approximately thirty five days after challenge. Since it is 
known that specific immunoglobulin promotes the uptake of organisms by 
phagocytes (Kazar et al., 1975); the rise in antigen excretion detected at this time 
may represent antigen released from infected phagocytes. 
The detection of urinary antigen was related to the initial infective dose received by 
the animals. The appearance of the antigen in urine closely followed the onset of 
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clinical signs. Similar results were reported during studies of experimental 
Legionnaires' disease in guinea pigs (Williams, A. & Featherstone, 1988) and 
brucellosis in mice (Limet et al., 1988). Following an acute (and lethal) aerosol 
challenge of L. pneumophila in guinea pigs, levels of L. pneumophila-specific 
antigen detected in the urine of infected animals rose sharply after day 1 post 
infection, to a peak at death on day 3 post-infection. Antigen was detected initially 
3 days post-infection after a lower (or chronic) infective dose of L. pneumophila 
was administered and peaked at day 6 post-infection. Antigen continued to be 
detected in guinea pig urine until day 17 post-infection. In experimental brucellosis 
in mice, B. abortus antigens were detected in urine for 85 -days following an 
intraperitoneal injection of 2x 106 cfu, with the maximum quantities of antigen 
appearing in the first days after infection. 
In summary, this chapter has described the development of a capture ELISA, and 
demonstrated by use of the ELISA , that guinea pigs experimentally infected with 
C. burnetii excreted specific antigen into their urine. The appearance of antigen in 
the urine was dependant on the initial infective dose and appears at approximately 
the same time as the IgM and IgG response. 
The demonstration of specific antigen in urine means that urinary antigen detection 
could be used as a method for the diagnosis of acute Q fever. It is not known if this 
antigen is excreted in human acute cases of Q fever, although the guinea pig model 
described in chapter 2 showed the guinea pig to be a relevant model for human 
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acute Q fever. Relevant human acute and chronic Q fever urine samples need to be 
tested to determine if antigen is present in human urine, and if disease state affects 
the excretion of the antigen. 
This assay also has potential application for testing the excretion of C. burneti! 
antigen in the urine of other animal species such as cows, sheep and goats. 
Valuable epidemiological data could then be obtained during sporadic outbreaks as 
well as determining infection within herds and flocks. 
This chapter concentrated on the development of an assay to detect antigen in the 
urine of guinea pigs experimentally infected with C. burnetii. Such an assay was 
developed, however the nature of the antigen in urine was not investigated. 
Evidence was presented which suggested that the antigen detected was not whole 
organisms but a degradation product. The next part of the investigation is to 
characterise the antigen appearing in the urine. 
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CHAPTER 4 
Characterisation of the antigen in urine from C. burnetii- 
infected guinea pigs. 
4.1 Introduction 
Acute C. burnetii infections are characterised by extensive bacteriemia which 
results in the formation of numerous infectious foci throughout the body. From an 
initial primary infection site, secondary infectious foci are established. C. burnetii 
organisms enter the blood and lymph systems from an infection site where they 
circulate freely in the plasma or are attached to the surface of blood cells, or are 
contained within macrophage-type cells released from infectious foci (Khavkin, 
1990). Organisms may be released into the urine from these secondary infection 
sites in the kidney, or degradation products of the organisms may be solubilised, 
thus enabling the passage of these components across the serous membranes into 
the urine (Coonrod, 1983). This has been reported in experimental infections in 
guinea pigs where glomeruli and kidney stroma were infected, resulting in 
excretion of whole C. burnetii into the urine (Khavkin, 1990). In addition, whole 
organisms were detected up to 14 days post-infection, in urine obtained from 
experimental C. burnetii infection in mice (Kruszewska & Tylewska- 
Wierzbanowska, 1992) and (Parker et at., 1951) reported the presence of whole 
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viable C. burnetii in dried guinea pig urine and noted the ability of the organism to 
survive for 49 days in the urine. 
Initial isolation studies for C. burnetii involved the injection of urine from infected 
abattoir workers into guinea pigs. A subsequent febrile response, and detection of 
organisms in the spleen of guinea pigs, indicated that organisms were present in 
three out of seven individuals' urine towards the end of the illness or during 
convalescence (Burnet & Freeman, 1937; Derrick, 1937). The human cases 
indicated that organisms had spread from the primary infection site (probably the 
lungs) to a secondary infection site in the kidneys where whole organisms had 
subsequently been excreted into the urine. 
Following entry into the host, C burnetii adheres to host cells such as alveolar 
macrophages and granulocytes. After internalisation into the cell by phagocytosis, 
phagosome-lysosome fusion takes place and C. burnetii multiplies within the 
phagolysosomal space of phagocytic cells (Hackstadt & Williams, 1981). 
The organism is able to resist a number of host antimicrobial activities, generated 
by the initial oxidative burst of the granulocytes and mononuclear phagocytes 
following phagocytosis, by the production of specific enzymes such as superoxide 
dismutase (SOD) and catalase (Akporiaye & Baca, 1983; Beaman & Beaman, 
1984). SOD converts the toxic superoxide anions to hydrogen peroxide, and 
catalase then converts this to oxygen and water. In addition, certain intracellular 
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parasites such as Legionella micdadei, Mycobacterium leprae and Leishmania 
donovani as well as C. burnetii have been shown to produce acid phosphatase 
(ACP) which inhibits toxic oxygen metabolites being generated by the host cell 
(Baca et al., 1993,1994). Although C. burnetii is adapted to survive intracellularly 
by the mechanisms outlined above, the eventual lysis of the vacuole releases 
further organisms into the environment as well as lysosomal contents, soluble 
antigens and fragments of the organism (McCaul, 1991). 
C. burnetil undergoes a complex developmental cycle, within the host 
phagolysosome. Initially, the infective stage of the organism (the small resting 
cell, SRC) undergoes development, activated by the acid conditions within the 
phagolysosome, to small and large vegetative cells (Williams, J. C. & Waag, 
1991). A number of these vegetative cells, depending on the prevailing conditions, 
may then produce endogenous spores. It is proposed that the spores mature at the 
time of exit from the mother cell and go on to produce the next generation of SRC. 
This cycle has been compared to the growth phases seen in normal bacteria. The 
activation of the SRC to vegetative forms is comparable to the lag phase. The 
exponential phase is the continued reproduction of large and small vegetative cells. 
The stationary phase results in no net increase in bacterial cell numbers because of 
the death of old vegetative large cells and renewal by vegetative small cells. 
Finally, the death phase is characterised by the death of old large vegetative cells 
and the lysis of mother cells liberating endogenous spores which mature to form 
SRC. Throughout this cycle, antigenic variation occurs in the cell wall of the 
128 
organism as determined by monoclonal antibodies directed against LPS and protein 
epitopes (McCaul et al., 1991). In particular a 29.5 kDa protein was identified 
which was present in large and small vegetative cells and the mother cells but not 
identified in the SRC or the spore. Consequently, the phagolysosome is filled with 
an heterologous population of C. burnetii including SRC, vegetative small and 
large cells, mother cells, and mother cells containing endogenous spores. The 
phagolysosome also contains cell walls, degraded large cells and soluble bacterial 
products (Williams, J. C. & Waag, 1991). An imbalance may occur where 
excessive substrates (bacterial products) are supplied to the lysosome for the 
lysosomal enzymes to degrade. The resultant accumulation of bacterial cells and 
soluble products may then influence the degradative capacity of the lysosome 
(Pfeifer, 1987). This enlargement of the phagolysosome has been reported in Q 
fever infections (Janigan & Marrie, 1990; Khavkin, 1990) and in continuously 
infected cells in tissue culture (Baca, 1989). An engorged cell will then 
occasionally lyse and spill the cell contents into the extracellular environment. 
4.2 Aim of this chapter 
The establishment of a capture ELISA (in Chapter 3), detected C. burnetii-specific 
immunoreactive product in the urine of experimentally infected guinea pigs. The 
assay described however, could not differentiate between viable C. burnetti, 
soluble antigens, or a combination of both. This chapter aims to determine the 
nature of the antigen shed into the urine of experimental C. burnetii infection and 
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determine if the antigen can be used as a specific marker of infection. The nature of 
the antigen will be investigated as shown in the flow diagram below (Fig. 4.1). 
Fig 4.1 Strategy of investigation to characterise the antigen in C. 
burnetii-infected guinea pig urine 
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4.3 Materials and methods 
4.3.1 Viability studies 
4.3.1.1 Tissue culture 
Samples of lung, liver, spleen and urine from animals infected with a high dose of 
C. burnetii by the aerosol route were collected and macerated with 10 ml sterile 
PBS in a class III cabinet within an ACDP level 3 laboratory. L929 cells (obtained 
from ECCAC, CAMR), in DMEM + 10% foetal calf serum (Gibco), with no 
antibiotics, at a concentration of 2.0 x105 cells ml" were seeded into duplicate 
75cm3 flasks and grown overnight at 37°C in an atmosphere of 5% CO2. Flasks 
were then inoculated with 10'1,10'2 and 10'3 dilutions of the above tissue samples 
and incubated at 37°C in 5% CO2 atmosphere for 14 days. Standard 
immunofluorescent staining techniques were used to detect the presence of C. 
burnetii, Briefly, media was decanted from the tissue culture flasks and cells were 
rinsed with sterile PBS. 5m1 of trypsin (Gibco) was added to each flask and cells 
incubated for 10 mins or until the cell sheet was observed to be lifting. PBS with 
0.001% bovine serum albumen (PBS/BSA) (5ml) was added and cell suspension 
decanted to a centrifuge tube and centrifuged at 3,000 rpm for 5 minutes. The 
resultant supernatant was descarded and the cell pellet resuspended into 500 µl of 
PBS/BSA. The method of (Cowley et al., 1992) was then followed using known 
human positive control serum which was reactive against C. burnetü as detector 
antibody, and goat antihuman IgG (Sigma) as conjugate. 
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4.3.1.2 Animal inoculation 
Aliquots (0.5m1) of the above samples were inoculated intraperitoneally (two 
guinea pigs per sample) and 21 days post-infection, serum was removed by 
cardiac puncture and tested for the presence of specific anti-C. burnetii antibodies 
by indirect ELISA. Additional guinea pigs were inoculated with urine obtained 
from non-infected guinea pigs, and non-infected guinea pig sera, was also used as 
negative controls. 
4.3.2 Molecular (PCR) 
4.3.2.1 DNA extraction from C. burnetii-infected guinea pig urine 
QlAamp method for extraction of DNA from body fluids was followed according 
to the manufacturers instructions (Qiagen Ltd, Crawley). Urine (140 µl) was added 
to 560 µl of lysis buffer in a 1.5 ml microfuge tube and mixed by vortexing. Tubes 
were incubated at room temperature (IS °C-25 °C) for 10 minutes then 
560 µl of ethanol was added to the sample and mixed by vortexing. To a spin 4 
column, 630 µl of the above solution was added and this was centrifuged at 6,000 x 
g for 1 minute and the filtrate discarded this was repeated twice. The spin column 
was then washed twice with 500 µl of distilled water by centrifugation at 20,000 x 
g for 3 minutes. DNA was eluted from the spin column by addition of 200 µd of 
distilled water heated to 70 °C followed by centrifugation as above. 
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4.3.2.2 PCR analysis of C. burnetii"infected samples 
This was as described in Section 2.2.11. 
4.3.3 Physical investigation {size exclusion chromatography by fast 
protein liquid chromatography (FPLC)} 
A Superose 6 gel filtration column was used with a fast protein liquid 
chromatography system (FPLC, Pharmacia). Samples were applied in 200 µl 
volumes at a flow rate of 1 ml min' using PBS as eluent. The column was 
calibrated at the above conditions using molecular weight markers and according to 
the manufacturers instructions (Pharmacia). Markers were Dextran Blue, 2,000 
kDa; thyroglobulin, 669 kDa; ferritin, 440 kDa; catalase, 232 kDa; albumen, 69 
kDa; ovalbumen, 43kDa; chymotrypsin A, 25 kDa and ribonuclease A, 13.7 kDa. 
Urine from guinea pigs administered high and low doses of C. burnetti by aerosol 
was centrifuged at 10,000 rpm for 5 minutes in a microfuge (MSE) and filtered 
through a 0.1µm syringe-fitting filter (Millipore) and injected onto the column. 
Fractions were tested in a direct ELISA (Section 4.3.4) for specific reactivity 
against polyclonal anti-C. burnetii whole cell phase 11 antibody. The ELISA- 
reactive fractions were pooled and concentrated by freeze drying. 
Non-infected guinea pig urine and non-infected guinea pig urine spiked with 
I µg/ml and 5 jig/ml LPS from C. burnetil phase I Lane strain were separated on the 
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size exclusion column and the eluent was tested by direct ELISA, to serve as 
controls. Additional control urine from guinea pigs infected with aerosols of either 
M tuberculosis or L. pneumophila were also separated on the column and tested 
for reactivity in direct ELISA. Non-infected guinea pig urine with 0.1 mg m14 
guinea pig albumin (Sigma) and 0.1 mg ml" ß2-microglobulin (Sigma) were also 
separated on the column and subsequent fractions were tested in the direct ELISA. 
4.3.4 Direct ELISA 
Putative antigen-containing solution was coated directly onto the ELISA plates 
(100 µl) and incubated, shaking at 37°C for three hours. Coating buffer, if 
necessary, was used as diluent. Rabbit anti"C. burnetii whole cell phase II IgG 
(1/1000 diluted in PBST + 10% HS) or guinea pig anti-ELISA reactive fractions, 
(serially diluted in PEST + 10% HS) was incubated at 37°C shaking for two hours. 
Plates were washed in PBST three times and anti-rabbit HRP conjugate (Sigma), 
diluted 1/2,000 in PBST + 10% HS or anti-guinea pig IgG (Sigma), diluted 1/2000 
in PBST + 10% HS, was added and plates incubated as above. Substrate 
development and absorbance reading was as described in Section 3.2.3. 
4.3.5 Enzymatic treatment of ELISA-reactive fractions 
Proteinase K digestion of the ELISA-reactive fractions from C. burnetil-infected 
urines was performed according to the method of (Heckels & Virji, 1988). 
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Fractions were incubated with proteinase K (Sigma; 100 pg ml'1 in PBS) at a ratio 
of 1: 1 at 60 °C for 60 minutes. Enzyme activity was stopped by denaturation of the 
proteinase K by boiling at 100 °C for 20 minutes. 
4.3.6 Antigenicity studies: immunisation of guinea pigs with ELISA- 
reactive fractions 
Antisera was raised in two guinea pigs by the intramuscular injection of 0.25 ml of 
concentrated, ELISA-reactive fractions. Two identical booster injections were 
administered at two weeks intervals and the animals were bled 3 weeks later. 
Negative control serum was obtained by the injection intramuscularly of one 
guinea pig with sterile PBS in identical volumes and serum removed as above. 
Serum reactivity against C. burnetii whole cell in phases I and 11 was investigated 
by Western blot, ELISA and IFA and reactivity against ELISA-reactive fractions 
was investigated by Western blotting and ELISA. 
4.3.7 Total protein determination 
Bicinchoninic acid protein assay kit (Sigma) was used to determine the total 
protein concentration according to manufacturers instructions. 
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4.3.8 SDS-PAGE 
Sodium dodecyl sulphate-polyacryamide gel electrophoresis (SDS-PAGE) of C. 
burnetli whole cells phase I and II was performed in pre-cast 8-25% acrylamide 
gradient gels and run on a horizontal gel electrophoresis system (Pharmacia) using 
the buffer system described by (Laemmli, 1970). All other samples were separated, 
using the same buffer system as above, in 10% acrylamide vertical slab gels and 
run using a Hoefer " Mighty-Small" SE200 series apparatus. The stacking gel was 
5% acrylamide, and the acrylamide/bisacrylamide ratio was 37.5: 1. 
Samples were dissociated at 100°C for 5 minutes in 0.0625M Tris HCl buffer pH 
6.8 containing 2% SDS, 5% 2-mercaptoethanol, 10% glycerol and bromophenol 
blue. Samples volumes loaded were 1 pl and 10 µl on the Phast gels and slab gels 
respectively. Molecular weight markers used with the Phast gel system were 
Sigma, SDS-6H (29,45,66,97.4,116 and 205 kDa), and Pharmacia (20.1,30,43, 
67, and 94 kDa) with the slab gels. Electrophoresis was at 250V, 13 mA for 40 
minutes with Phast gels and 40mA, constant current for slab gels. Gels were 
stained for proteins with either Coomassie blue or silver stained ( Silver Stain Plus, 
Bio-Rad) and stained for LPS using a modified version of a method by (Tsai & 
Frasch, 1981). Briefly, gels were fixed in 40% ethanol and 5% acetic acid in water 
overnight and then incubated in 0.7% periodic acid in fixative for 5 minutes. Gels 
were then washed three times for fifteen minutes each wash and agitated for 10 
minutes in stain solution, which consisted of solution A: 20% silver nitrate 
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solution and solution B: 6.7% v/v ammonia and 0.1 M sodium hydroxide, mixed 
together in the ratio of 1: 14 and then diluted 1: 3 with water. The gel was washed 
as before and developed (using developer from the Bio-Rad silver stain kit). The 
reaction was stopped by addition of 5% acetic acid in water. 
Analysis of protein profiles was performed using a BioRad GS690 imaging 
densitometer in conjunction with the BioRad Multi-Analyst software package. 
4.3.9 Western blotting 
Separated molecules (protein and LPS) in unstained gels were transferred onto 
nitrocellulose sheets 0.45 pm pore size (Hybond) using a semi-dry electro-blotter 
(Bio-Rad) at 3mA. /cm2 of gel for 30 minutes. Following incubation with 3% gelatin 
in 50 mM phosphate buffered saline (PBS) pH 7.4 containing 0.05% Tween 20 
(PBST) the nitrocellulose was immunostained immediately or stored at -20 °C. 
Blots were incubated in primary antibody (rabbit anti"C. burnetii whole cell phase 
II, diluted 1/1,000 or guinea pig anti-ELISA reactive fractions, diluted 1/10 in 
PBST) at 37 °C for 2 hours and washed three times in PBST. Bound antibodies 
were recognised with corresponding anti species antibodies conjugated to 
horseradish peroxidase (HRP) (anti-rabbit whole molecule, diluted 1/2,000 
{Sigma}, and anti-guinea pig IgG {Sigma}, diluted 1/2,000 in PISST) incubated for 
2 hours at 37 T. Blots were washed three times as before and substrate added. 
Substrate consisted of 20 mg of 4-chloro-1-naphthol (Sigma) in I ml methanol then 
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100 µl of this solution was added slowly to 10 ml PBS with 5 µl hydrogen 
peroxide. The reaction was stopped by washing in distilled water. 
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4.4 Results 
4.4.1 Viability studies 
4.4.1.1 Animal inoculation 
The presence of viable C. burnetii organisms in urine and tissue from aerosol- 
infected guinea pigs was investigated. Macerated tissue and urine from C. burnetii- 
infected guinea pigs was injected intraperitoneally into guinea pigs. Three weeks 
post-inoculation, sera was tested by ELISA for a rise in anti-C. burnetii phase II 
TgG antibodies. Sera from guinea pigs inoculated with non-infected guinea pig 
urine served as a negative control as did sera obtained from guinea pigs which 
received no inoculation (normal guinea pig sera). 
Sera from guinea pigs inoculated with macerated liver, spleen and urine (from 
group 1 animals), contained greater levels of anti-C. burnetii phase 11 IgG 
antibodies than the negative control sera. Urine from 1 day post-infection 
produced the greatest level of anti-C. burnetii phase II antibodies, followed by 
spleen and liver taken at 9 days post-infection. Urine taken at 3 and 8 days post- 
infection produced a similar anti-C burnetii phase II antibody response, which was 
higher than negative control sera (Fig 4.2). At three weeks post-inoculation, 
negative control sera contained the same level of anti-C, burnetii phase 11 IgG 
antibodies as normal guinea pig sera. However, both negative control sera and 
normal guinea pig sera had higher levels of reactivity than the PBS control. 
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Fig 4.2 ELISA IgG antibody responses in guinea pigs inoculated with C. 
burnetll-infected tissue and urine. Values indicate the mean obtained from two 
animals 
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4.4.1.2 Tissue culture 
Cell culture isolation of viable C. burnetii from tissue samples of liver, spleen and 
urine from 1,3, and 8 days post-infection from group 1 animals was attempted. 
Flasks inoculated with C. burnetii phase I organisms were incubated in parallel to 
serve as positive controls. Cell cultures inoculated with liver, spleen and urine 
samples all proved negative for the presence of whole C. burnetii following 
immunofluorescent staining with rabbit anti-C. burnetii IgG. In contrast, all 
positive control cultures inoculated with phase I C. burnetii were positive. 
4.4.2 Determination of the presence of C. burnetil DNA in urine obtained 
from C. burnetii-infected guinea pigs 
Samples of pooled urine (four animals), from each group of infected guinea pigs 
(aerosol- infected; groups 1 and 3 and intraperitoneally-infected; groups 2 and 4) 
were tested for the presence of C. burnetii DNA. A range of days was selected 
from each group to test. 
A 495 base pair product was detected for the positive C. burnetii DNA control, 
however, all urine samples tested from all groups proved negative for C. burnetii 
DNA. 
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4.4.3 Determination of C. burnetii components in infected guinea pig 
urines 
A size exclusion column (superose 6) was used to identify C. burnetii-specific 
components in guinea pig urine, other than whole organisms or C. burnetii DNA. 
Whole guinea pig urines, obtained from aerosol infected animals (groups 1 and 
3), were filtered through a 0.1 µm filter to remove cell debris and whole C. burnetii 
organisms. Filtered urines were run down a size exclusion column and components 
of the urine were separated by their retention time through the column. Retention 
time was directly related to molecular size, hence the higher molecular weight 
components passed more quickly through the column, leaving lower molecular 
weight components to be retained on the column for longer. Each fraction from the 
column was coated directly onto an ELISA plate, and tested for reactivity against a 
rabbit anti-C. burnetii phase 11 IgG antibody (the polyclonal antibody used in the 
capture assay in Chapter 3). 
The size exclusion column was calibrated, using molecular weight standards, 
(Table 4.1). The void volume (those molecules which passed through the column 
and were not separated by molecular size i. e. greater than 2,000 KDa) was 
determined to be fraction seven. 
142 
Table 4.1 Calibration of the size exclusion column (superose 6) using 
molecular weight standards 
Molecule Molecular weight (k1)a 11 ractiorn eluted 
Dextran Blue 2,000 7 
Thyroglobulin 669 12 
Ferritin 440 13 
Catalase 232 15 
Albumen 67 17 
Ovalbumen 43 18 
Chemotrypsin A 25 19 
Ribonuclease A 13.7 19 
4.4.3.1 Separation, by size exlusion chromatography, of positive control 
urines 
Urine obtained from non-infected guinea pigs spiked with 1 µg/nil and 5µg/ml LPS 
(from phase I C. burnetii) were separated, by size exclusion chromatography, to 
serve as positive controls. Specific reactivity, by direct ELISA with anti-C. burnetü 
1gG, was observed in fractions 8 and 11-15 in non-infected guinea pig urine spiked 
with I µg/ml LPS and fraction I and 8 in urine spiked with 5µg/ml ITS (Fig 4.3). 
No specific reactivity, in direct ELISA with anti-C. burnetii IgG, was observed in 
any fractions of non-infected guinea pig urine (negative control). 
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Fig 4.3 Non-infected guinea pig urine and non-infected guinea pig urine 
spiked with 1µg/m1 and 5µg/ml LPS from C. burnelii phase I organisms 
separated on a superose 6 column, and tested by direct ELISA 
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4.4.3.2 Separation, by size exlusion chromatography, of negative control 
urines 
Negative control urines were obtained from guinea pigs infected by aerosols of 
Mycobacterium tuberculosis and Legionella pneumophila. In addition, non- 
infected guinea pig urine spiked with ß2-microglobulin and guinea pig albumin 
served as negative controls. All controls were separated on the size exclusion 
column and tested in the direct ELISA. 
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Reactivity above background levels was demonstrated in the first eight fractions 
in L. pneumophila-infected guinea pig urine and non-infected guinea pig urine 
spiked with 0.1 mg/ml 02-microglobulin (Fig 4.4). No reactivity, detected by 
ELISA, was seen in any fractions obtained from separated M tuberculosis aerosol- 
infected guinea pig urine or non-infected guinea pig urine spiked with albumen. 
Fig 4.4 Urine from infected control guinea pigs, or non-infected guinea 
pig urine spiked with albumen or ß2- microglobulin separated by size 
exclusion chromatography. 
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4.4.3.3 Separation of urine from C. burneiii-infected guinea pigs 
Reactivity in fractions 1 and 8 -15, depending on the day post infection, was 
detected by direct ELISA on urine from high dose aerosol-infected (group 1) 
animals (Fig 4.5). Reactivity was detected in fraction 8 of all urines tested. Fraction 
13, reacted strongly in urine obtained at day 6 post infection, as did fractions 8-15 
from urine obtained at day 9 post-infection. Fractions 1-3 in urine obtained at day 8 
post-infection also showed reactivity in the direct ELISA. 
Reactivity was confined primarily to fraction 1 in urines obtained from low dose 
aerosol-infected guinea pigs (group 3). However fractions 8,14 and 15 also 
showed reactivity, primarily in urines from later days post-infection (Fig 4.6). 
Levels of reactivity, when detected, in low dose aerosol-infected animals (group 
3), were lower than levels of reactivity detected in fractions from animals that 
received a high dose of C. burnetli by aerosol (group 1). 
The molecular weight of antigens separated by the size exclusion column and 
appearing in fractions 8-15 ranged from approximately 300 KDa ->2,000 KDa. 
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Fig 4.5 Urine from high dose aerosol-infected guinea pigs (group 1), 
separated by size exclusion chromatography 
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Fig 4.6 Urine from low dose aerosol-infected guinea pigs (group 3), 
separated by size exclusion chromatography 
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4.4.4 Analysis of ELISA-reactive fractions 
4.4.4.1 Protein determination 
To obtain larger volumes of sample for analysis, repeated runs using the size 
exclusion column were performed on samples of urine obtained at 9 days post- 
infection from high dose aerosol-infected guinea pigs (group 1). After 4 separate 
runs, ELISA-reactive fractions 8-15 were tested by ELISA, and pooled. Pooled 
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[; LISA-reactive fractions 8-15 (10 ml) were freeze-dried and reconstituted in 300 
µl of sterile distilled water. A protein estimation on the concentrated freeze dried 
ELISA-fractions was performed (Table 4.2). 
Table 4.2 Total protein determination in concentrated ELISA-reactive 
fractions 
Prot : in (ttg / ml) Absorbance (562 tim) 
0U 
200 0.252 
400 0.532 
600 0.583 
800 0.943 
1000 1.003 
Concentrated ELISA-reactive fractions 0.192 
Total protein in ELISA-reactive fractions was 0.18 mg/ml. 
4.4.4.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) 
Pooled concentrated ELISA-reactive fractions from the size exclusion column were 
separated on a 10% SDS-PAGE. Silver stain analysis for protein revealed five 
major bands at approximately 120 kDa, 67 kDa, 62 kDa 40 kDa and 35 kl)a (Fig 
4.7). In addition, pooled concentrated fraction 1 (from non-infected guinea pig 
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urine), non-infected guinea pig urine, inactivated C. burnetii whole cells phase I 
and II and LPS I were analysed by SDS-PAGE. 
A single band was present in pooled concentrated fraction 1 at approximately 67 
kDa (Fig 4.7), and a number of bands, although fainter, were present in non- 
infected guinea pig urine (data not shown). C. burnetii whole cells phase I and II 
when silver stained for protein, revealed few distinct bands, and appeared 
smeared. Two bands were evident however, at 62 kDa and at <29 kDa in phase II 
organisms (Fig 4.8). Protein silver staining of phase I organisms revealed a protein 
at approximately 35 kDa and a number of low molecular weight (<29 kDa) minor 
bands (Fig 4.8). No protein was detected in the LPS I lane (data not shown). 
4.4.4.3 Proteinase K treatment of concentrated ELISA-reactive fractions 
4.4.4.3.1 SDS-PAGE analysis 
Concentrated ELISA-reactive fractions were separated by SDS-PAGE and silver 
stained for LPS after proteinase K treatment. The SDS-PAGE profile (LPS) 
revealed one band at approximately 35 kDa (Fig 4.9). Inactivated C. burnetii phase 
I and 11 whole cells and LPS I underwent identical proteinase K treatment which 
revealed a similar band at 35 kDa. No bands were detected in non-infected guinea 
pig urine treated with proteinase K or in proteinase K and buffer only (Fig 4.9). 
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Fig. 4.7 SUS-PAGE analysis of pooled, concentrated ELISA-reactive fractions 
from the size exclusion column. Samples were silver stained for protein. 
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Lane 1= Pooled, concentrated fraction 1 from non-infected guinea pig urine 
(negative control). 
Lane 2= Pooled, concentrated ELISA-reactive fractions. 
Lane 3= Molecular weight markers (kDa). 
Fig. 4.. 8 SDS-PAGE analysis of C. burnetii inactivated whole phase l and 11 
cells. Samples were silver stained for protein. 
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Lane 1= Molecular weight markers (kDa). 
Lane 2= C. burnetii phase II whole cells. 
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Lane 3= C. burnetii phase I whole cells. 
Fig. 4.9 SDS-PAGE analysis of C. burnetii whole cells phase 1,11 LPS I and 
ELISA-reactive fractions, after proteinase K treatment. 
Samples were silver stained for LPS. 
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Lane 1= Molecular weight markers (kI)a). 
Lane 2= C. burnelii phase 11 whole cells. 
Lane 3= C burnetii phase 1 whole cells. 
Lane 4= Pooled, concentrated ELISA-reactive fractions. 
Lane 5= Non-infected guinea pig urine treated with proteinase K. 
Lane 6= Proteinase K in buffer only (negative control). 
Lane 7= Lipopolysaccharide from C. bur netii phase I (LPS 1), (positive control). 
4.4.4.3.2 Analysis by ELISA 
Concentrated ELISA-reactive fractions were incubated with and without proteinase 
K to determine if reactivity was due to LPS. LPS, prepared from C. burnetfi phase 
I whole cells, was added to PBS and similarly incubated to serve as a positive 
control. Non-infected guinea pig urine was also incubated with and without 
proteinase K as a negative control. The reactivity of each sample was then assessed 
by direct ELISA against rabbit anti-C. burnetil phase II antibody. The results are 
summarised in Fig 4.10. A decrease in reactivity in the ELISA-reactive fractions, 
was detected after proteinase K treatment, however, some reactivity above 
background levels (negative controls) was retained. A small reduction in reactivity 
was detected in LPS controls after proteinase K treatment. 
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Fig 4.10 Reactivity of ELISA-reactive fractions after proteinase K 
treatment, as measured by direct ELISA 
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Key: LPS-K = LPS I with no proteinase K treatment 
LPS+K = LPS I with proteinase K treatment. 
Frac. -K = ELISA-reactive fractions with no proteinase K treatment. 
Frac. +K = ELISA-reactive fractions with proteinase K treatment. 
-ve-K = Non-infected guinea pig urine with no proteinase K treatment. 
-ve+K = Non-infected guinea pig urine with proteinase K treatment. 
4.4.4.4 PCR analysis of ELISA-reactive fractions 
Concentrated ELISA-reactive fractions, proved negative for the presence of C. 
burnetii DNA. Product was detected in positive controls (organisms from egg yolk 
extract). 
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4.4.4.5 Western immunoblotting against concentrated ELISA-reactive 
fractions, and C. burnetii phase I and II whole organisms 
Concentrated ELISA-reactive fractions, LPS I, inactivated phase I and II whole 
cells and concentrated fraction 1 from non-infected guinea pig urine (fraction 1 
reacted in the direct ELISA, Fig. 4.4,4.5,4.6), were separated by SDS-PAGE and 
then transferred to nitrocellulose membranes. Membranes were immunoblotted 
with purified rabbit anti-C. burnetii IgG (as used in the capture ELISA in Chapter 
3, and the direct ELISA this chapter). 
One band with a molecular weight of 62 kDa was observed from the ELISA- 
reactive fractions and one band at 67 kDa was observed in the concentrated 
fraction 1 lane. One band was detected at 35 kDa in the LPS I lane (Fig 4.11). A 
smear was observed in the high molecular weight region of both C. burnetii phase I 
and II whole cells. In addition bands were evident at approximately 35- 40 kDa in 
phase I whole cells and 62 kDa in phase II whole cells (Fig 4.12). 
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Fig. 4.11 Immunoblot analysis of concentrated, pooled ELISA-reactive 
fractions, concentrated pooled fraction I (from non-infected guinea pig urine) and 
LPS I using anti-C burnetii phase 11 IgG antibody. 
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Lane 1= Molecular weight markers (kI)a). 
Lane 2= Pooled, concentrated ELISA-reactive fractions. 
Lane 3= Pooled, concentrated fracton 1 from non-infected guinea pig urine. 
Lane 4= Lipopolysaccharide from C. burnetii phase I (LPS 1). 
Fig. 4.12 Immunoblot analysis of C. burnetii whole inactivated phase I and II 
cells, using anti-C. hurnetii phase II IgG antibody. 
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MWM= Molecular weight markers (kDa). 
Lane 1= C. hurnetii whole inactivated phase II cells. 
Lane 2= C. burnetii whole inactivated phase I cells. 
4.4.4.6 Reactivity of polyclonal antiserum raised against ELISA-reactive 
fractions 
Guinea pig serum, raised against concentrated ELISA-reactive fractions from 
infected guinea pig urine was produced to identify the C. burnetii-specific antigen. 
Whole inactivated phase I and II C. burnetii were coated onto an ELISA plate. 
Guinea pig "anti-ELISA-reactive fractions" antiserum, when tested in ELISA, 
showed higher levels of reactivity to C burnetii phase I and II organisms than 
negative control guinea pig sera (Fig 4.13). Reactivity was greater against phase II 
than I organisms; however the titre of the sera was low. 
Fig 4.13 Reactivity of guinea pig "anti-ELISA-reactive fractions" sera in 
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In Western immunoblotting, the guinea pig "anti-ELISA-reactive fractions " 
serum reacted against a protein with an approximate molecular weight of 62 kDa, 
which was present in the purified ELISA-reactive fractions (Fig 4.14). No 
reactivity was detected against C. burnetii phase I and II organisms or LPS from 
phase I organisms using Western immunoblotting or IFA with "anti-ELISA- 
reactive fractions" serum (data not shown). 
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Fig. 4.14 Immunoblot analysis of ELISA-reactive fractions using guinea pig 
anti "ELISA-reactive fractions" antibody. 
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Lane 1= Molecular weight markers (kDa). 
Lane 2= ELISA-reactive fractions. 
4.4.4.7 Summary of results 
A summary of the results is shown in fig. 4.15 below, based on the strategy 
outlined at the beginning of this chapter (fi g. 4. I). 
Fig. 4.15 Summary of antigen characterisation results 
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4.5 Discussion 
Chapter Three of this study demonstrated that a capture ELISA could detect C. 
burnetli-specific antigens in the urine of guinea pigs experimentally infected with 
C. burnetii. The nature of the antigen detected, however, was not determined. 
The aim in this section of the study was to characterise the antigen(s) excreted in 
the urine of guinea pigs during C. burnetii infection. 
4.5.1 Determination of whole C. burnetli in urine from infected guinea pigs 
Two methods were employed to determine the presence of viable C. burnetli in 
urine from infected guinea pigs. Intraperitoneal inoculation of suspected C. 
burnetii-containing material into guinea pigs produces a C. burnetii-specific 
antibody response. This antibody response is dependant on the multiplication of C. 
burnetii within the guinea pig and can be produced from an initial inoculum 
containing as few as 1-10 organisms (Waag et al., 1991) and is therefore highly 
sensitive. Intraperitoneal inoculation is a standard procedure for the isolation and 
determination of C. burnetii in tissue samples from human and animal origin, and 
the guinea pig is the animal of choice due to increased susceptibility to C. burnetii 
infection. Animal inoculation is particularly useful when potentially contaminated 
samples such as urine are used. The immune system of the animal is able to clear 
bacterial contaminants to allow the growth of C. burnetii. The appearance of C. 
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burnetii-specific titres to phase II whole organisms, in guinea pigs inoculated with 
urine from guinea pigs infected by aerosol with a high dose of C. burnetil (group 
1}, suggested that C. burnetii-specific antigen was present in the initial inoculum. 
In addition, homogenised tissues of liver and spleen from group 1 animals, when 
inoculated, produced an equivalent anti-C. burnetfi phase II antibody response to 
that seen with urine. Without supportive clinical data however, showing a febrile 
response indicative of C. burnetii infection, the presence of viable C. burnetii 
within urine and tissues remains unconfirmed. 
Attempts to isolate C. burnetii from urine and homogenated organs in tissue culture 
were unsuccessful. Samples may not have contained any viable C. burnetil 
organisms, or the number of organisms in the samples may have been too few to be 
detected by tissue culture techniques. It has been reported that strains of C. burnetil 
which were infective for mice were markedly less infective for L929 mouse 
fibroblast cells (Ormsbee et al., 1978). For tissue culture to be effective, C. 
burnetii must be taken up by the monolayer of cells. Centrifugation of organisms 
onto cells in shell vials, giving a 2-to 4-fold increase in adsorbed organisms, has 
been reported by (Raoult et al., 1990b). In this study, no such centrifugation step 
was employed and, therefore, the sensitivity of the tissue culture method may 
have been too low. Negative tissue culture does not exclude the possibility of 
whole viable organisms being present in the samples, but may indicate that few 
organisms were present. 
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The PCR technique, which was successful at detecting C. burnetii DNA in tissue 
samples (section 2.3.6), was applied directly to the detection of C. burnetii DNA in 
urine samples. No C. burnetii DNA was detected in any urine samples tested, 
however, this did not exclude the presence of C. burnetii DNA in the samples as a 
number of factors may have affected the outcome. The concentration of urea in 
normal human urine ranges from approximately 0.125 M to 0.25 M (Strasinger, 
1989). It has been reported that urea at a concentration of 0.5 M can completely 
inhibit a PCR reaction (Gelfand & White, 1990), however, other workers have 
reported no such inhibition (Maiwald et at., 1995) for the detection of L. 
pneumophila DNA in guinea pig and human urine. In addition, ammonium 
chloride (another component of urine ) has been reported to inhibit the PCR 
reaction (Gelfand & White, 1990). Failure to detect a PCR product in urine may be 
due to either or both these factors. In addition, the detection system used in this 
study (ethidium bromide staining), although sensitive enough to detect a specific 
product from infected tissues, may not have been sensitive enough to detect low 
levels amplified from urine. Silver staining of gels or radiolabelling of PCR 
products could improve the sensitivity of the technique. Degradation of C. burnetil 
DNA by endogenous DNAases present in urine, resulting in fragments of DNA 
too small to be amplified by the primers, may also explain the absence of a 
product. Also, the volume of urine extracted may have been insufficient to yield 
enough DNA for successful amplification. 
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In conclusion, animal inoculation studies indicated that C. burnetii-specific antigen 
was present in urine from animals which received a high dose of C. burentii by the 
aerosol route (group 1). Other methods of isolation for whole C. burnetii were 
unsuccessful. 
4.5.2 Determination of C. burnetil components in urine from C. burnetii- 
infected guinea pigs. 
It is possible that as well as whole organisms being excreted into the urine of C. 
burnetii-infected animals, soluble products of the organism are also excreted. This 
has been demonstrated in other diseases. Individuals with acquired 
immunodeficiency syndrome (AIDS) and disseminated Mycobacterium avium 
disease have been shown to excrete a protein antigen with a molecular weight of 
22.5 kDa in their urine. Cytomegalovirus was diagnosed by a monoclonal antibody 
directed against a 150-kDa protein antigen in the urine of patients (Yamanaka et 
al., 1992) and dogs experimentally infected with Trypanosoma cruzi were shown 
to excrete an 80-kDa glycoprotein urinary antigen (Corral et al., 1989). In addition, 
individuals suffering from leprosy produce a 35-70 kDa cell wall antigen 
(probably a phosphoglycolipid) in their urine (Sharma et al., 1992). 
Size exclusion chromatography has been employed during studies on urine 
obtained from experimental infection studies on pneumoccocal and Legionella 
pneumophila infections (Coonrod, 1983) and (Williams, A. & Lever, 1995). Size 
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exclusion chromatography, followed by a direct ELISA on eluted fractions, 
incorporates a number of advantages. Firstly, urines are filtered through a 0.1µm 
filter prior to loading onto the chromatography column. This removes whole C. 
burnetii organisms and cellular and particular material which may interfere with 
the ELISA. Secondly, filtering renders the urine safe to work with outside a class 
III safety cabinet, and thirdly, any inhibitory components, which are able to pass 
through the filter, are separated from antigen(s) by molecular size on the column. 
Direct ELISA was used as a final screening method to detect any specific 
antigen(s) present. 
In this study, for comparative purposes, non-infected guinea pig urine spiked with 
purified LPS from phase I C. burnetii Lane strain was separated by size exclusion 
chromatography (fig 1). The region of reactivity, detected by direct ELISA, in 
fractions 8-15 of LPS spiked urines was also detected in urine obtained from 
guinea pigs in groups land 3 (high and low dose by aerosol, respectively). No such 
reactivity was evident in non-infected urines, or urines from guinea pigs suffering 
from other respiratory diseases such as Legionniares'disease or Mycobacterium 
tuberculosis. This indicated that the reactivity seen in fractions 8-15 was specific 
for C. burnetii infection only and was of a comparable molecular weight to LPS 
from C. burnetil. This suggested that the antigenic product in guinea pig urine 
could be an LPS-related component. 
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Reactivity detected in fraction 1, during the separation of selected urines, was due 
to a non-specific component, with an approximate molecular weight of 67 kDa, 
when run under reduced conditions on SDS-PAGE. Gel filtration, however, 
removed this non-specific component which was not present in fractions 8-15. A 
non-specific serum component may be present in urine from all guinea pigs in 
greater or lesser amounts, and could explain why some urines showed no 
reactivity in fraction 1 whereas other urines did react. The molecule, ß2 - 
microglobulin, was discussed in Chapter 3 of this study as being a possible 
reaction inhibitor. Indeed, control experiments of urine spiked with ß2 - 
microglobulin in this chapter (Fig 4.4) indicated that low levels of cross-reactivity 
occurred between the anti-C burnetii IgG antibody and fractions 1-8 of separated 
urine containing P2' microglobulin. This provided further evidence, therefore, that 
P2 - microglobulin was a possible cause of the reaction inhibition observed. 
The detection of antigenic product in fractions 8-15 was related to the initial 
challenge dose. Guinea pigs administered the high challenge dose (group 1) 
demonstrated specific reactivity in fractions 8-15 from day 2 post infection. 
Animals given the low challenge dose (group 3) showed no specific reactivity in 
fractions 8-15 until day 5 post infection. Similar findings in experimental 
brucellosis in mice were reported by (Limet et al., 1988), where the LPS-related 
antigen in urine appeared sooner in animals challenged with the higher infective 
dose. Furthermore, a correlation between initial infective dose, disease state and 
the quantity of antigen eluted in fractions 8-15 was observed. By day nine post 
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infection, when guinea pigs had severe anorexia, pyrexia and a widespread, 
disseminated infection (data from chapter 2), large quantities of antigenic product 
were evident in the urine. Equivalent levels of antigen were not detected in the 
urine of those guinea pigs challenged with low dose C. burnetii (group 3), and 
probably reflects the less severe infection seen in these animals. 
All urines from animals given high infective dose by aerosol (group 1) tested 
positive for C. burnetii antigen, independant of the time post-infection. Until 9 
days post-infection, fraction 8 contained the majority of the reactivity, -indicating 
that a higher molecular weight antigen was being excreted into the urine of infected 
guinea pigs. As infection progressed (by 8 and 9 days post infection), a broader 
range of molecular weight antigens were detected. 
This trend was not seen in animals administered with a low challenge dose (group 
3). The molecular weight of the antigens shed into the urine of these animals was 
lower and independant of time post infection. The range of antigenic molecular 
weights detected, therefore, was related to the severity of the disease. This 
suggested that the specific C. burnetii antigens detected in the urine of infected 
animals remained within a defined molecular weight range i. e. 300 kDa- 2,000 
kDa. It also indicated that degradation of the antigens may have occurred, or that a 
greater number of antigenic products were appearing in the urine as infection 
progressed. (Coonrod, 1983) reported polysaccharides that appeared in urine, and 
which degraded over time, producing progressively smaller molecular weight 
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polysaccharides. This polysaccharide degradation, however, occurred after 
purified polysaccharide had been injected into rats and was not produced as a result 
of infection. In contrast, (Williams, A. & Lever, 1995) found that in experimental 
Legionnaires' disease in guinea pigs, LPS with a consistent molecular weight, 
was detected in the urine of infected animals throughout the course of infection. 
Soluble polysaccharides are produced during growth of pneumococci both in vivo 
and in vitro and are able to cross serous membranes to be excreted into the urine 
(Coonrod, 1979,1983). Other infections also result in specific polysaccharide 
antigens being excreted in the urine of infected individuals. Some of these are 
summarised in Table 4.3 below. 
Table 4.3 Infections resulting in excretion of specific polysccharides into 
urine 
... .. Organism/ e once 
Haemophilus influenzae type b (Kaldor et al., 1979), 
(Suksanong & Dajani, 1977), 
Neisseria meningitidis (Feigin et al., 1976), 
pneumococcal pneumonia (Coonrod, 1974), 
(Coonrod & Rytel, 1973) 
streptococcal infections (Seigal & McCracken, 1978) 
Legionella pneumophila (Williams, A. & Lever, 1995) 
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Evidence that the antigenic product, identified in urine from C. burnetii-infected 
guinea pigs, was associated with an LPS molecule was provided by resistance to 
proteinase K digestion. Silver staining for LPS revealed a common 35 kDa 
molecule present in C. burnetii phase I and II whole cells, LPS I and concentrated 
guinea pig reactive fractions. A 35 kDa antigen, was recognised by the rabbit anti- 
C. burnetii phase II antibody in phase I organisms and LPS I, but no such antigen 
was detected in C. burnetii phase 11 organisms or concentrated guinea pig reactive 
fractions by Western immunblotting techniques. This study confirmed, therefore, 
that LPS present on whole phase II cells was sufficiently immunogenic to induce 
an immune response, in rabbits, to phase I LPS and whole phase I cells, {as 
previously reported by (Williams, J. C. & Waag, 1991)}. The response, however, 
was not sufficient to show a reaction with phase II whole cells in Western 
immunoblotting. C. burnetii phase II whole cells, have been shown to contain 
approximately ten times less extractable LPS than C. burnetii phase I cells (Baca 4 
Paretsky, 1983), consequently, low sensitivity of the rabbit antibody for LPS or 
low levels of LPS present in the guinea pig fractions, may explain the lack of 
reaction. 
By the more sensitive ELISA procedure reduced reactivity was detected in guinea 
pig reactive fractions following incubation with proteinase K. This indicated that a 
proportion of the epitopes detected by the antibody in ELISA were sensitive to 
proteinase K. A small amount of reactivity remained which suggested that a 
proportion of the antigenic determinants in the guinea pig reactive fractions were 
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proteinase K-resistant and therefore LPS in origin. Likewise, the LPS control 
showed a reduction in reactivity after incubation with proteinase K, although a 
significant proportion of the reactivity remained. This was also found to be the case 
in antigen detected in urine from L. pneumophila-infected guinea pigs (Williams, 
A. & Lever, 1995). This showed that LPS from C. burnetti was resistant to 
proteinase K and that the guinea pig reactive fractions also contained a proportion 
of resistant antigens. This suggested that there was either (a) two antigenic 
products detected by ELISA, one of which was protein and the other LPS in origin, 
or (b) there was only one antigenic product, and this showed reduced reactivity 
following incubation with proteinase K. 
Immunoblots showed that the rabbit anti-C. burnetii phase II antibody recognised a 
62 kDa antigen, present in C. burnetii phase 11 whole cells and concentrated 
guinea pig reactive fractions, but not recognised in phase I whole cells or LPS I. 
(Williams, J. C. et al., 1990) reported a 62-kDa protein which was present in large 
amounts on the surface of phase II cells, but was not identified using polyclonal 
antibodies, on the surface of phase I cells. Failure to identify the protein on phase I 
cells may have been due to the close association of the protein with other 
molecules which caused stearic hinderance, or failure of the polyclonal antibodies 
to recognise the native conformation of the protein. Membrane lipids or phase I 
LPS have been shown to mask protein antigenic determinants, which were 
subsequently exposed after conversion from phase I to phase 11 (Williams, J. C. et 
al., 1986b) and (Williams, J. C. & Waag, 1991). This may explain the lack of 
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reactivity of the polyclonal antibody against such a 62 kDa protein in phase I 
organisms in this study. 
This evidence suggested that two separate antigens were excreted into the urine of 
C. burnetii-infected guinea pigs. The first was a protein antigen, of 62 kDa 
molecular weight, which was detectable by immunoblotting, and was also evident 
when phase II organisms were separated by SDS-PAGE. The second, was an LPS 
antigen of approximately 35 kDa molecular weight, which was present in fractions 
8-15, phase I organisms and LPS I, but not detectable in fractions 8-15 or phase II 
cells by immunoblotting, but remained reactive in ELISA alter the enzymatic 
removal of protein. 
Polyclonal antiserum was raised in guinea pigs against the concentrated guinea pig 
reactive fractions to determine the immunogenicity of the C. burnetii-specific 
antigen. Guinea pigs were immunised with the ELISA-reactive fractions 8-15 to 
produce only C. burnetii-specific antibodies with no contaminating antibodies 
against guinea pig components. The serum proved reactive in both immunoblotting 
and ELISA. Antibodies specific for anti-C. burnetil phase I and II whole cells, and 
concentrated guinea pig reactive fractions, were demonstrated by ELISA. A 62 
kDa antigen was identified when reactive guinea pig fractions were separated by 
SDS-PAGE and immunoblotted with the fractions 8-15 serum. No reaction, 
however, was detected against phase I or II cells, but the reaction with the 62 kDa 
antigen in immunblots corroborated the results seen earlier, using the rabbit anti- 
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C. burnetii phase II antibody, and proved this to be the immunodominant antigen in 
the guinea pig reactive fractions. Reactivity of the anti-fractions 8-15 serum in 
ELISA against C. burnetii phase I and II cells did not provide further evidence as 
to the nature of the antigen appearing in guinea pig urine. It did however, prove 
that the antigen was C. burnetfi-specific and immunogenic in guinea pigs. 
The end-point titre of the guinea pig anti-fractions 8-15 serum against C. burnetii 
phase I and II, in ELISA was low (between 1/128 -1/256). Corresponding 
absorbance levels were also low, which indicated that the sensitivity of the 
antiserum was low. This low sensitivity may explain the non-reactivity against 
phase I and II cells observed in less sensitive techniques such as immunoblotting 
and immunofluorescence. Highly purified antigens, containing concentrations as 
low as 50µg of total protein, have been reported as successful at inducing an 
immune response in rabbits, and a normal inoculum may contain between 0.1- 5.0 
mg of protein (Jurd, 1987). Total protein estimates indicated that protein 
concentrations in the reactive fractions contained 0.18 mg/ml; however, only a 
small percentage of this total protein content may be C. burnetil-derived. The final 
solution, inoculated into guinea pigs, therefore, may have contained sub-optimal 
concentrations of C. burnetii material than required, to elicit a strong antibody 
response. 
In conclusion, this chapter has provided evidence that viable C. burnetii organisms 
are present in the urine of aerosol-infected guinea pigs. In addition, a 62 kDa 
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soluble immunoreactive C. burnetii-specific protein antigen is present in the urine 
of experimentally-infected guinea pigs. Evidence also suggests that LPS is present 
in the urine. The quantity and appearance of the antigenic product(s) in the urine is 
related to the initial infective challenge of C. burnetii. 
A method has been described, using size exclusion chromatography followed by a 
direct ELISA, to detect these antigens and the next Chapter will investigate the 
effect of doxycycline and ciprofloxacin on the appearance of the antigenic product 
described above, in urine. The application of urinary antigen detection as a 
marker for antibiotic efficacy will then be assessed. 
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CHAPTER 5 
Use of C. burnetii-urinary antigen as a means of assessing the 
efficacy of doxycycline and ciprofloxacin in the treatment of 
experimental Q fever in guinea pigs 
5.1 Introduction 
Three methods of assessing antibiotic efficacy against C. burnetii have been 
utilised in the past: animal models, chick embryos (eggs) and cell culture (Yeaman 
and Baca, 1990; Yeaman, et al 1989 and Raoult, et al, 1989). Antibiotic efficacy 
against experimental infection in animals, is often determined by clinical 
symptoms, serology and the quantification of organisms in tissues such as the 
spleen and liver. To obtain such data, homogenated infected tissues are inoculated 
into either eggs or tissue culture, and the lethality in eggs or cells can be 
correlated directly to the number of C. burnetil present in the tissue. These figures 
are expressed in tissue culture infective doses (TCID50) or egg infectious doses 
(EID50). Infected embryonated eggs or tissue culture systems for determining C. 
burnetii antibiotic susceptibility also rely on the comparison of TCID50 or EID50 
between treated and untreated groups. 
An experimental infection that accurately models the disease seen in humans can 
provide the opportunity to determine the efficacy of antibiotic treatment. 
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Pharmacokinetic and pharmacodynamic data can be obtained and antibiotic 
concentrations in tissues can be determined and compared to levels that are 
achievable in humans. Both chick embryos and cell culture, are more convenient, 
less expensive and require less extensive containment facilities than in vivo 
methods. For facultative intracellular organisms such as C. burnetii, however, 
minimum inhibitory concentration (MIC) and minimum bacteriocidal 
concentration (MBC) values obtained using in vitro techniques often differ 
markedly from those obtained by in vivo methods (Jepras, et al 1985). 
In Chapter four, C. burnetii-specific antigens were identified, that appeared in the 
urine of C. burnetii-infected guinea pigs by the aerosol route. The usefulness of 
these antigens as a marker of efficacy during treatment of C burnetti infection with 
doxycycline and ciprofloxacin was investigated. If successful the technique could 
provide physicians with an early means to monitor antibiotic efficacy during 
patient management of C. burnetli infection. 
A similar approach was investigated with urine obtained from humans suffering 
from Legionnaires' disease (Kashuba & Ballow, 1996). Such studies showed that 
by ten days post antibiotic treatment, a small number of patients (4 %) became 
urinary antigen negative. In the same study, however, 3% of patients remained 
urinary antigen positive for more than one hundred days after initiation of 
antibiotic therapy. Results suggested that the use of urinary antigen as a marker of 
177 
disease, and subsequently as a method to monitor clearance of infection, was 
variable. 
Acute Q fever in humans, when diagnosed promptly, has been successfully treated 
with a number of antibiotics including lincomycin, erythromycin, chloramphenicol 
and the antibiotic of choice, doxycycline. In addition, the fluoroquinalone, 
ciprofloxacin, has been shown to be effective against C. burnetii strain Nine Mile 
in a persistently infected tissue culture model (Yeaman and Baca, 1990). 
In this study, the efficacy of doxycycline and ciprofloxacin against C. burnetil in a 
guinea pig model of acute C. burnetii infection was investigated. Guinea pigs were 
infected with C. burnetii Lane strain by the intraperitoneal route. Febrile response, 
weight loss, serology and direct antigen detection by PCR were used to monitor the 
course of infection. 
5.2 Aim of Study 
The aim of this part of the study was to determine the excretion of C. burnetii 
antigens in urine over time, obtained from experimentally-infected guinea pigs 
after antibiotic treatment. The detection of urinary antigen would be assessed as a 
marker for disease and compared to other disease markers such as febrile response, 
weight loss, serology and direct antigen detection in tissues. Finally, detection of 
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C. burnetii-specific antigen in urine would be used as a parameter for assessment 
of antibiotic efficacy against C. burnetii. 
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5.3 Materials and methods 
5.3.1 Intraperitoneal infection 
Guinea pigs were divided into five groups. Group A consisted of eighteen guinea 
pigs which were inoculated intraperitoneally with O. lml suspension containing 
approximately 109 organisms ml*'. Groups B and C each contained fourteen 
animals, infected as above, and treated with either doxycycline or ciprofloxacin 
(see Section 5.3.3). The remaining two groups of fourteen animals were not 
infected but were administered doxycycline or ciprofloxacin at an equivalent dose 
to above. Animals were killed at 28 days post-infection and tissue and blood 
samples for PCR analysis and measurement of the serological response were taken 
from two animals approximately every four-seven days. 
5.3.2 Urine samples 
Urine was obtained from infected guinea pigs by manual expression of the bladder. 
Samples were taken at the same sample times as tissue and blood samples 
(approximately every four-seven days). Urine from four animals was removed each 
sample day and pooled. 
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5.3.3 Antibiotic administration 
Doxycycline (Pfizer) and ciprofloxacin (Bayer) were administered subcutaneously 
(O. lml) immediately post-C. burnetii infection, at a concentration of 10 mg kg'I 
body weight (Lever et al., 1998). Treatment continued every 12 hours for 5 days 
post-infection. The dose level of antibiotic was based on previous work performed 
on antibiotic prophylaxis for experimental inhalation anthrax at CAMR (Jones et 
al., 1994) and was approximately equivalent to a human dose of 600 mg daily. To 
prevent the establishment of clinical infection the short-term efficacy of 
doxycycline and ciprofloxacin treatment immediately after exposure was 
investigated in this study. The doseage schedule was therefore predetermined based 
on existing practice. 
5.3.4 Urinary antigen detection 
Urine samples were treated and separated by size exclusion chromatography as 
described in Section 4.3.3. Fractions were tested for specific C. burnetil reactivity 
by direct ELISA as previously described (4.3.4). Fractions eluting between 8-15 
ml, which proved positive by direct ELISA, were considered to contain C. 
burnetii-specific antigens (Section 4.4.3). Positive fractions were those which had 
an absorbance value in the direct ELISA greater than twice the standard deviation 
of non-infected urine (background). 
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5.4 Results 
5.4.1 Clinical signs 
A febrile response of greater than 40°C was detected in infected, untreated animals 
between 4 and 8 days post-infection (Figs 5.1,5.2). Ciprofloxacin administered at 
10 mg/kg proved ineffective at reducing pyrexia, with temperatures of treated 
animals remaining in-line with those of untreated controls. However, doxycycline 
administered at 10 mg/kg reduced pyrexia, between day 4 to 8 post-infection to 
near normal levels. 
During the course of the infection the guinea pigs were inactive during -the febrile 
phase of illness and reduced their intake of food and water, which affected their 
weights and general condition. Noticeably, the guinea pigs inoculated with C. 
burnetii that received no antibiotic, did not put on any weight during the first 7 
days post-infection, after which there was a gradual weight increase. In contrast, 
the condition of guinea pigs treated with doxycycline (10 mg/kg) showed no 
evidence of anorexia and developed normally. 
Treatment with ciprofloxacin (10 mg/kg) did not alter the course of disease with all 
animals showing characteristic signs of C. burnetii infection. In addition, the 
animals showed some distress to the administration of the antibiotics (Figs 5.3, 
5.4). 
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5.4.1.1 Pyrexia 
Fig 5.1 Temperature of guinea pigs treated with doxycycline 
immediately after C. burnetii infection. Values represent the mean of four 
animals 
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Fig 5.2 Temperature of guinea pigs treated with ciprofloxacin 
immediately after C. burnetii infection. Values represent the mean of four 
animals 
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5.4.1.2 Weight 
Fig 5.3 Weight of guinea pigs treated with doxycycline immediately after C. 
burneiii infection. Values represent the mean of four animals 
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Fig 5.4 Weight of guinea pigs treated with ciprofloxacin immediately after 
C. burnetii infection. Values represent the mean of four animals 
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5.4.2 Serology 
Doxycycline treatment reduced the level of anti-C. burnetii IgM phase II antibody 
responses compared to infected, untreated control animals (Fig 5.5). Treatment 
with doxycycline delayed the appearance of anti-C. burnetif IgM antibodies until 
15 days post-infection, compared to 9 days post-infection in infected control 
animals. Levels then gradually increased to a maximum at 22 days post-infection. 
Ciprofloxacin treatment reduced the level of anti-C. burnetii IgM phase II antibody 
responses compared to infected, untreated control animals (Fig 5.6). Anti-C. 
burnetii IgM antibodies appeared at 9 day post-infection, in both treated and 
untreated animals; however, levels peaked lower and earlier in ciprofloxacin- 
treated animals compared to infected controls. 
Doxycycline treatment greatly reduced the level of anti-C. burnetii IgG phase II 
antibody responses compared to infected, untreated control animals. In the 
untreated infected controls, anti"C. burnetfi phase II IgG antibodies appeared on 
day 9 post-infection, peaking at day 19 post-infection. In comparison, antibodies 
produced in infected animals treated with doxycycline did not appear until day 15 
post-infection. Antibody levels then gradually increased to a level (1: 50000) at day 
28 post-infection compared to 1: 25000 in untreated infected controls (Fig 5.7). 
Ciprofloxacin treatment proved less effective than doxycycline when comparing 
antibody production as a measure of infectivity. Treatment with ciprofloxacin did 
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not delay the appearance of anti-C. burnetii phase II IgG antibodies, but antibody 
responses were diminished between 13 and 22 days post-infection (Fig 5.8). 
Fig 5.5 Appearance of anti-C. burnetii IgM antibodies in guinea pigs 
treated with doxycycline immediately after infection. Points indicate the mean 
of two animals 
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Fig 5.6 Appearance of anti-C. burnetii IgM antibodies in guinea pigs treated 
with ciprofloxacin immediately after infection. Points indicate the mean of two 
animals 
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Fig 5.7 Appearance of anti-C. burnetii IgG antibodies in guinea pigs treated 
with doxycycline immediately after infection. Points indicate the mean of two 
animals 
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Fig 5.8 Appearance of anti-C. burnetii IgG antibodies in guinea pigs treated 
with ciprofloxacin immediately after infection. Points indicate the mean of two 
animals 
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5.4.3 PCR 
C. burnetii DNA was not detected in non-infected, antibiotic-treated animals 
(group A (dox) and group A (cip), Table 5.1). No C. burnetil DNA was detected in 
any organ examined after day 15 post-infection in any tissue in the infected 
controls (group B, Table 5.1). C. burnetii DNA was detected in the heart, lung, 
liver and spleen of infected animals treated with doxycycline and ciprofloxacin; 
however, more tissues proved positive in ciprofloxacin-treated guinea pigs (group 
D) than doxycycline-treated animals (group C), particularly the lung (Table 5.1). 
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Table 5.1 Detection of C. burne/ii DNA in tissues from non-infected, 
infected and antibiotic treated guinea pigs. Data based on two animals per 
sample point 
Day Dost-infection 
Tissue Grou 38 12 15 18 28 
A (dox) ------ 
A (cip) ------ 
Heart B-++--- 
C (dox) +----- 
D ci -+++-- 
A (dox) ------ 
A (cip) ------ 
--- Lung B-++ 
----- C (dox) + 
D ci -++--- 
A (dox) ------ 
A (cip) ------ 
--- Liver ß +` ++ 
C (dox) +----- 
D ci +++--- 
A (dox) ----- 
A (cip) ------ 
Spleen B +` +++-- 
C (dox) ++++-- 
D ci +' +++-- 
Key: 
Group A (dox) = Non-infected guinea pigs treated with doxycycline 
Group A (cip) = Non-infected guinea pigs treated with ciprolloxacin 
Group B= Infected guinea pigs with no antibiotic treatment 
Group C= Infected guinea pigs, treated with doxycycline 
Group D= Infected guinea pigs, treated with ciprolloxacin 
-= No C. burnetii DNA detected, +=C. burnetii 1)NA detected and +` = C. 
burnetii DNA detected in one animal only. 
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5.4.4 Urinary Antigen Detection 
Urines were separated on a size exclusion column (as described previously, 
Chapter 4) and fractions tested for C. burnetii-specific antigens using the rabbit 
anti-C. burnetii whole cell phase II antibody, in direct ELISA. Non-infected 
guinea pig urine was also separated and served as a negative control to provide 
background absorbance values. Fractions were considered positive for C. burnetli 
antigen if they reacted above background levels in ELISA and eluted in fractions 8- 
15 (as determined previously in Chapter 4, Fig 4.5 and 4.6). All urines which 
proved to contain C. burnetii antigens eluted in fractions 11-15. Throughout the 
duration of the study (19 days after infection), no C. burnetii-specific antigen was 
detected in the urine of non-infected guinea pigs. Levels of C. burnetii-specific 
antigen appeared at two days post infection (the first day tested) in infected, 
untreated control guinea pigs (Fig 5.9). Between three to nine days post-infection, 
however, antigen decreased below background levels in these animals. From nine 
days post-infection until the end of the study, antigen levels increased above 
background values. Levels decreased slightly at 18 days post-infection, but still 
remained above background values. Antigen levels in guinea pigs treated with 
doxycycline remained below background levels throughout the study, except at 5 
days post-infection where levels just above background levels were recorded. 
Antigen levels in guinea pigs treated with ciprofloxacin were greater than those 
detected in the doxycycline group. Peak values were recorded at five and nineteen 
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days post-infection, and levels were higher than background at twelve and fifteen 
days post-infection. 
Antigen levels in infected control animals were generally higher than those 
detected in urine from infected, treated animals. Day five post-infection proved the 
only exception to this. 
Fig 5.9 Detection of C. burnetii-specific urinary antigen in infected and 
treated guinea pigs. Background was defined as twice the standard deviation 
of the mean of non-infected urine. Points represent the mean of duplicate 
tests 
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5.5 Discussion 
5.5.1 Urinary antigen detection in untreated control animals 
Urine from guinea pigs infected intraperitoneally with C. burnetii has been shown 
to contain a C. burnetII-specific antigen by direct ELISA on FPLC-separated urine 
fractions. Animals were febrile from four to eight days post infection, and weight 
loss was evident throughout this period. In contrast, levels of urinary antigen were 
at their lowest throughout the same period. Immune responses such as antibody- 
antigen reactions and a generalised CMI response to an infection are responsible 
for the febrile response (Mims, C., A et al., 1995). The inflamatory response 
develops when C. burnetii are released from destroyed host cells, and in the 
guinea pig it is known to coincide with fever and weight loss (Khavkin, 1990). 
The excretion of C. burnetii-specific antigens into the urine may reflect the cyclic 
nature of the infection in the guinea pig. At one to three days post-infection, 
organisms from the original inoculum multiply within peritoneal phagocytes and at 
initial foci of infection in organs such as the liver and spleen. The antigen detected 
in the urine, therefore, from one to three days post-infection may originate from 
this initial infection. Four to eight days post infection, extensive ricketsiemia 
occurs, characterised by the febrile response and the development of the humoral 
and inflamatory response. The anti-microbial response in the guinea pig may 
temporarily reduce the quantity of antigen excreted into the urine by the 
development of circulating immune complexes (as has been reported by {Williams, 
J. C. et al., 1981)), and by the increased numbers of phagocytic cells. By nine 
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days post infection, the increase in antigen levels in the urine may represent the 
increased elimination products of phagocytosis. 
After day twelve post-infection, C. burnetii DNA was not detected in any organ 
tested from infected, untreated guinea pigs. This suggests that organs containing 
sites of infectious foci had successfully been cleared of C. burnetii. Urinary 
antigen, however, continued to be detected up to nineteen days post-infection (the 
end of the experiment), in infected only animals. This provided further evidence 
that the C. burnetii-specific antigen detected in the urine was an elimination 
product released from host phagocytic cells following clearance of the organisms 
from the tissues. 
Alternatively, the variation in levels of urinary antigen over time may be simply 
due to individual day-to-day and animal-to-animal variation. Urine was taken from 
four guinea pigs and pooled for each sample point. Levels of urinary antigen 
detected may vary, therefore, depending on small variations in the stage of the 
disease in each animal, and on other factors such as fluid intake and volume of 
urine collected. Pooling urine samples, however, would reduce animal-to-animal 
variation. 
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5.5.2 Urinary antigen detection in antibiotic treated animals 
PCR data, in combination with febrile response and serological evidence, 
suggested that doxycycline treatment reduced the number of circulating C. burnetii 
organisms, and that the severity of the disease in doxycycline treated animals was 
reduced. Indeed, levels of urinary antigen from guinea pigs treated with 
doxycycline was less than those detected in the infected only guinea pigs 
throughout the experiment, except at five days post-infection. Doxycycline 
treatment is known to be bacteriostatic for C. burnetti (Yeaman & Baca, 1990), and 
may have delayed the initial appearance of urinary antigen (detected at two to three 
days post-infection in infected only animals) until five days post-infection in 
treated animals. 
Ciprofloxacin treatment was shown to be ineffective at reducing the number of 
organisms present (as determined by serological evidence), and the severity of the 
disease (as determined by weight loss and pyrexia). Levels of urinary antigen 
detected at all sample points were higher than those levels from doxycycline 
treated animals. At five and nineteen days post-infection, levels of urinary antigen 
were higher than untreated controls. Greater variation was detected in the levels of 
antigen from ciprofloxacin-treated animals, and this may reflect the inherent 
fluctuation in levels of urinary antigen excreted throughout C. burnetil infection as 
mentioned earlier. 
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5.5.3 Intraperitoneal infection compared to aerosol infection 
Comparison of the excretion of urinary antigen from intraperitoneally-infected 
guinea pigs (this Chapter) with that from aerosol-infected animals (Chapter 3) was 
difficult, as the retained dose of each group was different. Guinea pigs challengd 
with high dose C. burnetii by the aerosol route (group 1, Chapter 3) developed 
severe disease characterised by a febrile response by two days post-infection (Fig 
2.1), high levels of mortality, and high, rising anti-C. burnetii antibodies (Fig 
2.3). Urinary antigen was detected, using the size exclusion column technique, 
from two days post infection (the earliest sample time) and at every day post 
infection, when tested, until animals were killed. By nine days post-infection, the 
high levels of urinary antigen reflected the severity of the disease (Fig 4.5). 
A much less severe disease was produced in guinea pigs challenged with a low 
dose by the aerosol route (group 3, Chapter 3). The febrile response occurred much 
later (approximately fourteen days post infection, Fig 2.2) and levels of urinary 
antigen were lower and primarily confined to the third and fourth week post- 
infection (Fig 4.6). In addition, no antigen was detected in the urine from some 
days sampled from this group of animals. 
In contrast, urinary antigen was detected consistently in the urine of guinea pigs 
infected with a high dose of C. burnetii by the intraperitoneal route (this chapter, 
Fig 5.10), on all days sampled from day 8 post-infection to the end of the 
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experiment (day 19 post-infection). In these animals, the febrile response oceured 
later than in animals which received high dose C. burnetii by aerosol (group 1), but 
earlier than animals which received a low dose of C. burnetii (group 3). In 
addition, the disease was less severe (no mortality occured) in intraperitoneally- 
infected guinea pigs, but more acute than that seen in animals infected with low 
dose C. burnetii by the aerosol route. This data suggests, therefore, that the 
appearance of specific urinary antigen is dependent on the initial infective dose 
rather than the route of infection. Consequently, consistent excretion of high levels 
of urinary antigen correlated with a high initial challenge dose. The route of 
infection was more important in determining the severity of the disease. 
This study has confirmed that the combined use of size exclusion chromatography 
and direct ELISA provides a direct antigen detection method for experimental C. 
burnetii infection in guinea pigs. Furthermore, after the initial filtering step, the 
procedure can be performed on the bench without category III containment 
facilities, and provides an extra parameter with which to measure the efficacy of C. 
burnetii treatment. 
In addition, levels of urinary antigen, in general, supported the febrile response 
data, serology, and PCR data which indicated that doxycycline was more effective 
than ciprofloxacin in the treatment of C. burneffi infection in the guinea pig. 
Variation in levels of urinary antigen from day-to-day (particularly in the levels of 
urinary antigen from ciprofloxacin-treated animals) suggested that the 
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determination of antibiotic efficacy could not rely solely on urinary antigen 
excretion. 
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CHAPTER 6 
Concluding discussion 
The aim of the studies presented in this thesis were to determine if C. burnetii 
antigens appeared in the urine in an experimental guinea pig model of Q fever, and 
if the detection of such antigens could provide the basis of a specific laboratory 
diagnostic test for Q fever. 
To this end a number of stages had to be achieved. Firstly, an experimental guinea 
pig model was established which accurately represented the characterisitic features 
that are recorded in acute Q fever in humans, in terms of clinical signs, serology 
and pathology. The primary route of transmission of C. burnetii to humans is via 
the aerosol route (Baca & Paretsky, 1983) and in this study guinea pigs were 
administered C. burnetii in a small particle aerosol. Infective doses for humans can 
be estimated by the onset time of the febrile response, which is dependent on the 
initial infective dose (Tigertt et al., 1961), but which normally ranges from 2-30 
days (Baca & Paretsky, 1983). In this study guinea pigs that received a low dose by 
the aerosol route, received a realistic infective dose of C. burnetii (approximately 
1-10 organisms) as demonstrated by initiation of a febrile response at 14 days post- 
infection. 
The severity of the disease was shown to be dependant on the route of infection, 
Mortality was a feature of guinea pigs infected with C. burnetü by the aerosol 
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route. In this study, the generation of infectious aerosols was achieved using a 
Collison nebuliser in conjunction with a contained Henderson apparatus. The 
primary feature of this system was the ability to generate, and deliver to the 
alveolus small infectious, monodispersed particles, less than 5 µm with a mean 
diameter of 1-2µm (Henderson, 1952; May, 1973). In such a system, single droplet 
nuclei would be delivered to the guinea pigs. The high rates of mortality and the 
infectivity of the Lane strain used in this study could therefore be due to the 
delivery system used. Particle size has been shown to be important to the eventual 
disease outcome for such organisms as Bacillus anthracis (Druett et al., 1953) and 
Yersinia pestis (Druett et al., 1956) where aerosol droplets that contained single 
organisms (approximately 1 µm) were more infective (in terms of mortality), than 
particles larger than 5 µm in diameter. Indeed, B. anthracis delivered as small 
particles (approximately 1µm) was 17 times more infective for guinea pigs than 
when the bacteria were delivered in 12 µm particles (Druett et al., 1953). 
Comparison with work recorded by (Marcie et al., 1996) and (La Scola et al., 
1997), where route of infection (intranasal versus intraperitoneal) was 
investigated, concluded that the route of infection and dose of inoculum 
determined the eventual disease outcome in acute Q fever. However, intranasal 
instillation results in flooding of the upper respiratory tract and produces relatively 
few particles small enough to be deposited in the terminal respiratory bronchioles 
and alveoli (Fitzgeorge et al., 1983). Other workers who have administered C 
burnetii by the aerosol route include (Kishimoto & Burger, 1977; Powanda et al., 
1978; Williams, J. C. et al., 1986a) and (Kazar et al., 1993b), however, mortality 
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rates reported by all these workers was less than in this present study. In addition, 
the delivery systems used, when stated, did not specify the size of the administered 
particles. The present study has therefore confirmed that C. burnetil is more 
infective when delivered by the aerosol route, and advanced the work of previous 
workers by suggesting that particle size may play an important role in the severity 
of the disease. 
C. burnetii exhibits pleomorphism, existing as both small and large cells, 
depending on the stage of the developmental cycle (McCaul, 1991). A delivery 
system, such as employed in the present studies, to deliver an aerosol to guinea 
pigs, would be more likely to select for smaller particles. A greater number of 
small cells would therefore be expected in the infectious aerosol delivered to the 
animals in this study. The small cell variant has been shown to be highly resistant 
to environmental stresses such as osmotic lysis and chemical disinfectants 
(McCaul, 1991) and would therefore be the most likely cell-type to be transmitted 
in aerosols from natural environments to hosts (McCaul et al., 1981). An 
experimental infection which selects for the small cell variant would more 
accurately reflect human infection with C. burnetü in the environment. Future 
studies could concentrate, therefore, on the relative infectivity and virulence, in 
guinea pigs, of the small and large cell variants and the effect of particle size on 
infectivity. 
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Aerosol transmission of C. burnetü Lane strain proved highly infectious for guinea 
pigs, persisting in heart tissues for up to thirteen weeks post-infection. Since the 
Lane strain originated from a patient suffering from chronic Q fever (endocarditis) 
current findings contradict the theory that strains associated with human 
endocarditis are highly infective but poorly pathogenic for guinea pigs (Waag et 
al., 1991). However, this work confirmed the findings of (Kazar et al., 1993a) that 
strains of C. burnetii associated with chronic disease were able, when delivered 
by the aerosol route, to cause disease in guinea pigs. To extend these findings, a 
greater number of strains associated with both chronic and acute disease need to 
be tested in our infection system. In addition, the persistence in tissue of those 
strains associated with acute disease needs to be investigated in the future. 
The specific laboratory diagnosis of C. burnetil relies on a number of procedures 
including serodiagnosis, culture, DNA amplification and immunodetection of C. 
burnetii in tissues (Fournier et al., 1998). In the experimental guinea pig model of 
C. burnetii infection developed in this thesis, it was possible to compare the 
detection of C. burnetii-specific antigen in urine to detection by serology. The 
capture ELISA described (Chapter 3), proved able to consistently detect C. 
burnetii-specific antigens in the urine of infected guinea pigs that had been 
administered a low dose of C. burnetfi, from day 10 post-infection until day 43 
post-infection. An anti-C. burnetil whole cell phase II antibody response was also 
evident at day 10 post-infection. The data show that the detection of urinary 
antigen provides a novel method, using a non-invasive technique, for the rapid 
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detection of acute experimental Q fever infection. In addition, the detection of C. 
burnetii antigen in urine provides direct evidence of current infection, as do 
techniques such as PCR, culture and immunodetection (Fournier et a!,, 1998). A 
longitudinal study was not performed comparing the detection of urinary antigen 
with such techniques, as the number of animals involved was prohibitive in terms 
of cost of animals and practical difficulties of working within a category 3 animal 
containment facility for long periods of time. However, post mortem samples 
tested for the presence of C. burnetii by PCR and immunodetcction (Chapter 2) 
indicated that antigen was present 92 days post-infection in the heart and lungs of 
animals administered a low dose of C. burnetii by aerosol (group 3). In contrast, no 
antigen was detected in urine beyond 43 days post-infection suggesting that PCR 
and immunodetection were more sensitive. Immunodetection, however, requires 
tissue removal by biopsy, and is only suitable, therefore, in cases of chronic Q 
fever (Fournier et al., 1998). The detection and diagnosis of Q fever by PCR has 
been reported from clinical samples (Mallavia et al., 1990; Frazier et al., 1992; 
Willems et al., 1993; Fritz et al., 1995) and from cows milk (Willems et al., 1994) 
and provides a sensitive and specific technique for the diagnosis of Q fever 
(Fournier et at., 1998). However in this study, no C. burnetil DNA could be 
detected in any urine sample, and to date no references to the detection of C. 
burnetti DNA in human urine are present in the literature. This thesis concentrated 
on the immunological detection of C. burnetii-specific antigens in urine, as 
previous studies with L. pneumophila had proved promising (Lebrun et al., 1983; 
Williams, A. & Featherstone, 1988). In contrast, (Maiwald el al., 1995) described 
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the detection of L. pneumophila DNA in human and guinea pig urine and stated 
that PCR was more sensitive than ELISA for the diagnosis of lcgionellosis from 
urine samples. The development of a PCR urinary test in future studies may 
therefore prove useful as a more sensitive technique for the diagnosis of Q fever 
infection. 
Previously, it has been reported that whole C. burnetil has been detected in the 
urine of experimentally-infected mice (Kruszewska & Tylewska"Wierzbanowksa, 
1991) and in urine of humans suffering from Q fever (Burnet & Freeman, 1937; 
Derrick, 1937; Baca & Paretsky, 1983; Tylewska-Wierzbanowska & Kruszewska, 
1993). This study however, concentrated on the detection of C. burnelil specific 
antigens, and is the first to report the presence of such antigens in the urine of 
experimentally-infected animals. 
Characterisation of the antigen appearing in urine obtained from C. burnetii- 
infected guinea pigs (Chapter 4) discovered for the first time that urine from 
guinea pigs that received high dose C. burnetü by aerosol contained a C. burnetli- 
specific protein with an approximate molecular weight of 62 kDa. Evidence also 
suggested that LPS from C. burneüi was present in the urine from these guinea 
pigs. Urine, used to obtain these results, was taken from guinea pigs at day 9 post- 
infection (when the animals were severely diseased) to maximise the antigenic 
yield. Therefore, although the 62 kDa protein was present in urine from severely 
diseased animals, other antigens may be excreted in greater quantities during other 
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phases of the disease. Indeed, less antigen was detected in urine from guinea pigs 
infected with a low dose of C. burnetii by aerosol, and antigen that was detected 
in these animals was primarily of a low molecular weight. The detection of low 
molecular weight antigens, later on post-infection, may represent LPS molecules, 
as has been reported in various other diseases (Coonrod, 1983). Therefore, the 62 
kDa protein antigen may only be a marker for severe disease. Such a theory was 
supported by gel filtration experiments on urine obtained from guinea pigs infected 
by the intraperitoneal route in Chapter 5. Antigenic reactivity was confined to 
lower molecular weight fractions and the infection in these guinea pigs was less 
severe with no mortality. Therefore, in future studies on C. burnetii urinary 
antigen, an antibody directed against LPS may prove more specific and, therefore, 
possibly more sensitive. In addition, with a more specific and sensitive antibody, 
urines from human acute and chronic cases of Q fever could be investigated for the 
presence of C. burnetii-specific antigens. 
As well as providing a diagnostic test for suspected cases of Q fever, preliminary 
data presented in Chapter 5 indicated that detection of C. burnetil"specifc antigens 
in urine could provide a rapid and convenient method to monitor the efficacy of 
antibiotics against Q fever. This has not been attempted before for Q fever, 
although a similar approach has been described for Legionnaires' disease (Kashuba 
& Ballow, 1996) and for Schistosoma infections (Deedler et al., 1994). This 
technique may prove particularly useful for monitoring antibiotic efficacy in 
chronic cases of Q fever, where numerous treatment regimens may be tried, 
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treatment is often prolonged and in many cases ineffective (Raoult el al., 1989; 
Yeaman et al., 1989; Yeaman & Baca, 1990). 
Many suspected cases of C. burnetii infection encountered in a diagnostic 
laboratory are of chronic infection (G. Lloyd, personal communication). Most 
patients suffering from C. burnetil endocarditis, present with a low grade fever, 
intermittent fever or are afebrile. In addition, infectious foci are limited to discrete 
sites in the heart tissues and are not disseminated throughout the body (Raoult et 
al., 1990a). It would be expected, therefore, that lower or irregular levels of 
antigenic product would be excreted into the urine of individuals suffering from 
chronic Q fever than those suffering from acute C burnetil infection. These studies 
have conclusively proved that C. burnetil antigens appear in the urine during 
experimental Q fever infections, therefore, future studies should concentrate on the 
identification of such antigens in the urine of humans suffering from both acute and 
chronic Q fever. 
The future strategy for the clinical laboratory diagnosis of Q fever, could therefore 
incorporate urinary antigen detection as shown in Fig. 6.1. 
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Fig 6.1 The potential role of urinary antigen defection in the clinical 
laboratory diagnosis of Q fever 
Urine 
P('ll ELISA 
Shaded boxes denote the existing techniques used in the clinical laboratory 
diagnosis of C. burnetü infections. 
In conclusion the establishment and characterisation of a relevant experimental in 
vivo model of acute Q fever provided defined samples on which to base the 
development of a capture ELISA. Subsequent data obtained by the capture II. ISA 
proved that antigens of C. burneiii appeared in the urine (luring experimental acute 
Q fever and characterisation of' the antigens provided data on specific markers of' 
disease. The preliminary investigation of such markers in urine, to determine the 
efficacy of antibiotic treatment of experimental Q lever, proved of limited value. 
The detection of such markers in urine, however, could provide it method Iur the 
early and rapid diagnosis ol'Q ikvcr infections. 
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